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 Glycosylation is one of the most common post-translational modifications found 
in eukaryotes.  Glycan structural characterization is a difficult undertaking, because full 
characterization demands knowledge of saccharide linkage, branching, sequence, 
glycosylation location, heterogeneity, and occupancy.  Mass spectrometry, with its 
sensitivity and tandem mass spectrometric capabilities, is an extremely valuable tool in 
this endeavor.   
 In this thesis, the utility of gas-phase ion electron reactions, including electron 
capture dissociation (ECD) and electron detachment dissociation (EDD), for 
glycosylation structural characterization is explored.  Both ECD and EDD have been 
shown to be valuable techniques for the characterization of post-translationally modified 
peptides, including both phospho- and glycopeptides.  However, further applications of
 xvii
these techniques remain to be explored.  
 The combination of vibrational excitation (here infrared multiphoton dissociation 
(IRMPD)) and ion-electron based fragmentation (ECD) for de novo sequencing of a 
lectin with rare carbohydrate binding specificity is demonstrated.  Despite the 
disadvantages associated with IRMPD and ECD, when used in conjunction these 
techniques proved to be a powerful tool for sequencing purposes.  Over 75% of the 
protein was sequenced with the combination of vibrational excitation and ion-electron 
based fragmentation. 
 IRMPD and ECD are also utilized for the characterization of high-mannose type 
glycopeptides.  This category of glycopeptides had not been previously examined with 
these techniques.  IRMPD of high-mannose type glycopeptides is shown to often result in 
a mixture of glycan and peptide backbone cleavage, while ECD results in exclusively 
peptide cleavage (allowing for glycosylation localization). 
 Ion-electron based fragmentation for oligosaccharide structural characterization is 
investigated.  ECD of metal–adducted oligosaccharides is shown to result in 
complementary structural information compared to IRMPD, and provide more cross-ring 
fragmentation than ECD of protonated species.  Neutral and sialylated oligosaccharides 
are also examined with vibrational excitation and EDD.  EDD often results in more cross-
ring fragmentation compared to vibrational excitation, thus providing additional 
structural information. 
 Strategies for examining pancreatic cancer associated O-linked glycans are 
explored.  A protocol is developed for examining oligosaccharides in conditioned media 







 Since the introduction of electrospray ionization (ESI)1,2 and matrix-assisted laser 
desorption/ionization (MALDI),3,4 these “soft” ionization techniques have dramatically 
changed the field of mass spectrometry (MS).  ESI and MALDI allow for the ionization 
of large nonvolatile molecules, while yielding little or no fragmentation.  They are also 
applicable to a wide variety of biomacromolecules, ranging from peptides, proteins, 
oligonucleotides, oligosaccharides, polymers, to lipids.   Currently, ESI and MALDI are 
the most commonly used ionization techniques for biomolecules.   
 The unique ability of ESI and MALDI to generate gas-phase ions from proteins 
and peptides dramatically changed the field of protein analysis when they were 
introduced in the late 1980s.  Due to the sensitivity, resolution, and mass accuracy 
provided by mass spectrometry, along with the ability to generate protein and peptide 
ions from ESI and MALDI, mass spectrometry has become an essential tool in 
proteomics.  MS-based proteomics is made possible by the availability of gene and 
genome databases, which permit the identification of proteins by matching peptide 
masses from a proteolytic digest or peptide fragmentation data to proteins 
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represented in available databases.5-12  Peptide fragmentation is accomplished through 
tandem mass spectrometry (MS/MS or MSn) and provides primary structure information; 
MS/MS techniques are described in detail in Section 1.3.3.  In addition to protein 
identification and primary structure determination, mass spectrometry is also playing an 
increased role in characterizing protein higher order structure and non-covalent protein 
complexes, and also applications in imaging.13-15     
 One major challenge in proteomics is the characterization of post-translational 
modifications (PTMs).  The proteome is highly dependent on the physiological 
conditions encountered by the cell and is by no means a direct translation of gene 
sequences to protein sequences, but instead is highly complex and dynamic.  A protein 
often exists in several diverse states within a cell, largely due to different splice variants 
and post-translational modifications that can occur at multiple positions within the 
protein.  PTMs are chemical modifications to proteins including proteolytic cleavage, 
addition of a functional group, or the formation of inter- and intra-peptidic linkages 
(including disulfide bridges).16  PTMs on a protein may affect properties such as protein 
localization, stability, activity, turnover, and interactions with other proteins.17  Common 
PTMs include phosphorylation, acetylation, methylation, and glycosylation.  To date, 
over 300 varieties of PTMs are known and new ones are currently being discovered.18 
 Among PTMs, glycosylation is one of the most prevalent in eukaryotes, with a 
previous survey indicating that at least 50% of all proteins are glycosylated.19  
Glycoproteins have been found to play several key roles in biological systems including: 
cell-cell adhesion, cell-extra cellular membrane adhesion, folding and secretion, 
fertilization, glycoprotein targeting, and immune defense.20,21  Glycan expression is 
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affected by cellular conditions, and it has often been shown that glycan structures change 
with the onset of cancer and inflammation.  With cancer, glycosylation alterations may 
affect growth, differentiation, transformation, adhesion, metastasis, and immune 
surveillance of the tumor.22  For several forms of cancer, such as ovarian and prostate, 
specific changes in glycosylation profiles indicate their utility as diagnostic tools.23  
Based on these changes, it may be possible to utilize the immune system to target cells 
based on abnormal glycosylation patterns.  The development of glycan-based vaccines 
that target cancer-associated glycans is a rapidly developing field.    
 Unlike most other biomolecules, carbohydrate synthesis is not template-driven, an 
attribute which has encumbered biologists in their efforts to decipher the molecular 
details of carbohydrate synthesis and functionality.  The attachment and processing of 
carbohydrates in eukaryotes occurs through complex pathways within the ER and Golgi 
apparatus, and are carried out by glycosyltransferases and glycosidases.  The majority of 
glycosylation sites are found on plasma-membrane and secreted proteins, but simple 
glycosylated structures can also be observed on cytoplasmic and nucleoplasmic 
proteins.24  There are two key types of protein glycosylation, which involve either 
covalent attachment of an oligosaccharide through the oxygen in serine or threonine (O-
glycosylation) or through nitrogen in asparagine (N-glycosylation).  With N-
glycosylation, a common pentasaccharide core is attached to Asn in the consensus 
sequence Asn-X-Ser/Thr, where X may be any amino acid except Pro.  There is no 
consensus sequence or single common saccharide core region for O-glycosylation, 
however the majority of eukaryotic O-linked glycans contain N-acetylgalactosamine 
(GalNAc) linked to serine or threonine.  There are three categories of N-linked glycans, 
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which are defined by the saccharides attached to the common pentasaccharide core (see 
Figure 1.1).  High-mannose glycans only contain mannose saccharides attached to the 
common core.  With hybrid type structures, N-acetylglucosamine is attached to one core 
mannose saccharide.  Both core mannose saccharides are linked to N-acetylglucosamines 
in the case of complex N-glycans.  Complex N-glycans are the most common glycan type 
found in vertebrates.20  Figure 1.1 illustrates representative structures of N-glycans, 
common O-glycan cores, and saccharide chemical structures.  
 
Figure 1.1. Representative N-glycans and common O-glycan cores.  The common 
pentasaccharide N-linked core is indicated with dashed lines.  The saccharides which are 
attached to this core define whether the glycan is high-mannose, hybrid, or complex type.  
The majority of O-linked structures have N-acetylgalactosamine linked to serine or 
threonine.   
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 Carbohydrates, or glycans, are unlike linear biomolecules such as DNA, RNA, 
and proteins in that they can form complicated highly branched structures, containing 
multiple antennae, where saccharide units may be connected to each other through a 
variety of linkage types.  The number of antennae for N-linked glycans typically ranges 
from two (biantennary) to four (tetraantennary),21 whereas O-linked glycans tend to be 
less branched.  Several different enzymatic reactions, as carried out by 
glycosyltransferases and glycosidases, are responsible for forming the carbohydrate 
portion of glycoproteins.  These enzymatic reactions may not go to completion, which 
results in a wide array of glycoprotein forms (glycoforms).  Consequently, glycosylation 
sites within a protein may not be fully occupied and may contain a wide range of glycans 
at an individual site.  Due to their vast complexity, the determination of glycan profiles 
and glycan structures is a difficult undertaking, and no single technique is capable of 
providing a complete profile.  Complete glycan structural characterization demands 
knowledge of saccharide linkage, branching, sequence, glycosylation location, 
heterogeneity, and occupancy.25 
  A plethora of techniques have been utilized for glycosylation characterization, 
and are discussed in Section 1.2.  Mass spectrometry, often in combination with 
separation methodologies, is one of the most versatile techniques for characterizing 
glycans and glycoproteins due to its sensitivity and low sample consumption.  Tandem 
mass spectrometry in particular, has proven to be a valuable tool for glycoprotein analysis 
and the characterization of glycopeptide and saccharide structures.26,27  Fourier transform 
ion cyclotron resonance mass spectrometry (FT-ICR MS), with its ultrahigh resolution 
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and mass accuracy is an especially powerful tool for glycosylation characterization.  FT-
ICR mass spectrometry is discussed in Section 1.3. 
1.2 Current Methods for Glycosylation Characterization 
 As previously discussed, complete glycosylation characterization demands 
knowledge of saccharide linkage, branching, sequence, glycosylation location, 
heterogeneity, and occupancy.  There are three main approaches for glycosylation 
characterization.  One is to analyze the intact glycoprotein, following glycoprotein 
purification.  Another common approach is investigation at the glycopeptide level, after 
enzymatic digestion of the intact glycoprotein.  Alternatively, glycans can be removed 
from the protein and both species characterized separately.   
 The first step towards glycoprotein characterization is the initial isolation of the 
glycoprotein of interest.  Glycoproteins may be found as either soluble or membrane-
bound molecules, and thus isolation strategies will differ depending on where the protein 
is located in the cell.  Both electrophoretic separations in gels and liquid chromatographic 
separations are commonly used for glycoprotein isolation.  Liquid chromatographic 
separations include ion exchange, size exclusion, partition, hydrophobic interaction, dye 
ligand, and affinity chromatography.28  Lectin affinity chromatography is an especially 
powerful technique.  A wide variety of lectins from plant and animal sources, with 
different binding specificities, are now available. In addition, capillary electrophoresis 
has been reported in several instances for the separation of glycoprotein isoforms as well 
as glycopeptides, and oligosaccharides.25,29   
 To some extent, conventional MALDI-TOF-MS and ESI-MS are capable of 
characterizing intact glycoproteins.25,28,30  Glycoproteins can often be resolved to their 
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individual glycoforms depending on the molecular weight and extent of glycosylation.  
Typically, intact glycoprotein analysis with mass spectrometry has been limited to 
smaller glycoproteins, less than 40 kDa.28  In addition to mass spectrometry, X-ray 
crystallography is another powerful tool for whole protein structural analysis.  However, 
X-ray crystallography is not usually amenable to glycoprotein characterization, because 
part or all of the glycan portion is not observed in the high-resolution electron density 
map.  This is often due to glycan structure heterogeneity and the flexibility of the 
attached saccharides. 
 To determine glycosylation locations and heterogeneity, investigation of protein 
glycosylation at the glycopeptide level is another general approach.  It is often difficult to 
detect glycopeptides in a complex protein digestion by mass spectrometry, partly due to 
the low sensitivity of detection of glycopeptides due to glycan heterogeneity.  Also, 
acidic glycans may result in glycopeptide signal suppression, since positive ion mode 
mass spectrometry is typically used in proteomic applications.  For these reasons, it is 
often necessary to separate glycopeptide and peptide mixtures with liquid 
chromatography prior to mass spectrometric analysis.  A variety of strategies have also 
been reported for glycopeptide enrichment, and often rely upon lectin affinity 
chromatography.  Alternatively, NMR spectroscopy has been utilized for glycopeptide 
characterization.31  NMR analysis of glycopeptides is more difficult compared to NMR of 
oligosaccharides, and generally leads to less precise structural interpretation.32  
 A final strategy for glycosylation characterization is the chemical or enzymatic 
removal of glycans from the protein, and subsequent analysis of the glycan mixture.  A 
disadvantage of this technique is that information regarding glycosylation location and 
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heterogeneity is lost.  Chemically, both N- and O-linked glycans can be released from 
glycoproteins with hydrazine.  There are several disadvantages to this procedure, 
including cleavage of peptide bonds and subsequent destruction of the protein, hydrolysis 
of saccharide acyl groups (requiring a reacetylation step), and incomplete removal of 
intermediates from the reducing terminus of the released glycans.30  O-linked glycans are 
also frequently removed via β-elimination.  A disadvantage of β-elimination is that the 
reducing terminus of the oligosaccharide is reduced, which typically prevents subsequent 
labeling (which may be needed for the attachment of a chromophore or other tag).  N-
linked glycans can also be released enzymatically, with several glycosidases 
commercially available.  Unfortunately, no reliable enzymes are available for the 
enzymatic release of O-linked glycans.   
 Following glycan release, chromatographic and sometimes electromigration 
techniques may be utilized for distinguishing isomeric glycan structures (a feat which is 
difficult with MS).  In particular, high-performance anion-exchange chromatography 
with pulsed-amperometric detection is an extremely powerful technique for 
oligosaccharide analysis, due to its separation of anomeric, structural, linkage and branch 
isomers.  However, this form of chromatography is not easily coupled to MS due to its 
high salt requirements.  Hydrophilic-interaction chromatography, reverse-phase 
chromatography, and graphitized carbon chromatography are also commonly used for 
glycan separation and are much more compatible with MS.  With these forms of 
chromatography, derivatization of the glycan is often implemented in order to improve 
detection with the attachment of a chromophore.  This derivatization often improves 
separation with reverse-phase LC.  In addition to mass spectrometry, nuclear magnetic 
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resonance (NMR) spectroscopy is a customary technique for oligosaccharide structural 
characterization.32  NMR provides unambiguous structural assignments, which is difficult 
with mass spectrometry.  However, a chief disadvantage of NMR compared to mass 
spectrometry is sensitivity, which often makes NMR an unsuitable technique for 
oligosaccharide analysis in proteomic-type applications. 
1.3 Fourier Transform Ion Cyclotron Resonance Mass Spectrometry 
1.3.1 Overview 
 Fourier transform ion cyclotron resonance mass spectrometry was first introduced 
by Comisarow and Marshall in 1974.33  There are several advantages for using FT-ICR 
MS for biomolecular structural characterization, including the capability of providing 
extremely high mass accuracy, on the order of low to sub-ppm levels.  Another advantage 
offered by FT-ICR MS is its tremendous resolving power: For large biomolecules, 
resolving power in excess of 106 has been obtained.  This high performance is partly due 
to the numerous cycles of cyclotron motion in the analyzer cell (resulting in long-lasting 
signal), and because cyclotron frequency is not affected by a spread in kinetic energy.  
Unit mass resolution, which allows for the determination of the charge state of a 
molecule, based upon the m/z spacing between isotopic peaks, has been achieved for 
proteins as large as 112 kDa with FT-ICR MS.34    
 There are several key features common to all FT-ICR instruments, including an 
ionization source, ultrahigh vacuum system, magnet, analyzer cell (ICR cell), and data 
acquisition system.35  The most commonly used ionization technique combined with FT-
ICR MS for biomolecule analysis is ESI.36,37  One characteristic of ESI is its ability to 
generate multiply-charged ions, which is beneficial because FT-ICR MS resolving power 
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decreases linearly with increasing m/z.38  Furthermore, mass resolving power, mass 
accuracy, and limits of detection are also enhanced in the low m/z region.  Contrary to 
ESI, MALDI typically produces singly-charged ions, resulting in larger m/z values.  
MALDI can also be coupled to FT-ICR MS, and constitutes a powerful technique for the 
characterization of moderate size biomolecules (< 3-5 kDa).39-45  An ultrahigh vacuum 
system is necessary in an FT-ICR mass spectrometer because ion detection needs to 
occur in a low pressure environment, typically in the region of 10-9 – 10-10 Torr.35,38  
Superconducting magnets of 3 to 15 Tesla are typically utilized in FT-ICR mass 
spectrometers.  Increasing magnetic field strength offers several improved parameters, 
including mass resolving power, upper mass limit, mass accuracy, and signal-to-noise 
ratio.46  Ion motion within the ICR cell, which is located within the magnet, is the 
governing principle behind FT-ICR MS and will be discussed shortly in the next section.   
1.3.2 Operating Principles 
 Under the influence of a spatially homogenous magnetic field, B = -B0z where B0 
is magnetic field strength, an ion experiences a force that is perpendicular to both the 
direction of its velocity and the magnetic field: 
F = mass●acceleration = qv x B    1-1 
where q is charge and v is velocity.  This force, called the Lorentz force, bends ions into a 
circular orbit which is perpendicular to the magnetic field axis.  If vxy denotes ion velocity 
in the xy plane (perpendicular to the magnetic field axis) and because angular 







xy =      1-2 
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Here, m is ionic mass and r is the radius of the circular orbit.  If these ions do not change 
speed (no collisions), equation 1-2 can be re-written as the basic cyclotron equation: 
m
qB0=ω  (S.I. units)      1-3 
where ω is angular velocity.  By dividing equation 1-3 by 2π, an ion’s cyclotron 
frequency, v (in Hz), can be determined.  The unique feature of an ion’s cyclotron 
frequency is that it is independent of ion velocity and kinetic energy, eliminating the need 
for “focusing” ions which is often necessary in other types of mass spectrometers.35,38 
 The magnetic field in an FT-ICR instrument traps ions radially in the ICR cell, 
but does not prevent them from leaving the cell along the axial direction.  Trapping plates 
are mounted perpendicular to the magnetic field with an applied potential.  This 
configuration creates a potential well in the analyzer cell, causing ions to oscillate 
between the two endplates.   
 The initial ion cyclotron radius in the ICR cell is small (<1 mm) compared to the 
analyzer cell dimensions (on the order of 10 cm).  Ion excitation is necessary in order to 
accelerate ions to a larger detectable cyclotron radius.  Such acceleration is accomplished 
by applying differential rf voltages to a pair of opposing excitation plates in the analyzer 
cell (shown in Figure 1.2).  Those ions which are in resonance with the frequencies of the 
applied rf voltage gain kinetic energy and spiral outwards to a larger cyclotron radius.  
Ions are excited coherently as a tight packet, commonly referred to as an ion cloud.  The 
orbiting ion cloud induces an alternating current on the two opposing detection plates, 
which have parallel resistance and capacitance components and connects to a detection 
preamplifier.38  The image current is measured as a time-domain signal and is composed 
of all the frequencies of the ion clouds in the analyzer cell.  By applying a Fourier 
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transform to the time domain signal, the frequency components of the signal can be 
determined.  The inherent advantages of ion detection in an FT- ICR MS are that it is 
non-destructive and a wide range of m/z ratios can be detected simultaneously.   
 
Figure 1.2. Ion excitation and detection in an ICR analyzer cell.  A sinusoidal voltage is 
applied to a pair of opposing excitation plates.  Ions in resonance with the applied 
frequencies spiral outwards to a larger cyclotron radius.  An image current is induced in 
an opposing pair of detection plates, which are connected to an amplifier.   
 
1.3.3 Tandem Mass Spectrometry  
 There are a wide variety of fragmentation techniques available in FT-ICR MS.  
These include sustained off-resonance irradiation collision activated dissociation (SORI-
CAD),47 infrared multiphoton dissociation (IRMPD),48,49 blackbody infrared radiative 
dissociation (BIRD),50,51 surface induced dissociation (SID),52-54 electron capture 
dissociation (ECD),55 and electron detachment dissociation (EDD).56  CAD is the most 
common ion activation method in modern day mass spectrometers.57-60  Beam-type CAD 
can be achieved with hybrid FT-ICR mass spectrometers, such as the one used in this 
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work.  Fragmentation techniques used in this dissertation include CAD, IRMPD, ECD, 




















Figure 1.3. A summary of the fragmentation techniques used throughout this dissertation.  
CAD and IRMPD are vibrational excitation based fragmentation techniques, while ECD 
and EDD are electron based.  “M” indicates the precursor ion.  For vibrational excitation 
techniques, “n” can be any value and both cations and anions may be examined.  For both 
ECD and EDD, “n” must be greater than two because electron capture and electron 
detachment will result in charge reduction of the precursor ion.  Charge reduced radical 
species will undergo further fragmentation. 
 
Vibrational Excitation Based Fragmentation. CAD, SORI-CAD, IRMPD, and BIRD 
can be categorized as vibrational excitation based fragmentation techniques.  
Fragmentation products from these “slow-heating” techniques  form by the lowest energy 
pathways.61  For peptides, this slow internal temperature increase results in preferential 
C-N bond cleavage, producing b- and y-type ions (see Figure 1.4).62  The mobile proton 
model is the generally accepted mechanism describing peptide backbone cleavage.57,63  
For modified peptides, the application of vibrational excitation based fragmentation 
Vibrational excitation based fragmentation
● Collision Activated Dissociation (CAD): inelastic collisions with 
neutral gas molecules
● Infrared Multiphoton Dissociation (IRMPD): absorption of photons 
from an IR laser
Electron based fragmentation
● Electron Capture Dissociation (ECD): capture of low energy 
electrons (<1 eV) by polycationic species
● Electron Detachment Dissociation (EDD): irradiation of polyanionic















techniques generally results in cleavage of the modification, such as glycosylation.  
Vibrational excitation techniques (typically CAD and IRMPD) are also frequently 
utilized for the structural characterization of oligosaccharides, and may result in several 
product ion types as illustrated in Figure 1.5.  There are two types of cleavages observed 
for oligosaccharides; glycosidic cleavages correspond to cleavages between saccharide 
residues (B, C, Y, and Z-type ions) whereas cross-ring cleavages occur across the 
saccharide ring (A and X-type ions). 
 
Figure 1.4. Peptide cleavages observed following vibrational excitation (CAD and 
IRMPD) and electron-based fragmentation techniques (ECD and EDD).  Vibrational 
excitation results in preferential cleavage of the peptide C-N bond, yielding b and y-type 
ions.  ECD of multiply charged peptide cations results in preferential cleavage of the N-
Cα bond, yielding c and radical z-type ions.  EDD of multiply charged peptide anions 
results in preferential cleavage of the Cα-C bond, yielding radial a and x type ions. 
 
 During CAD, ions are activated through inelastic collisions with neutral gas 
molecules, which results in a conversion of translational energy into internal energy (see 
Figure 1.3).  Internal energy is redistributed throughout the ion, and if it exceeds its 
threshold energy dissociation occurs.  SORI-CAD is similar to CAD, except during the 
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fragmentation process an excitation frequency is applied which is slightly off-resonance 
from the precursor ion’s cyclotron frequency, resulting in an alternating increase and 
decrease in ion cyclotron radius as ions collide with inert gas molecules pulsed into the 
analyzer cell.64,65  Another commonly used vibrational excitation technique is IRMPD, 
which also results in preferential C-N bond cleavage.  IRMPD requires the absorption of 
an extensive number of IR photons before dissociation occurs (Figure 1.3).  Typically, 
10.6 μm CO2 lasers are used for IRMPD.  BIRD is a less commonly used fragmentation 
technique, and is rarely applied in proteomic applications with FT-ICR MS. 
 
Figure 1.5. Oligosaccharide fragmentation nomenclature.66  Glycosidic cleavages occur 
between saccharides (B, C, Y, and Z ions) while cross-ring cleavages are due to the 
cleavage of two bonds (A and X ions) 
 
Electron Based Fragmentation. Electron capture dissociation and electron detachment 
dissociation are relatively recent ion activation techniques, and rely upon ion-electron 
reactions to induce fragmentation.  The application of ion-electron reactions to 
biomolecules typically results in different fragmentation patterns compared to vibrational 




















Electron capture and detachment triggers gas-phase radical ion chemistry, however the 
precise mechanisms of these ion-electron reactions have yet to be fully elucidated, and 
are still widely debated.56,67-74       
 ECD was first applied in 1998 by Zubarev and co-workers for the dissociation of 
multiply charged protein cations.55,75-77  This technique is based upon the dissociative 
recombination of polycationic molecules with low-energy electrons, typically less than 1 
eV (see Figure 1.3).  Unlike traditional fragmentation techniques, which generally cleave 
the peptide amide bond to yield b and y fragments, ECD is dominated by N-Cα bond 
cleavage yielding predominantly c and radical z-type ions (see Figure 1.4).77  ECD 
cleavage tends to be more random than vibrational excitation techniques, and more 
extensive sequence coverage is usually achieved for peptides and proteins.  When applied 
to modified peptides, ECD tends to result in extensive backbone cleavage without the 
loss of modifications, such as phosphorylation78,79 and glycosylation.80-83  The 
combination of vibrational excitation and ECD thus provides complementary structural 
information for modified peptides.  
 Electron detachment dissociation was introduced in 2001 as a fragmentation 
technique for polyanions.56  In EDD, polyanions are irradiated with >10 eV electrons, 
resulting in electron detachment and subsequent product ions (see Figure 1.3).  EDD of 
peptides yields predominantly radical a ions and x ions due to Cα-C bond cleavage (see 
Figure 1.4).  Fragment ions generated by EDD have been shown to retain modifications 
such as sulfation and phosphorylation, which indicates that EDD also shows the potential 
for peptide sequencing and for mapping PTMs.56,84,85   
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 Conversely, one chief disadvantage of ECD and EDD compared to other ion 
activation techniques is that fragmentation efficiency is relatively low, with typically less 
than 30% of precursor ions being converted to product ions.86  As a consequence, a high 
signal-to-noise (S/N) ratio is required for precursor ions.  In addition, ECD and EDD are 
difficult to implement in mass spectrometers other than FT-ICR instruments because of 
the trapping requirements; ions and electrons must be trapped simultaneously for 
dissociation to occur.  Despite these disadvantages, the applications of ECD and EDD for 
biomolecular structural characterization are steadily increasing.  In addition to PTM 
characterization, ECD has been utilized for de novo sequencing of peptides,87 top-down 
protein analysis,88,89 characterizing protein-ligand non-covalent interactions,90 and 
oligosaccharide structural characterization.91  EDD has also been applied to 
oligonucleotides,92,93 gangliosides,94 and glycosaminoglycans (GAGs).95,96  
1.3.4. Experimental Setup 
 A schematic diagram of the 7T ESI quadrupole-FT-ICR mass spectrometer 
(Bruker Daltonics, Billerica, MA) used in this work is shown in Figure 1.6. The 
instrument is equipped with either a regular or nano-electrospray ion source, and a dual 
ion funnel inlet.  The ion funnels consist of a series of ring electrodes with applied rf and 
dc electric potentials.  Smith et. al. first introduced an ESI ion funnel in 1998 as a means 
to more effectively focus and transmit ions from regions of higher pressure to lower 
pressure.97  Our instrument is also equipped with two hexapoles for external ion 
accumulation of electrosprayed ions.98  The quadrupole and second hexapole allow for 
mass-selective ion accumulation in addition to external CAD.  The dynamic range and 
sensitivity of an FT-ICR mass spectrometer is generally enhanced when external ion 
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selection is utilized prior to ion accumulation in the ICR cell.99  Furthermore, ESI is a 
continuous ion source, whereas FT-ICR MS is a pulsed detector.  External ion 
accumulation is utilized to keep the duty cycle high.  To transport ions into the ICR cell 
and overcome the magnetic mirror effect, the instrument contains a series of ion transfer 
optics.  The ICR cell in this instrument is cylindrical, which is a relatively common 
geometry.  Located behind the ICR cell is a hollow cathode (HeatWave, Watsonville, 
CA) and 10.6 μm CO2 laser (Synrad, Mukilteo, WA), which are used to fragment ions by 
ECD, EDD, and IRMPD.   
 
Figure 1.6. A schematic diagram of a 7 T Q-FT-ICR mass spectrometer used throughout 
this work.  This instrument is equipped with an electrospray source, dual ion funnels, a 
quadrupole for mass selective accumulation, hexapole for external CAD, hollow cathode 
for gas phase ion-electron reactions, and a 10.6 μm CO2 laser for IRMPD. 
 
1.4. Dissertation Overview 
 The research presented in this dissertation focuses on the utilization of ion-
electron based fragmentation techniques and vibrational excitation for glycosylation 
characterization with an FT-ICR mass spectrometer.  As discussed in Section 1.3.3, both 
ECD and EDD have shown utility for the characterization of post-translationally 
modified peptides, including both phosphorylation and glycosylation.  However, further 
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utility of ion-electron reactions are investigated for de novo sequencing of a carbohydrate 
binding protein (Chapter 2), characterization of high-mannose type glycopeptides 
(Chapter 3), and the structural characterization of oligosaccharides (Chapters 4 and 5).  
Chapter 6 focuses on strategies for the analysis of pancreatic cancer associated O-linked 
glycans.   
 Chapter 2 explores the combination of vibrational excitation and ECD for de novo 
sequencing of a lectin from the mushroom species Lyophyllum decastes.  This work was 
a collaborative project with Professor Irwin Goldstein in the Department of Biological 
Chemistry at the University of Michigan  The combination of ECD and vibrational 
excitation has previously been shown to be an attractive tool for de novo sequencing of 
proteins.87,100  However, unlike previous efforts which have utilized the combination of 
ECD and CAD for sequencing purposes, the genome of this organism has not been 
sequenced.  At the time this work was conducted, the combination of ECD and IRMPD 
(or CAD) had not been employed previously to de novo sequence an entire protein.     
 Chapter 3 explores the application of IRMPD and ECD for the structural 
characterization of high-mannose type glycopeptides.  While ECD had been applied to 
the structural analysis of xylose type83,101 and complex type82 N-glycopeptides and O-
glycosylated peptides,80,82 it had not been applied towards the characterization of high-
mannose type N-glycopeptides.  Similarly, neither had the utility of IRMPD for the 
structural characterization of such glycopeptides been explored.  This work has been 
published in the Journal of Proteome Research (2006, volume 5, page 493). 
 Chapter 4 describes the combination of metal adduction and ECD for 
oligosaccharide structural analysis.  ECD had been previously applied to protonated 
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chitooligosaccharides, and yielded primarily glycosidic cleavages (similar to vibrational 
excitation).91  Is has been previously shown that oligosaccharides ionized with alkali, 
alkaline earth, and transition metals often fragment to yield more cross-ring cleavages 
compared to their protonated counterparts with CAD and IRMPD.  ECD fragmentation 
patterns of oligosaccharides ionized with various cationizing agents were examined, to 
determine whether the combination of ECD and metal ion adduction is a viable analytical 
tool for oligosaccharide structural characterization.  Following ECD and IRMPD, 
fragmentation patterns were compared to determine whether ECD provides 
complementary information.  This work has been published in Analytical Chemistry 
(2007, volume 79, page 2901).  
 Chapter 5 focuses on the combination of EDD and vibrational excitation for the 
analysis of neutral and sialylated oligosaccharides.  EDD has, to our knowledge, not 
previously been applied to a wide variety of oligosaccharides, including neutral and 
sialylated glycans, as well as branched oligosaccharides.  In Chapter 5, the fragmentation 
patterns of neutral and sialylated oligosaccharides following EDD are examined and 
compared to those obtained from IRMPD and CAD.  This work has been published in the 
Journal of the American Society for Mass Spectrometry (2007, volume 18, page 2162).      
 Chapter 6 explores strategies for the analysis of pancreatic cancer associated O-
linked glycans.  This work was a collaborative project with Professor Diane Simeone in 
the Department of Surgery at the University of Michigan.  This project focuses on the 
investigation of O-glycans from glycoproteins shed into growth media by pancreatic 
cancer cells.  Lebrilla and co-workers presented a similar approach for ovarian cancer cell 
lines with a MALDI FT-ICR mass spectrometer.102  However, ESI has a lower tolerance 
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to salt contaminants and glycan ionization is not as efficient compared to MALDI.  
Chapter 6 investigates various approaches for sample preparation with a model 
glycoprotein, fetuin.  A protocol was designed and applied for the examination of 
oligosaccharides from various cell lines.   
 In addition, a summary of all results in this dissertation are presented in Chapter 
7, along with future directions.  The appendix includes data of glycopeptide anion 
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De Novo Sequencing of a Mushroom Lectin by Combined Infrared 
Multiphoton Dissociation and Electron Capture Dissociation 
 
2.1 Introduction 
 Mass spectrometry is a vital tool in proteomic analysis for the characterization of 
peptides and proteins.1-3  It can be used to identify unknown proteins by matching peptide 
masses from a proteolytic digest or peptide fragmentation data to proteins represented in 
a genomic database.4-11  However, there are several factors which complicate this 
approach, including modifications after transcription (such as alternative splicing), post-
translational modifications, unknown mutations, and sequence errors in the database.  
This method also fails if the genome of the organism from which the protein is derived 
has not been sequenced.  In such cases, protein de novo sequencing becomes necessary. 
 Protein de novo sequencing aims to reconstruct a protein sequence exclusively 
using fragmentation data from peptide (bottom-up approach) or intact protein (top-down 
approach) tandem mass spectra (MS/MS spectra).  One of the most commonly used 
techniques for peptide fragmentation is collision activated dissociation (CAD).12-14  CAD 
is a vibrational excitation fragmentation technique that results in preferential C-N bond 
cleavage of peptides, producing b- and y-type ions (see Scheme 1).15  Another commonly
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 used vibrational excitation technique is infrared multiphoton dissociation (IRMPD),16,17 
which also results in preferential C-N bond cleavage.  Vibrational excitation of peptide 
cations shows a strong preference for cleavage on the N-terminal side of proline and also 
 
Scheme 2.1.  a) Peptide fragmentation nomenclature.  IRMPD preferentially cleaves C-N 
bonds, resulting in b and y-type ions whereas ECD preferentially cleaves N-Cα bonds, 
resulting in c and radical z-type ions.  Characteristic differences in masses between b and 
c-type, and y and z-type ions (the “golden complementary pair” rules) help distinguish N-
terminal from C-terminal product ions.  N- and C-terminal amino acids are assigned 
based upon characteristic mass differences between the precursor ion mass and a product 
ion mass corresponding to cleavage adjacent to the N- or C- terminus.  For example, a c-
type cleavage would appear as the loss of the C-terminal amino acid and an additional 
0.984 Da.  Potential c-type cleavages adjacent to the C-terminus are indicated with 
quotation marks around amino acid assignments.   b) An example of how “golden pairs” 
can be utilized for de novo sequencing.  Here, the combination of IRMPD and ECD and 
the appearance of two “golden pairs” sequences this peptide as GAKSK. 
 
the C-terminal side of aspartic acid.18,19  Due to preferential cleavage sites, a major 
difficulty facing de novo sequencing with CAD or IRMPD is incomplete backbone 
fragmentation, i.e., lack of cleavage between all amino acid residues.  Furthermore, 
vibrational excitation of peptides often results in multiple fragmentation sites, generating 
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product ions which do not necessarily contain the N- or C- terminus of the peptide.  Such 
fragments often complicate mass spectral interpretation.  Although several peptide 
derivatization techniques have been developed in order to improve mass spectral 
quality,20 a disadvantage is that they generally increase sample requirements.  Due to 
several drawbacks associated with vibrational excitation based fragmentation, a technique 
which provides complementary sequence information is desired for de novo sequencing 
of proteins. 
 Electron capture dissociation (ECD) was introduced in 1998 as a tandem mass 
spectrometric fragmentation technique for peptide polycations.21  ECD is based upon the 
dissociative recombination of protonated polypeptide molecules with low-energy 
electrons (<0.2 eV).21-24  This technique has been shown to be complementary to 
vibrational excitation and a valuable tool for proteomic applications.  Unlike CAD or 
IRMPD, ECD shows preferential cleavage of N-Cα bonds, resulting in c- and radical z•-
type product ions (see Scheme 1).21  ECD has also been shown to retain labile 
modifications such as glycosylation and phosphorylation and shows preferential cleavage 
of disulfide bonds.22,23  Unlike vibrational excitation techniques, cleavage on the N-
terminal side of proline is generally absent following ECD due to the cyclic structure of 
proline.  ECD data can be utilized for determining whether ions observed from 
vibrational excitation are b or y- type ions, based on characteristic mass differences 
between b and c, and y and radical z type ions (see Scheme 1), so called “golden pairs”.25  
A recent comprehensive study on 15,000 pairs of ECD and CAD mass spectra showed 
that the cleavage sites in ECD and CAD are truly complementary,26 attesting that the 
combination of ECD and vibrational excitation is a powerful tool for peptide 
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characterization.  However, one disadvantage of ECD is its lower fragmentation 
efficiency compared to vibrational excitation.27,28  In addition, product ions observed 
from ECD can lose or gain an additional hydrogen, which can complicate spectral 
interpretation.29,30   However, the complementary information that ECD provides makes 
it an attractive method to be used in conjunction with vibrational excitation for de novo 
sequencing.  Recently, Savitski et al. developed a de novo sequencing algorithm, which 
uses the combination of ECD and CAD fragmentation.  They demonstrated a proteomics-
grade de novo sequencing approach which had the same level of efficiency and reliability 
as conventional database-identification strategies, but which alleviated the problems 
associated with using only CAD for sequencing.31  In order to achieve this advantage, 
high mass accuracy measurements from a Fourier transform or similar performing 
instrument are required.  In a recent bottom-up effort, combined ECD and CAD in a 
hybrid linear ion trap-Fourier transform ion cyclotron resonance (FT-ICR) mass 
spectrometer were utilized to de novo sequence cytochrome c4 from the organism 
Thiocapsa roseopersicina whose genome has not yet been sequenced.32  However, in that 
work, golden pair product ions were not utilized and hydrogen rearrangement, which 
frequently occurs in ECD, was not discussed.29,30 Also, because a gene sequence is 
unavailable, it is difficult to evaluate potential protein sequence errors although the 
authors mention, e.g., oxidation and deamidation during sample handling.    
 The high mass accuracy and combined ECD/IRMPD capabilities of an FT-ICR 
mass spectrometer are utilized here for de novo sequencing of a 10 kDa lectin from the 
mushroom Lyophyllum decastes.  This protein is a recently discovered α-galactosyl 
binding lectin from this organism.33  Relatively few lectins with α-galactosyl specificity 
 30
have been described but such proteins constitute valuable reagents for glycobiological 
experiments.  The genome of L. decastes has not been sequenced.  Our goal was to utilize 
the combination of ECD and IRMPD to re-construct the amino acid sequence of the L. 
decastes lectin.  To our knowledge, the combination of ECD and IRMPD has not been 
employed previously to de novo sequence an unknown protein.  In addition to the amino 
acid sequence, the molecular weight and disulfide bond content of this protein were also 
examined.  Furthermore, we compare the MS-derived sequence with that obtained from 
concurrent biochemical experiments, including Edman sequencing and, ultimately, 
cloning and gene sequencing.  Challenges of MS-based analysis are also discussed. 
 
2.2 Experimental 
2.2.1 Sample Preparation 
 Lectin isolation and purification were performed as previously described.33  
Samples (1-2 mg) of a lectin fraction from melibiose-sepharose affinity chromatography 
were dialyzed against distilled water and lyophilized prior to mass spectrometric analysis. 
Automated Edman sequencing and matrix-assisted laser desorption/ionization time-of-
flight (MALDI-TOF) mass analysis were performed by the Protein Structure Facility at 
the University of Michigan.  Reverse transcription polymerase chain reaction (RT-PCR) 
was performed from mRNA with oligonucleotide primers based on peptide sequences 
determined by Edman sequencing that allowed for the lowest amount of degeneracy.  3’ 
rapid amplification of cDNA ends (RACE) was employed to obtain the protein sequence 
located 3’ to the amino acids sequenced by RT-PCR.  Details of RNA isolation and 
cDNA synthesis have been previously described.33   
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 For disulfide bond determination, 0.25 nmoles of protein was treated with 10 mM 
dithiothreitol for 15 minutes at 100°C, diluted to 2 μM in 50% acetonitrile/water with 
0.1% formic acid, and immediately analyzed by FT-ICR mass spectrometry.  A 1 μM 
solution of untreated protein was also examined.  The monoisotopic mass of the protein 
was determined from the 8+ and 7+ charge states, using external calibration with 
reference masses from Hewlett-Packard ESI-MS tuning mixture (part number G2421A).  
Average molecular weights were determined with MIDAS HD Helper.34  Lectin peptides 
for MS/MS analysis were generated with a variety of endoproteases, including trypsin 
(Promega, Madison, WI), chymotrypsin (Sigma, St. Louis, MI), and GluC (Roche, 
Indianapolis, IN).  Between 0.125 - 1 nmoles of protein was reduced in 10 mM 
dithiothreitol (Sigma) at 95-100°C for approximately 15 minutes.  Samples were next 
treated with 45 mM iodoacetamide (Sigma) at room temperature in darkness for 
approximately 45 minutes.  Ammonium bicarbonate (Fisher, Fair Lawn, NJ) was added 
to all digestion solutions, to a final concentration of 50 mM.  Chymotrypsin samples also 
had 10 mM CaCl2 (Sigma) present.   The enzyme:protein ratio was between 1:30-1:50 for 
overnight digestions.  For a short trypsin digestion, the protein was digested for 15 
minutes at an enzyme:protein ratio of 1:50.  For a short chymotrypsin digestion, the 
protein was digested for 2 hours at an enzyme:protein ratio of 1:15.  All samples were 
desalted with either C18 ziptips (Millipore, Billerica, MA) or PepClean C-18 spin 
columns (Pierce, Rockford, IL).  After desalting, overnight digestion samples were 
diluted into a solution of 50% acetonitrile (Fisher)/water with 0.1% formic acid (Acros 
Organics, Morris Plains, NJ) to a final concentration of 5-6 μM prior to mass 
spectrometric analysis.  Short digestion samples were diluted to a concentration of 1 μM. 
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2.2.2 FT-ICR Mass Spectrometry 
 All experiments were performed with an actively shielded 7 T FT-ICR mass 
spectrometer with a quadrupole front-end (APEX-Q, Bruker Daltonics), as previously 
described.35  Samples were electrosprayed via either an Apollo electrospray ionization 
(ESI) source at 60 μL/hour, or with a static nanoelectrospray source using PicoTip 
GlassTips (New Objective, Woburn, MA).  Following a brief (0.05 ms) ion accumulation 
in the first hexapole, ions were mass selectively accumulated in the second hexapole for 2 
- 4 s.  Ions were then transferred through high-voltage ion optics and captured with 
dynamic trapping in an Infinity ICR cell.36  Only ions with at least two charges were 
further examined with IRMPD and ECD.  Precursor ions were further isolated in the ICR 
cell by correlated harmonic excitation fields (CHEF).37  IRMPD was performed with a 
vertically mounted 25-W, 10.6-μm, CO2 laser (Synrad, Mukilteo, WA).  An indirectly 
heated hollow dispenser cathode (HeatWave, Watsonville, CA) was used to perform 
ECD.38  The cathode heating current was kept constant at 1.8 A and the lens electrode 
located immediately in front of the cathode was kept at 1-2 V.  For activated-ion ECD 
(aiECD), ions were heated with a brief (55 ms) IR laser shot prior to ECD.  Product ions 
between m/z 200-2000 were detected. 
2.2.3 Data Analysis 
 All mass spectra were acquired with XMASS software (Bruker Daltonics) with 
256k data points and summed over 20-80 scans.  Data processing was performed with 
MIDAS software.39  Data were zero filled once and Hanning apodized.  IRMPD and ECD 
spectra were manually charge-deconvoluted to their neutral state based on product ion 
isotopic distributions.  Low abundance product ions, typically with m/z values below 800, 
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often appeared without their heavier isotopes.  In these instances, these ions were 
assumed to be singly charged.  This trend has been repeatedly observed following 
IRMPD and ECD of doubly and triply protonated peptides in this instrument.   
 From the list of neutral masses, mass gaps between product ions were manually 
assigned to a potential amino acid residue (with an initial mass error tolerance of ± 0.1 
Da).  Product ions due to water loss (18.01 Da) were assigned in IRMPD spectra and not 
considered when assigning “golden pairs”.  Following ECD, hydrogen 
addition/abstraction often occurs,29,30 therefore deviations of ± 1 Da were also considered 
for ECD data.  From these criteria, several potential amino acid assignments could often 
be made for each mass gap.  However, confident amino acid assignments were made 
when IRMPD and ECD data agreed (so called “golden pairs” were observed).  Amino 
acid assignments made from IRMPD data had a mass error typically less then 0.005 Da 
while from ECD the error was usually less than 0.01 Da.  Larger mass errors observed 
following ECD were typically due to smaller signal-to-noise ratios and because of space-
charge effects caused by the introduction of electrons into the ICR cell.  To distinguish 
N-terminal and C-terminal fragments, IRMPD and ECD data were examined for “golden 
pairs”.25  When IRMPD and ECD cleavage occurs between the same amino acid residues, 
the mass difference between a b ion and a c ion is - 17.03 Da while the difference 
between a y ion and a radical z ion is 16.02 Da (see Scheme 1).  Deviations of ± 1 Da 
were also considered in assigning “golden” pairs, to account for c and z product ions with 
additional hydrogen abstraction/addition.  N- and C-terminal amino acids are assigned 
based upon characteristic mass differences between the precursor ion and a product ion 
corresponding to cleavage adjacent to the N- or C- terminus (see Scheme 2.1).   
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2.3 Results and Discussion 
 FT-ICR mass spectrometric characterization of the novel α-galactosyl binding 
lectin occurred concurrently with other biochemical characterization.  Automated Edman 
sequencing determined that the N-terminal sequence of the lectin was 
ACWKANSCPGSAFESKDRLRLxFALLYxRYN (where x is undetermined).  This 
information, along with knowledge from MALDI-TOF of the intact molecular weight 
(10,279 Da ± 0.01%), was the only structural information available at the onset of the 
investigation presented here, which focuses on de novo sequencing of this protein with 
mass spectrometry.  Several proteolytic enzymes, including trypsin, GluC, and 
chymotrypsin, were utilized to generate a variety of multiply charged peptides.  Examples 
of IRMPD and ECD spectra from various proteolytic digestions are presented below to 
demonstrate how the combination of these two techniques can be utilized for the purpose 
of sequencing unknowns.  A comparison of the final mass spectrometric results versus 
those obtained through gene sequencing is also provided. 
 With positive ion mode ESI FT-ICR MS, the monoisotopic mass of the untreated 
protein was observed as 10,270.1 Da (Figure 2.1a).  Only one form of the protein was 
detected, indicating that this lectin does not contain abundant heterogeneous forms.  
Following treatment with DTT the average molecular weight of the protein increased by 
5.9 Da (Figure 2.1b), indicating the presence of three disulfide bonds.  Ion abundances in 
Figure 1b were lower than those in 1a, likely due to the presence of DTT in the solution.  
For de novo sequencing of this protein, all peptide samples were reduced and alkylated 
prior to mass spectrometric analysis. Therefore, information regarding which cysteine 
residues are involved in a particular disulfide bond could not be determined.  Although a 
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Figure 2.1.  a) Positive ion mode FT-ICR mass spectrum (5 scans) of a lectin from the 
mushroom Lyophyllum decastes.  b) Positive ion mode FT-ICR mass spectrum (30 scans) 
of the lectin treated with dithiothreitol for 15 minutes.  The average molecular weight 
was determined from the 7+ and 8+ charge states.  A mass increase of 5.9 Da was 
observed, indicating the presence of three disulfide bonds.  Insets show a zoomed-in view 
of the 8+ charge state before and after DTT treatment. 
 
top-down characterization of the untreated protein has the potential to indicate disulfide 
bond positions, both IRMPD and ECD of the intact untreated protein resulted in 
relatively poor fragmentation.  Trypsin digestion of the native protein was also 
performed, in order to obtain disulfide linked peptides which could then be subjected to 
MS/MS.  However, no disulfide linked peptides were observed with this strategy.  
Multiple chemical or enzymatic cleavage reagents may be able to produce disulfide-
containing peptides,40 however this approach was not explored. 
2.3.1 Trypsin Analysis 
 Following an overnight trypsin digestion, several peptides were selected for 
further MS/MS characterization.  Results for one of these peptides are shown in Figure 
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2.2, wherein the combination of IRMPD and ECD resulted in extensive sequence 
information.  This Figure shows the deconvoluted FT-ICR MS/MS spectra of a doubly 
charged tryptic peptide with a mass of 1253.5 Da.  Arrows indicate potential single amino 
acid differences between fragments (based on mass) and values in parentheses indicate 
the corresponding mass error in Daltons.  For example, the label E (0.002) in Figure 2.2a 
signifies that the mass gap between the indicated product ions is 129.044 Da (0.002 Da 
heavier than glutamic acid).  Filled squares indicate product ions that are likely due to 
secondary water loss in IRMPD.  Neutral molecule losses, such as water (18.011 Da) and 
ammonium (17.027 Da), are commonly observed in vibrational excitation fragmentation.  
Generally, these neutral losses complicate spectral interpretation.  Several potential short 
amino acid sequences are indicated in Figure 2.2a, including the sequences EFA (or 
AFE) and PCS (or SCP).  The IRMPD spectrum does not confirm the directionality of 
these sequences or how they are arranged within the peptide.  However, the product ion 
with a mass of 821 Da (labeled as cleavage next to proline) is one of the most abundant 
product ions observed following IRMPD and can therefore be hypothesized to 
correspond to cleavage on the N-terminal side of proline, given that such cleavage is 
preferred following vibrational excitation.  This product ion, and all others in the same 
series, are therefore potentially y-type ions.  In Figure 2.2a, there are two sets of product 
ions which indicate the sequence FA (or AF).  One set is due to b or y type cleavage, 
while the other set is likely due to internal fragmentation.    
 Figure 2.2b shows the ECD spectrum of the same peptide as examined in Figure 
2.2a.  This spectrum is more difficult to interpret compared to the IRMPD spectrum  
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Figure 2.2.  Deconvoluted a) IRMPD FT-ICR MS/MS spectrum (40 scans, 1.5 s, 10 W) 
and  b) ECD FT-ICR MS/MS spectrum (80 scans, 75 ms, - 0.5 bias voltage) of a doubly 
protonated peptide from trypsin digestion (1253.5 Daltons).  Arrows indicate a potential 
amino acid assignment, and values in parentheses indicate the mass error (Daltons).  
Squares indicate peaks which are likely due to water loss.  +/- hyd indicates gain/loss of a 
hydrogen.  Quotations around an amino acid assignment indicate a potential c-type ion 
(the mass gap is equal to the mass of the indicated amino acid and 0.984 Da, see Scheme 
2.1).  “Golden pairs” are indicated with asterisks.  Specific product ions discussed in the 
text are indicated with mass labels.  
 
because hydrogen addition/abstraction, which often occurs in ECD,29,30 must be 
considered.  Product ions with potential hydrogen addition and abstraction are indicated 
by the labels “- hyd” and “+ hyd.”.  Although c- and z-type cleavages are prevalent 
following ECD, a- and y-type ions may also be observed.22,23  The possibility of all these 
product ions to be either even or odd electron species increases the number of potential 
amino acid assignments.  In addition, several reports have demonstrated the occurrence of 
amino acid side chain losses in ECD of peptides.41-44  Despite these difficulties, several 
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product ions observed in Figure 2.2b are complementary to those from IRMPD (Figure 
2.2a).  The ECD product ion with a mass of 494 Da (labeled as cleavage next to alanine) 
is 15.01 Da lighter than the IRMPD product ion at mass 509, which was also assigned as 
cleavage adjacent to an alanine residue.  This mass difference indicates a “golden pair”, 
consisting of a y-type ion and an even-electron z ion (“golden pairs” are denoted with 
asterisks in Figure 2.2).  The ECD product ions with a mass of 565 Da (labeled as 
cleavage next to serine) and 709 Da (cleavage adjacent to glycine) also have 
corresponding y-type product ions in Figure 2.2a.  With these three sets of “golden pairs”, 
a large portion of the peptide, SCPGSAFE, can be confidently sequenced.  Assuming this 
sequence is correct, Figure 2.2a indicates that the total mass of un-sequenced amino acids 
on the C-terminal end of the peptide is 215.125 Da.  Meanwhile, the ECD spectrum 
indicates that FESK is a potential amino acid sequence for the C-terminal end.  The 
potential loss of lysine from the precursor ion is denoted as “K” in Figure 2.2b, because 
c-type cleavage adjacent to the C-terminus appears as the loss of the amino acid residue 
and an additional 0.984 Da (as shown in Scheme 2.1).  Given that this peptide was 
generated from a trypsin digestion, the presence of a C-terminal lysine or arginine would 
be highly expected.  The combined mass of serine and lysine is 215.127 Da and, because 
none of the other potential C-terminal amino acid assignments (E”D” or W”G”) in Figure 
2.2b corresponds to this mass, the combined data imply the amino acid sequence 
SCPGSAFESK.  This sequence corresponds to 1068.5 Da of this peptide, which is 85% 
of the total mass (1253.5 Da).  Thus, 85% of the peptide was confidently sequenced from 
combined IRMPD and ECD.  Although golden pairs were not observed within the C-
terminal portion of the peptide, a potential C-terminal amino acid sequence was deduced 
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from ECD fragmentation information.  However, even with the combination of IRMPD 
and ECD, the N-terminal amino acids of this peptide could not be sequenced. 
2.3.2 GluC Analysis 
 Following an overnight GluC digestion, five peptides were selected and examined 
with IRMPD and ECD.  The amino acid sequence of one of the GluC peptides was found 
to partially overlap with the previously examined trypsin digest peptide (Figure 2.2).  
Figure 2.3a and 2.3b show deconvoluted IRMPD and ECD spectra of a doubly charged 
peptide with a mass of 1583.6 Da generated from a GluC digest.  The IRMPD spectrum 
contains the sequence SC (or CS), which was also identified in Figure 2.2.  Several other 
potential amino acid assignments are also indicated in this spectrum, such as the presence 
of glutamic acid and valine, but these were later identified as either due to internal 
fragmentation (for glutamic acid), or as product ions due to multiple neutral molecule 
losses (valine).  Similar to Figure 2.2b, the ECD spectrum in Figure 2.3b is more difficult 
to interpret than the corresponding IRMPD spectrum.  A comparison of the IRMPD and 
ECD spectra for the GluC digest peptide indicates two “golden pairs” consisting of two 
pairs of b- and c-type cleavages.  These ions confirm the presence of alanine, with the 
product ion at mass 1306 Da in Figure 2.3b and at mass 1289 in Figure 2.3a.  Figure 2.3b 
indicates the C-terminal sequence GSAFE, which is also present in the sequence 
determined from Figure 2.2.  From a GluC digestion of the protein, the terminal amino 
acid of this peptide is expected to be glutamic acid.  The mass difference between the 
product ion at mass 834 Da (labeled as cleavage adjacent to serine) and the product at 
1092 Da (due to cleavage next to glycine) is 258.07.  Referring to the sequence 
SCPGSAFESK determined from Figure 2.2, this mass gap would correspond to the  
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Figure 2.3.  Deconvoluted a) IRMPD FT-ICR MS/MS spectrum (40 scans, 0.25 s, 10 W) 
and  b)  ECD FT-ICR MS/MS spectrum (80 scans, 60 ms, - 0.5 bias voltage) of a doubly 
protonated peptide from a GluC digestion (1583.6 Da).  This peptide overlaps with the 
peptide examined in Figure 2.2.  Squares indicate peaks which are likely due to water 
loss.  +/- hyd indicates gain/loss of a hydrogen.  Quotations around an amino acid 
assignment indicate a potential c-type ion (the mass gap is equal to the mass of the 
indicated amino acid and 0.984 Da, see Scheme 2.1).    “Golden pairs” are indicated with 
asterisks.  Specific product ions discussed in the text are indicated with mass labels.    
 
combined mass of proline and an alkylated cystine residue along with hydrogen 
abstraction.  Figure 2.3b also fills in the missing amino acids not sequenced from MS/MS 
data in Figure 2.2, and indicates the sequence ANSCPGSAFE.  This sequence 
corresponds to 66% of the total mass of this GluC digest peptide, with a remaining 545.2 
Da still un-sequenced at the N-terminal end.  However, N-terminal Edman sequencing of 
the protein provided the sequence ACWKANSCPGSAFESKDRLRLxFALLYxRYN, 
which contains the ANSCPGSAFE partial sequence from Figure 2.3 preceded by 
ACWK, which indeed corresponds to the missing 545.2 Da.  This example highlights 
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that, in many cases, IRMPD and ECD of a single peptide do not always allow for 
complete sequencing.  This outcome is due to incomplete fragmentation and because of 
complications arising from several potential amino acid assignments with similar mass 
errors.  When “golden pairs” are observed, there is higher confidence in amino acid 
assignments.  However, in Figure 2.2 only three “golden pairs” were observed while only 
two were observed in Figure 2.3.  To provide missing amino acid assignments, MS/MS 
of overlapping peptides (such as the ones shown in Figures 2.2 and 2.3) was often 
necessary. 
2.3.3 Chymotrypsin Analysis 
 Following an overnight chymotrypsin digestion, sixteen peptides were selected 
and examined with IRMPD and ECD.  Unlike trypsin and GluC, chymotrypsin 
hydrolyzes peptide bonds on the C-terminal side of numerous amino acids, including 
tyrosine, phenylalanine, tryptophan, leucine and, to some extent, methionine, isoleucine, 
serine, threonine, valine, histidine, glycine and alanine.45  MS/MS revealed that the 
majority of peptides examined from a chymotrypsin digest had overlapping sequences, 
which is expected given the nature of chymotrypsin.  Figure 2.4 shows deconvoluted 
IRMPD and ECD spectra of a doubly protonated chymotrypsin digest peptide with a 
mass of 2107.9 Da.  IRMPD of this peptide resulted in extensive fragmentation (Figure 
2.4a).  The product ion observed in Figure 2.4a at mass 1943 corresponds to loss of a 
phenylalanine residue and water from the precursor ion, which indicates that it is a b-type 
ion (as shown in Scheme 2.1).  A C-terminal phenylalanine is consistent with the 
cleavage tendencies of chymotrypsin.  Several additional adjacent b-type product ions are 
also observed, indicating the C-terminal sequence ETEAQCI(L)NTF.  Isoleucine and 
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leucine have the same monoisotopic mass, and therefore cannot be distinguished with 
IRMPD.  In the lower mass region of Figure 2.4a, another series of product ions provides 
the sequence I(L)CQAETE.  These ions overlap with the previously mentioned b ion 
series.  The latter series is presumably a y ion series, indicated by the reversal in sequence 
(since amino acids are now lost from the N-terminus as opposed to the C-terminus for b-
type ions).  This assignment can be further verified by adding corresponding b-type ion 
masses to these y-type ion masses, to observe a total mass of 2107.9 Da (the mass of the 
intact peptide). 
Figure 2.4.  Deconvoluted a) IRMPD FT-ICR MS/MS spectrum (30 scans, 0.75 s, 10 W) 
and  b)  aiECD FT-ICR MS/MS spectrum (60 scans, 75 ms, - 0.5 bias voltage, preceded 
by 55 ms 10 W laser pulse) of a doubly protonated peptide from a chymotrypsin digest  
(2107.9 Da).  Squares indicate peaks which are likely due to water loss.  +/- hyd indicates 
gain/loss of a hydrogen.  Quotations around an amino acid assignment indicate a potential 
c-type ion (the mass gap is equal to the mass of the indicated amino acid and 0.984 Da, 
see Scheme 2.1).  “Golden pairs” are indicated with asterisks.  Specific product ions 
discussed in the text are indicated with mass labels.   
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 Figure 2.4b shows the ECD spectrum of the same peptide as examined in Figure 
2.4a.  To efficiently fragment this peptide, activated ion ECD was necessary, presumably 
due to intramolecular non-covalent interactions, which are more common for larger 
peptides and prevent product ions from separating in ECD.46-48  For aiECD, ions were 
heated with an IR laser pulse before they underwent electron capture.  This activation 
was to aid in the destabilization of gas-phase secondary structure.46  Following ECD, c-
type ions were identified along with several b- and y-type ions.  The latter products were 
assumed to be due to vibrational excitation from the laser pulse.  Unlike previous IRMPD 
and ECD spectra, several abundant “golden pairs” are observed.  A total of ten b/c type 
“golden pairs” are observed, consisting of 10 b-type ions observed following IRMPD and 
10 corresponding c-type ions observed following ECD.  No y/z type “golden pairs” were 
identified.  These 10 “golden pairs” confirm the sequence ETEAQCI(L)NTF, as 
determined from the IRMPD spectrum in Figure 2.4a.  ECD also indicates that residues 
GW are preceding this sequence.  For this peptide, the combination of IRMPD and ECD 
allowed 69% of the total peptide mass to be sequenced.  However, neither fragmentation 
technique provided information regarding the amino acid sequence at the N-terminal end 
of the peptide.  In addition, neither IRMPD nor ECD can distinguish isoleucine from 
leucine.  Zubarev and co-workers have demonstrated that hot electron capture 
dissociation (heECD) may result in secondary fragmentation of radical z-type ions, 
generating residue specific w-type ions which distinguish isoleucine from leucine.  
However, in these experiments heECD was not examined. 
 As a final example, Figure 2.5 shows the deconvoluted IRMPD and ECD spectra 
of a doubly charged peptide from a chymotrypsin digest with a mass of 1517.7 Da.  The 
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deconvoluted IRMPD spectrum of this peptide has several potential amino acid 
assignments and is relatively difficult to interpret (see Figure 2.5a).  Unlike the other 
IRMPD spectra shown above, this spectrum likely contains extensive internal fragments 
and neutral molecule losses, which complicate spectral interpretation.  Between masses 
698-1055 Da, the IRMPD spectrum indicates that this peptide contains the sequence YPP 
(or PPY).  The presence of multiple proline residues within this peptide may result in 
extensive internal fragmentation.49-51  The amino acids adjacent to this sequence are 
unclear; however the sequences YPPKG (or GKPPY) and YPPGK (or KGPPY) are both 
possible assignments (direction of peptides is unknown).  Product ions in the low mass 
region (the ion series indicating the partial sequence PKG (or GKP)) support the 
sequence YPPKG.  Similar to the other ECD spectra shown above, several potential 
amino acid assignments can be made from the ECD spectrum in Figure 2.5b.  This 
spectrum suggests that the C-terminal sequence of the peptide is FGY, indicating a 
peptide with at least one chymotrypsin missed cleavage.  The sequence preceding FGY 
could not be confidently sequenced here, due to several possible assignments with similar 
mass error, and lack of overlap with the IRMPD data.  A comparison of Figures 2.5a and 
b shows the presence of only two “golden pairs”, consisting of one b/c pair and one y/z 
pair.  Overall, there is very little overlap between IRMPD and ECD data and due to the 
complicated nature of both the spectra no additional sequence information could be 
obtained.  However, IRMPD and ECD spectra of other chymotrypsin digest peptides 
which were found to overlap with this peptide confirmed the partial sequence KPPY, and 
indicated the longer sequence GKPPYKGQFGY (data not shown).  Overall, Figure 2.5 
demonstrates that, in some cases, the combination of IRMPD and ECD provided very 
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little sequence information due to a lack of extensive b and y-type product ions following 
IRMPD and poor overlap between IRMPD and ECD data.  Thus, it was necessary to 
perform MS/MS of several additional overlapping peptides in order to sequence this 
stretch of amino acids.   
Figure 2.5.  Deconvoluted a) IRMPD FT-ICR MS/MS spectrum (24 scans, 0.09 s, 10 W) 
and  b) ECD FT-ICR MS/MS spectrum (80 scans, 35 ms, - 0.2 bias voltage) of a doubly 
protonated peptide from a chymotrypsin digest  (1517.7).  Squares indicate peaks which 
are likely due to water loss.  +/- hyd indicates gain/loss of a hydrogen.  Quotations 
around an amino acid assignment indicate a potential c-type ion (the mass gap is equal to 
the mass of the indicated amino acid and 0.984 Da, see Scheme 2.1).  “Golden pairs” are 
indicated with asterisks.  Specific product ions discussed in the text are indicated with 
mass labels.   
 
2.3.4 Comparison of MS/MS Derived Sequence to Biochemical Gene Sequencing 
 A total of 28 peptides from overnight trypsin, GluC, and chymotrypsin digests 
were examined with IRMPD and ECD.  Although large portions of each peptide could 
frequently be sequenced from a combination of fragmentation techniques (see Figures 
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2.2-2.5), only in some cases did these peptide sequences overlap.  To arrange these 
peptide sequences within the protein, larger peptides from limited trypsin and 
chymotrypsin digestions were also examined.  Several peptides, ranging in size from 
2,100 Da to 6,100 Da, were fragmented with IRMPD and ECD (data not shown).  
Although MS/MS of these larger peptides could have been used directly for sequencing, 
their relatively large size resulted in fragmentation which was insufficient for de novo 
sequencing purposes (for both IRMPD and ECD).  A summary of the amino acid 
sequence of the lectin derived from MS/MS data is shown in Figure 2.6a.  The 
combination of IRMPD and ECD revealed the sequences of several large portions of the 
protein.  However, several sections could not be sequenced with tandem mass 
spectrometry, and are underlined in Figure 2.6a.  These areas could not be sequenced due 
to poor fragmentation.  In some examples, the mass gaps can be quantified from tandem 
mass spectra of peptides from limited trypsin and chymotrypsin digests.  
 As previously discussed, a mass spectrometric characterization of this protein 
occurred concurrently with gene sequencing.  Following the completion of de novo 
sequencing with tandem mass spectrometry, the protein sequence was also obtained with 
RT-PCR and 3’ RACE.  The peptide sequence determined from automated Edman 
sequencing was used to generate forward and reverse primer combinations for RT-PCR.  
This analysis identified the first 57 amino acids of the protein.  3’RACE was employed to 
obtain the protein sequence 3’ to these 57 amino acids.  The complete protein sequence 
obtained through these techniques is shown in Figure 2.6b, along with a comparison of 
the sequence obtained from tandem mass spectrometry.  The protein, as sequenced with 
RT-PCR and 3’RACE, has a monoisotopic mass of 10,275.8 Da, which, with the  
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Figure 2.6. a) MS/MS derived amino 
acid sequence of a lectin from 
Lyophyllum decastes.  Several portions 
of the protein could be sequenced using 
a combination of IRMPD and ECD.  
Unsequenced portions are underlined in 
the Figure, and when the mass of the 
missing gap is known, these have been 
indicated. b) A comparison of the 
sequence derived from MS/MS versus 
that obtained through RT-PCR and 3’ 
RACE.  Squares around an amino acid 
indicate incorrectly sequenced residues 
(by MS/MS), while dashes indicate 







presence of three disulfide bonds would be 10269.8 Da.  This value is within 0.3 Da of 
the value measured with ESI FT-ICR MS.  Figure 2.6b indicates that the combination of 
IRMPD and ECD correctly sequenced 73 out of 94 amino acids, which corresponds to 
77% of the total mass of the protein.  Of the amino acids not sequenced correctly, 9 were 
incorrectly sequenced with mass spectrometry (indicated in Figure 2.6b with boxes) and 
13 could not be sequenced at all due to insufficient fragmentation information (indicated 
in Figure 2.6b with dashes).  Figure 2.6a indicates several gaps in the amino acid 
sequence which could not be determined with tandem mass spectrometry.  The masses of 
two of these gaps are 325.1 Da and 384.1 Da.  RT-PCR and 3’ RACE indicated that these 
gaps correspond to STH (325.1 Da) and SCH (384.1 Da).  In Figure 2.6b, Residue 73 was 
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incorrectly sequenced with MS/MS as aspartic acid instead of asparagine.  This 
discrepancy is likely an artifactual deamidation that was introduced during enzymatic 
digestion.  MS/MS also incorrectly sequenced residue 63 as GA instead of Q.  The 
combined mass of glycine and alanine is the same as that of glutamine.  MS/MS data 
indicated a glycine residue in this position, which may have been due to internal 
fragmentation, or a contaminant peak.  MS/MS data also incorrectly sequenced a serine 
residue after phenylalanine at residue 22.  In this example, ECD indicated the peptide 
sequence FSAI(L)(L)YCR, but IRMPD data could not confirm this sequence.  Residues 
36-38 were also incorrectly sequenced from ECD data, possibly due to artifact or 
contaminant mass spectral peaks. 
 
2.4 Conclusions 
 The results presented here demonstrate that the combination of IRMPD and ECD 
is a valuable tool for de novo protein sequencing, and can be especially useful for 
proteins from organisms with unsequenced genomes.  While IRMPD spectra were 
complicated by internal fragmentation and neutral molecule losses, ECD spectra were 
complicated by hydrogen addition and abstraction, multiple product ion types (a, c, y, and 
z-type), and low fragmentation efficiency.  Despite these disadvantages, when used in 
conjunction these techniques proved to be a powerful tool for sequencing purposes.  In 
these experiments, the overlap between IRMPD and ECD data, indicated by so called 
“golden pairs”, was used to sequence peptides generated from trypsin, chymotrypsin, and 
GluC digestions.  In instances where very few “golden pairs” were observed, 
fragmentation information from either IRMPD or ECD could be used for sequencing.  
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Several enzymes were used in order to generate overlapping peptides, which was found 
to be vital for de novo sequencing.  Although 100% of the amino acid sequence of this 
protein was not sequenced, several improvements can be made to make complete 
sequencing feasible.  Utilizing a wider variety of proteolytic enzymes and increasing the 
total number of peptides examined would generate additional MS/MS data, and fill in the 
blanks where amino acid sequences were unassigned due to insufficient fragmentation 
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Infrared Multiphoton Dissociation and Electron Capture Dissociation of 
High-Mannose Type Glycopeptides 
 
3.1 Introduction 
 A protein can exist in several diverse states within a cell, largely due to different 
splice variants and the great number of post-translational modifications (PTMs) that can 
occur at multiple positions within the protein.  Glycoproteins are a highly diverse class of 
biomolecules that have been found to play several key roles in biological systems 
including: cell-cell adhesion, cell-extra cellular membrane adhesion, folding and 
secretion, fertilization, glycoprotein targeting, and immune defense.1,2  Abnormal 
glycosylation patterns have been linked to several disease states, such as protein 
misfolding in neurodegenerative diseases,3,4 susceptibility to infection,5 evasion of the 
immune system by cancer cells,6,7 and congenital disorders of glycosylation (CDGs).8  
Despite their frequency and importance to protein structure and function, analyses of 
carbohydrates have been underrepresented compared to nucleic acids and proteins.  
 The two key types of glycosylation involve either covalent attachment of an 
oligosaccharide through the oxygen in serine or threonine (O-glycosylation) or through 
nitrogen in asparagine (N-glycosylation).  In cases of N-glycosylation, a common 
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pentasaccharide core is attached to Asn in the consensus sequence Asn-X-Ser/Thr, where 
X may be any amino acid except Pro.  There are three main classes of N-glycosylation, 
distinguished by the saccharide units which extend beyond the common core.  These 
include hybrid type, complex type, and high-mannose type glycans.  Representative 
structures of these glycans are shown in Figure 1.1 in Chapter 1.  Although typically not 
considered a key glycan category, xylose type glycans are distinguished by the 
attachment of xylose to the common pentasaccharide core and are found predominantly 
in plants.9       
 Mass spectrometry (MS) is a valuable tool for glycoprotein analysis, and tandem 
mass spectrometry (MSn) is particularly effective in characterizing peptide and saccharide 
structures.10-12  Fourier transform ion cyclotron resonance (FT-ICR) MS, with its 
ultrahigh resolution, mass accuracy, and multiple tandem mass spectrometry abilities, is a 
powerful tool for the determination and structural examination of several types of 
biological macromolecules.13  The current procedure for mass spectrometry-based 
glycoprotein characterization often employs release of glycans through chemical or 
enzymatic means, followed by separate analyses of the protein and carbohydrate.  
Another approach is to investigate glycosylation on the glycopeptide level with tandem 
mass spectrometry.  This strategy minimizes sample manipulation and allows mapping of 
glycan structures to specific sites.14-16  
 Electron capture dissociation (ECD)17 and infrared multiphoton dissociation 
(IRMPD)18,19 are powerful fragmentation techniques for FT-ICR MS characterization of 
glycoproteins.  ECD is a rather recently introduced technique, but its expanding 
implementation has been a significant advance in the field of biomolecular structural 
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analysis.  ECD involves the irradiation of multiply charged cationic analyte ions with low 
energy electrons (< 1 eV), generating charge reduced radical species and product ions.20-
23   It has been extensively shown that ECD of peptides results in preferential cleavage 
along the peptide backbone generating c′-type and radical z-type ions (Zubarev 
nomenclature)24 while retaining labile modifications such as phosphorylation and 
glycosylation.25-32  IRMPD of N-glycosylated peptides is understood to selectively cleave 
glycosidic bonds rather than the peptide backbone.  This preference has been 
demonstrated for both xylose type and complex type glycopeptides.29,31,33   Accordingly, 
the combination of ECD and IRMPD has been shown to provide complementary 
structural information regarding peptide and glycan structure.29,31  In addition, the recent 
combination of electron transfer dissociation (ETD) and CAD in a quadrupole ion trap 
mass spectrometer has shown similar capabilities for a xylose type glycopeptide.34  
 While ECD has been applied to the structural analysis of xylose type29,31 and 
complex type30 N-glycopeptides and O-glycosylated peptides,26,30,35 it has not been 
widely applied towards the characterization of high-mannose type N-glycopeptides.  
Similarly, neither has the utility of IRMPD for the structural characterization of such 
glycopeptides been extensively explored.36  Ribonuclease B, which has been 
characterized with MS,37-40 X-ray crystallography,41 and NMR,42 was chosen as a model 
glycoprotein containing high-mannose type glycans.  With this model, we employ the 
combination of ECD and IRMPD for the structural characterization of high-mannose type 
glycopeptides.  The utility of ECD and IRMPD is examined for glycopeptides ranging in 
size from four to forty amino acids, the latter being, to our knowledge, the largest N-
glycosylated peptide characterized through these fragmentation techniques to date. 
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3.2 Experimental 
3.2.1 Ribonuclease B Preparation 
 Approximately 1.25 nmoles of ribonuclease B (Sigma, St Louis, MI) in 100 mM 
ammonium bicarbonate (NH4HCO3, Fisher Scientific, Fair Lawn, NJ) was mixed with 10 
μL of 10 mM dithiotreitol (DTT, Sigma) and incubated at 56°C for one hour.  After 
cooling to room temperature (RT), 10 μL of 100 mM iodoacetamide (Sigma) was added 
followed by incubation in the dark at RT for one hour.  Another 10 μL of 10 mM DTT 
was added to the solution at RT and, after 45 minutes, either 12.5 ng/μL of trypsin 
(Princeton Separations, Adelphia, NJ) or GluC (Roche, Indianapolis, IN) in 25 mM 
NH4HCO3 was added (modified procedure43).  For a tryptic digestion, 100 μL of trypsin 
was used and the digestion proceeded for 15 hours at 37 °C.  For GluC digests, between 
15-50 μL of enzyme was used and digestion proceeded at 25°C for 15-18 hours.  In 
addition, a limited tryptic digest was prepared by adding 14 μL of trypsin and allowing 
the reaction to proceed for five minutes at 2 °C.  Following both trypsin and GluC 
digestion, all solutions were acidified to 0.1% formic acid. 
 For the overnight trypsin digest, concanavalin A tips (Glygen Corporation, 
Columbia, MD) were used to selectively bind glycopeptides.  Loading buffer consisted of 
100 mM sodium acetate (CH3COONa, Sigma) and 200 mM NaCl (Fisher), washing 
solution consisted of 50 mM CH3COONa and 200 mM NaCl, and elution was performed 
in 150 mM glucose (Fluka, Milwaukee, WI), 25 mM CH3COONa, and 100 mM NaCl.  
Following enrichment with concanavalin A tips, the glycopeptide sample was desalted 
using a C18 reverse-phase micro-column, Ziptip (Millipore, Billerica, MA).  For GluC 
digests and the short tryptic digest, samples were desalted following the addition of 
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formic acid.  All samples were diluted to 5x10-6 M with electrospray solvent consisting of 
1:1 methanol and water with 2% acetic acid. 
3.2.2 Lectin Preparation 
 Approximately 150 μmoles of a lectin from Erythrina cristagalli (Sigma) in 50 
μL of water was mixed with 20 μL of 12.5 ng/μL of trypsin in 25 mM NH4HCO3.  
Digestion proceeded for 15 hours at 37 °C.   Desalting conditions were used as described 
above.  The sample was diluted to 1x10-6 M with electrospray solvent. 
3.2.3 FT-ICR Mass Spectrometry 
 All experiments were performed with an actively shielded 7 T FT-ICR mass 
spectrometer with a quadrupole front-end (APEX-Q, Bruker Daltonics, Billerica, MA), as 
previously described.44   An indirectly heated hollow dispenser cathode45 was used to 
perform ECD.  IRMPD was performed with a vertically mounted 25-W, 10.6-μm, CO2 
laser (Synrad, Mukilteo, WA). 
 Peptide solutions were infused via an external Apollo electrospray ion source at a 
flow rate of 60 μL/h with the assistance of N2 nebulizing gas.  Ions were accumulated in 
the first hexapole for 0.05 s, transferred through a mass-selective quadrupole, and mass-
selectively accumulated (2-10 m/z isolation window) in the second hexapole for 1-4 s.  
Ions were then transferred through high-voltage ion optics and captured by dynamic 
trapping (IRMPD experiments) or gas-assisted dynamic trapping (ECD experiments) 
with argon as the collision gas in an Infinity ICR cell.46  The experimental sequence up to 
the ICR cell fill was looped 1-5 times to achieve maximum precursor ion signal.  The 
cathode heating current was 1.8 A, and during the ECD event the cathode voltage was 
pulsed for 15 ms to - 0.25 V to generate low energy electrons.  A lens electrode located 
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immediately in front of the cathode was kept at 1 V to improve electron injection.  
IRMPD was performed at 30% laser power with firing times ranging from 45-100 ms.  
All mass spectra were acquired with XMASS software (Bruker Daltonics) with 256 data 
points from m/z 200-2500 and summed over 30-50 scans.  Data processing was 
performed with MIDAS software47,48 and exported to Microsoft Excel for internal 
frequency-to-mass calibration with a two-term calibration equation.49  All IRMPD 
product ions were within 10 ppm error whereas ECD product ions were assigned within 
20 ppm.  The larger error allowed in ECD was due to smaller signal to noise ratios, the 
pulsing of gas into the cell, and because a two-point calibration does not properly account 
for space-charge effects caused by the introduction of electrons into the  ICR cell.  
 
3.3 Results and Discussion 
 Ribonuclease B is a protein of 124 amino acids, with the heterogeneous glycan 
structure GlcNAc2Man5-9 (GlcNAc=N-acetylglucosamine, Man=mannose) attached to 
Asn34.  NMR experiments have determined the structures of the several high-mannose 
type glycans found on Asn34, as well as their relative abundances.42  With such extensive 
characterization, this glycoprotein is a suitable model system to examine high-mannose 
type glycopeptides.  When glycan structures are shown throughout this Chapter, the most 
abundant glycan species are indicated in cases where multiple isomers exist.  All 
saccharide units, excluding xylose (indicated by a rhombus), are represented according to 
the nomenclature designated by the Consortium for Functional Glycomics (CFG).50  In 
this nomenclature scheme, green circles indicate mannose, blue squares indicate N-
acetylglucosamine, and red triangles indicate fucose. 
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3.3.1 IRMPD and ECD of a Trypsin Digest Glycopeptide 
 The electrospray ionization (ESI) FT-ICR mass spectrum from a non-separated 
tryptic digest of ribonuclease B showed that glycopeptide ion abundances were very low 
compared to non-glycosylated peptides (data not shown).  This behavior is a general 
occurrence for glycoprotein digests, due to the spread of glycopeptide ion signals over a 
population of several peptides with varying glycan structures.  For this reason, 
chromatographic separation is often necessary to enrich glycopeptides prior to further 
analysis.  Lectin affinity chromatography is a commonly used strategy for purification 
and fractionation of glycoproteins, glycopeptides, and oligosaccharides.51-53  This 
technique is based on the high affinity of lectins towards carbohydrate structures.  For 
example, concanavalin A is a lectin with broad carbohydrate specificity and was used 
here to enrich glycopeptides from the ribonuclease B tryptic digest. 
 Figure 3.1 shows the IRMPD mass spectrum from a doubly protonated N-
glycosylated high-mannose type glycopeptide observed following concanavalin A 
treatment.  The peptide sequence and predicted glycan structure are also shown in Figure 
3.1, along with observed cleavage sites (indicated by red dotted lines).  Most product ions 
observed correspond to the precursor ion, [M + 2H]2+, with one or more monosaccharide 
losses and with charge retention on the reducing end of the glycopeptide.  Also observed 
are several singly protonated, dehydrated sugar ions.  All glycosidic bonds are cleaved, 
yielding extensive information regarding glycan composition.  The sequential loss of 
seven 162 Da masses confirms the known mannose content of this glycopeptide.  Similar 
to previous IRMPD spectra of xylose type and complex type glycopeptides, no peptide 
backbone cleavage is observed.  These results re-emphasize the utility of IRMPD for 
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Figure 3.1. IRMPD FT-ICR (50 scans, 45 ms irradiation at 7.5 W laser power) tandem 
mass spectrum of a ribonuclease B glycopeptide from an overnight trypsin digestion.  
The precursor ion, denoted as [M + 2H]2+, consists of amino acids 34-37 with a high 
mannose glycan, GlcNAc2Man7, attached at Asn34.  Extensive cleavage within the 
glycan is observed (indicated by red dotted lines); however, no cleavage is seen between 
Asn-GlcNAc.  Similarly to previous IRMPD of xylose type and complex type 
glycopeptides, no backbone fragmentation is observed. (ν3=harmonic peak, *=noise, 
■=GlcNAc, ●=Man). 
 
glycopeptide structural characterization, this technique being particularly useful for 
uncharacterized glycopeptides due to selective glycan cleavage. 
 Analogous to previous characterizations of xylose type and complex type glycans, 
the ECD spectrum of the same high-mannose glycopeptide resulted in only peptide 
backbone cleavage (data not shown).  No cleavage occurred within the glycan but, 
because of the small size of the peptide, only one c′-type ion (containing the glycans) was 
detected.  However, as with previous analyses, the fragmentation observed in IRMPD  
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and ECD was strictly complementary. 
3.3.2 IRMPD of a GluC Digest Glycopeptide 
 To investigate the utility of the IRMPD/ECD approach for the characterization of 
larger high-mannose type glycopeptides, we performed a GluC digest of ribonuclease B.  
In the mass spectrum obtained following direct infusion of this digest (without 
glycopeptide enrichment), several glycopeptides in the 5900-6600 Da range were readily 
observed.  One of those was selected for further analysis with IRMPD and ECD.  To 
demonstrate that these two fragmentation techniques are applicable to a variety of high-
mannose glycopeptides, a glycopeptide with a different glycan structure, GlcNAc2Man6, 
was chosen. 
 Figure 3.2 shows the IRMPD mass spectrum of this high-mannose type 
glycopeptide consisting of amino acids 10-49 with the glycan GlcNAc2Man6 attached at 
Asn34.  The precursor ion is indicated by [M + 7H]7+.  Unlike the IRMPD mass spectrum 
of the smaller tryptic glycopeptide, very limited glycan cleavage is observed.  The only 
ions that correspond to glycosidic cleavage are losses of one and two mannoses from the 
precursor ion.  In contrast to previous IRMPD mass spectra of glycopeptides, peptide 
backbone cleavage is readily observed, including five b type ions and one y′ type ion 
(Zubarev nomenclature).24  This effect is not due to a longer laser irradiation time used 
here (100 ms), versus the shorter pulse (45 ms) used for the smaller trypsin digest 
glycopeptide.  A longer irradiation time was necessary for fragmentation due to the 
increased number of vibrational degrees of freedom of this larger glycopeptide.  
Irradiation times ranging from 60-90 ms still resulted in peptide backbone cleavage, and 
irradiation for less then 60 ms resulted in the loss of one mannose, with no other 
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Figure 3.2. IRMPD FT-ICR (30 scans, 100 ms irradiation at 7.5 W laser power) tandem 
mass spectrum of a ribonuclease B glycopeptide from a GluC digestion.  The precursor 
ion, denoted as [M + 7H]7+, consists of amino acids 10-49 with a high-mannose glycan, 
GlcNAc2Man6, attached at Asn34.  Very limited glycan cleavage is observed (the most 
likely glycosidic cleavages are indicated by red dotted lines).  Contrary to what has been 
shown previously for IRMPD of glycopeptides, several b and y′ type product ions are 
also detected (indicated by red solid lines). (ν3=harmonic peak, *=noise, ■=GlcNAc, 
●=Man). 
 
cleavages observed (data not shown).  These experiments demonstrate that the 
fragmentation pattern observed was not a result of “harsh” experimental parameters.  
Increasing the irradiation time to 150 ms resulted in no additional glycan cleavages, 
indicating that incomplete glycosidic bond cleavage was not due to insufficient energy 
input (data not shown). 
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 It is also interesting to note here that b and y′ ion abundances are similar to those 
corresponding to glycan cleavage, indicating that the degree of backbone cleavage and 
glycan cleavage is comparable.  This mixture of glycan and peptide backbone cleavage 
greatly complicates spectral interpretation, and would render structural characterization 
of an unknown glycopeptide difficult.   These results are in disagreement with IRMPD 
data observed for xylose type and complex type glycopeptides, which showed that 
IRMPD selectively induces dissociation of glycosidic bonds in N-linked glycans and 
leaves the peptide backbone intact.29,31,33  
 Caprioli and co-workers have shown that CAD of high-mannose type 
glycopeptides results in minor peptide backbone cleavage in addition to extensive 
glycosidic cleavage.54  In one particular example, poor glycopeptide fragmentation was 
explained due to ion suppression effects and or as a result of increased glycopeptide mass 
preventing efficient dissociation and/or detection of product ions.  However, Zaia has 
reasoned that the tendency towards peptide backbone cleavage is due to the lack of a 
labile HexNAc (N-acetylhexosamine) residue in the antennae region of the sugar.11  
Cleavage to the reducing side of HexNAc is favored due to the proximity of a charged 
group to the glycosidic oxygen.  Other labile saccharides include sialic acid and 
fucose.11,55,56 
 McLafferty and co-workers found that CAD of large (>6 kDa) high-mannose type 
glycopeptides from immunoglobulin constructs resulted in product ions formed from a 
mixture of peptide backbone cleavage and glycosidic cleavage.57  In that example 
complete glycan sequencing was still feasible, contrary to the poor glycosidic cleavage 
observed here in IRMPD of a GluC ribonuclease B glycopeptide.  The tendency towards 
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peptide backbone cleavage over glycan cleavage was also observed in ion trap CAD of 
whole ribonuclease B.58  Here, the authors proposed that for the whole glycosylated 
protein, the N-linked sugar was “inert” to fragmentation due to the competition from 
facile amide bond cleavage predominantly N-terminal to Pro and C-terminal to Asp and 
Lys.  This competition was able to “protect” glycosidic bonds from cleavage.  To 
determine whether the lack of glycan cleavage for a ribonuclease B GluC glycopeptide 
was due to size effects, a peptide of smaller length, but larger than the previous tryptic 
glycopeptide, was also examined (see Section 3.3.4). 
3.3.3 ECD of a GluC Digest Glycopeptide 
 Figure 3.3 shows the ECD mass spectrum of the same ribonuclease B GluC digest 
glycopeptide that was examined with IRMPD.  To our knowledge, this GluC proteolytic 
peptide is the largest glycopeptide that has been subjected to ECD.  Extensive 
fragmentation was observed, corresponding mostly to c′ and z• type ions.  Of the 38 
peptide backbone bonds available for fragmentation, cleavage was observed at 32 sites.  
The N-terminal side of proline was not considered because cleavage at this site is 
generally not observed in ECD due to proline’s cyclic structure.17  As seen in previous 
ECD experiments,26,59,60 z ions were a mixture of both radical (z•) and even-electron (z, z′) 
species.  These even-electron z ions have been proposed to be formed by direct hydrogen 
atom capture during the ECD process or by hydrogen rearrangement.59  In addition, two 
y′ ions (y′122+, y′183+) and two radical a (a223+•, a284+•) ions were detected. Formation of  
such ions is a minor fragmentation pattern in ECD, although it has been seen as a 
predominant pathway for non-standard peptide-like structures.61  As expected, no 































































































































Figure 3.3. ECD FT-ICR (40 scans, 15 ms irradiation, - 0.25 V bias voltage) tandem mass 
spectrum of a ribonuclease B glycopeptide from a GluC digestion.  The precursor ion, 
denoted as [M + 7H]7+, consists of amino acids 10-49 with a high-mannose glycan, 
GlcNAc2Man6, attached at Asn34.  Most product ions correspond to c′ and z• type ions, 
however some a• and y′ type ions are also observed. (ν3=harmonic peak, *=noise, ø=due to 
quadrupole isolation, ■=GlcNAc, ●=Man). 
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 The most abundant ion (Fig. 3.3, top) corresponds to the precursor ion, amino 
acids 10-49 with GlcNAc2Man6 attached at Asn34, indicated by [M + 7H]7+.  ECD 
product ions observed in Figure 3.3 are a result of electron capture induced dissociation 
of the precursor ion, [M + 7H]7+, and charge stripped species resulting from quadrupole 
isolation of the precursor ion; [M + 6H]6+, [M + 5H]5+, and [M + 4H]4+.  The major 
product of electron capture dissociation is often [M + nH](n-1)+•, which fragments to yield 
c′ and z• type ions.  However, an examination of the isotopic distribution of the 6+ species 
reveals that the even electron species (charge stripped species) is more dominant than the 
6+ radical species.  An examination of the 5+ and 4+ species revealed that these were a 
mixture of even and odd electron species.  Neutral losses were also quite dominant in the 
spectrum, labeled as [M - 57]n+ and [M - 42]n+.  The former corresponds to the loss of 
C2H4ON (58.023 Da) from the charge reduced species (the charge reduced species is one 
hydrogen heavier then the neutral species, [M], thus the loss of 57 Da), which has been 
previously observed due to the elimination of a portion of the carboxyamidomethylated 
side chain of a cysteine residue.32  The other prominent neutral loss is either from the loss 
of CH3N2 (43.029 Da)62 or CH3CO (43.018 Da)63 from the charge reduced species.  Both 
losses have been observed in ECD, although the latter was specifically attributed to the 
loss of an acetyl radical from a glycopeptide.  These results demonstrate that ECD is a 
highly effective technique for the characterization of particularly large glycopeptides, 
resulting in almost complete sequence coverage and indicating the site of glycosylation 




3.3.4 IRMPD of a Short Trypsin Digest Glycopeptide 
 While the IRMPD spectrum of a relatively small glycopeptide from an over-night 
trypsin digest showed extensive glycosidic cleavage (Figure 3.1), that of a larger 
glycopeptide from a GluC digest showed little glycan cleavage and several product ions 
corresponding to peptide backbone cleavage (Figure 3.2).  To determine whether the lack 
of glycan cleavage for the GluC glycopeptide was due to size effects, a peptide of smaller 
length, but larger than the previous tryptic glycopeptide, was examined.  This peptide, 
consisting of amino acids 34-39 with the glycan GlcNAc2Man5 attached at Asn34, was 
produced by a short (5 min) trypsin digestion at 2 °C.  Figure 3.4 shows the 
corresponding IRMPD spectrum of the doubly protonated [M + 2H]2+ precursor ion.  
Similar to the IRMPD spectrum of the glycopeptide NLTK-GlcNAc2Man7 (Figure 3.1), 
extensive glycosidic cleavage is observed yielding all necessary information regarding 
glycan composition.  However, highlighted in the spectrum is a b-type ion, corresponding 
to peptide backbone cleavage.  This fragmentation pattern shows that IRMPD will likely 
result in a mixture of glycosidic and backbone cleavage for high-mannose type 
glycopeptides, regardless of their size.  A resulting mixture of backbone and glycosidic 
cleavage is a major obstacle, because it can complicate spectral interpretation.  This 
behavior is of particular concern in the current example, where the b-type ion exhibits 
both backbone cleavage and glycosidic cleavage.  Thus, in cases where the glycan 
structure of a high-mannose type glycopeptide is unknown, IRMPD alone would likely 
be insufficient in determining the glycan composition.  In such cases, alternative 
fragmentation techniques such as ECD would be necessary. 
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Figure 3.4. IRMPD FT-ICR (30 scans, 90 ms at 7.5 W laser power) tandem mass 
spectrum of a ribonuclease B glycopeptide from a five minute cold trypsin digestion.  
The precursor ion, denoted as [M + 2H]2+, consists of amino acids 34-39 with a high-
mannose glycan, GlcNAc2Man5, attached at Asn34.  Similar to the IRMPD mass 
spectrum shown in Figure 3.1, extensive cleavage within the glycan is observed 
(indicated by red dotted lines).  In addition, backbone cleavage is also observed in the 
form of a b type ion (indicated by red solid line).  (ν3=harmonic peak, *=noise, ø=due to 
quadrupole isolation, ■=GlcNAc, ●=Man). 
 
3.3.5 IRMPD of a Xylose Type Glycopeptide 
 The results presented above show that for high-mannose type glycopeptides, 
peptide backbone cleavage competes with glycosidic bond cleavage when IRMPD is 
employed.  This effect can be interpreted as a higher resistance to gas-phase cleavage by 
mannose-linking glycosidic bonds compared to peptide backbone bonds.  To further 
investigate this occurrence, we re-examined the IRMPD behavior of a xylose type 
glycopeptide from a tryptic digest of Erythrina cristagalli lectin.13  A similar xylose type 
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glycopeptide from Erythrina corallodendron had been previously characterized with 
IRMPD,29,31 and those results are also used for comparison.  Figure 3.5 shows the glycan 
structure for the xylose type glycopeptide from Erythrina cristagalli, and zoomed in 
regions corresponding to the loss of one and two monosaccharide residues.  We expected 
that product ions corresponding to the loss of one mannose should be more abundant than 
those due to loss of xylose because mannose loss can occur through two combinations, 
i.e. via cleavage of two different glycosidic bonds.  However, loss of mannose is not the 
most abundant pathway observed in the spectrum, demonstrating that mannose-linking 
glycosidic bonds are more resistant to cleavage compared to both xylose and fucose 
glycosidic bonds.  These results are the same as those from an IRMPD characterization of 
an Erythrina corallodendron lectin glycopeptide.29,31   As previously stated, fucose is 
considered a labile saccharide, consistent with our findings.  However, our results also 
demonstrate lability of xylose, which has not been thoroughly discussed in the literature.  
An examination of product ions corresponding to two monosaccharide losses in Figure 
3.5 shows similar results.  Here, the combined loss of fucose and xylose is quite 
abundant, while the loss of two mannose residues is hardly observed.  In  previous 
Erythrina corallodendron IRMPD examinations of xylose type glycopeptides, the loss of 
two mannose residues was either not observed at all or also seen to a much lower 
degree.29,31   Similarly, a CAD study of a xylose type glycopeptide did not report the loss 
of only two mannose residues.34  These results are notable, because several current 
research efforts involve the gathering of statistical information that can be used to predict 
MS/MS behavior.64-66  Several strategies are employed in order to aid the interpretation of 
mass spectra of carbohydrates. These strategies typically rely on carbohydrate MS/MS 
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libraries and/or algorithms to predict glycan structure based on experimental data.67-76  
No reliable strategy exists yet for the interpretation of glycopeptide fragmentation.  
Nonetheless, the unique behavior of mannose needs to be incorporated into such models 
if they are to be useful for glycopeptide structural characterization. 
 
Figure 3.5. IRMPD FT-ICR (10 scans, 50 ms at 10 W laser power) tandem mass 
spectrum of a lectin glycopeptide from Erythrina cristagalli.  The precursor ion, denoted 
as [M + 3H]2+, consists of amino acids 100-116 with a xylose type glycan attached at 
Asn113.  Similar to other IRMPD spectra of glycopeptides, extensive cleavage within the 
glycan is observed (indicated by red dotted lines).  No backbone cleavage is seen in the 
spectrum. The zoomed in regions correspond to losses of one and two monosaccharides, 






 We have found that high-mannose type glycopeptide fragmentation differs from 
xylose type and complex type glycopeptides in IRMPD.  IRMPD analyses of high-
mannose type glycopeptides from ribonuclease B demonstrated that peptide backbone 
cleavage competes with glycosidic cleavage, rather than selectively inducing glycosidic 
cleavage as has been previously observed.  This observation is not due to size effects, as 
has been previously suggested, because it occurs for both small (~2000 Da) and large 
(~6100 Da) high-mannose type glycopeptides.  As predicted, ECD of a high-mannose 
type glycopeptide results in extensive peptide backbone cleavage while none occurs 
within the glycan.  Repeatedly, ECD has been shown to be a valuable technique for 
characterizing and locating post-translational modifications, and here we demonstrate its 
utility for high-mannose type glycoproteins. Furthermore, our results extend the mass 
range for the successful application of ECD towards glycopeptide characterization.  
Previous examinations of glycopeptides using IRMPD and ECD emphasized the 
effectiveness of this combination for glycopeptide structural characterization; the former 
technique was shown to selectively induce glycan cleavage while the latter cleaves the 
peptide backbone.  However, caution must be used when applying IRMPD for the 
structural characterization of unknown glycopeptides, because spectral interpretation can 
be complicated by a mixture of glycan and peptide cleavage when examining high-
mannose type glycopeptides.  In addition, the unique behavior in IRMPD for high-
mannose type glycopeptides needs to be incorporated in models predicting peptide 
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Electron Capture Dissociation of Oligosaccharides Ionized with Alkali, 
Alkaline Earth, and Transition Metals  
 
4.1 Introduction 
 Oligosaccharide-containing biomolecules, known as glycoconjugates, are highly 
diverse and prevalent in biological systems.  The role of glycoconjugates in nature is 
extensive,1 ranging from protein folding2 to immune system response.3  The multiple 
functions of glycoconjugates are largely due to the increased degree of complexity 
oligosaccharides impart to these biomolecules.  Oligosaccharides may exist as several 
isomeric forms with diverse linkages and unlike other biomolecules can form highly 
branched structures.  Complete structural characterization of oligosaccharides requires 
information regarding linkage, sequence, branching, and anomeric configuration (a term 
which refers to the configuration, α or β, of the glycosidic bond of a sugar).  Structural 
characterization of the oligosaccharide portion of glycoconjugates is often accomplished 
by releasing the sugar from the biomolecule.  It is frequently necessary to utilize a wide 
range of analytical methodologies in order to fully characterize these diverse and 
structurally complex molecules.   
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 Mass spectrometry is an important tool for oligosaccharide characterization and 
offers high sensitivity and minimum sample requirements.  Tandem mass spectrometry 
(MSn) has been employed extensively for oligosaccharide structural analysis.4-13  In 
particular, Fourier transform ion cyclotron resonance mass spectrometry (FT-ICR MS) 
offers several advantages for oligosaccharide analysis,14 including high mass accuracy, 
ultrahigh resolution, and the availability of several tandem mass  
spectrometric techniques.   
 Oligosaccharides undergo two main types of fragmentation (shown in Figure 1.5 
in Chapter 1).  The predominant fragmentation pathway for protonated oligosaccharides 
is generally glycosidic cleavage, which occurs between monosaccharide units and 
provides information regarding saccharide sequence and branching.  However, valuable 
information regarding sugar linkage can be gained from cross-ring cleavages, which are 
less prevalent than glycosidic cleavages.  Several factors are known to affect the degree 
of oligosaccharide fragmentation and the extent of glycosidic versus cross-ring cleavage.  
These factors include variables such as the ionizing cation, the lifetime of the ion prior to 
detection and the energy deposited into the ion.  Oligosaccharides ionized with alkali, 
alkaline earth, and transition metals often fragment to yield more cross-ring cleavages 
compared to their protonated counterparts.15-27  These fragmentation patterns are highly 
dependent on the specific metal adduct chosen and also the degree of oligosaccharide 
branching.22  In addition, fragmentation of deprotonated oligosaccharides may also result 
in additional cross-ring fragmentation.10,28-30   
 Conventionally, tandem mass spectrometry is accomplished with low energy 
collision activated dissociation (CAD), and results in mostly glycosidic cleavages.  
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However, several alternative fragmentation techniques have been utilized for 
oligosaccharides including high-energy CAD,11,31-33 infrared multiphoton dissociation 
(IRMPD),34-36 electron capture dissociation (ECD),37 and 157 nm photodissociation.38  
High-energy CAD and 157 nm photodissociation of oligosaccharides results in more 
extensive cross-ring fragmentation.  IRMPD and low-energy CAD are both low energy 
vibrational excitation techniques.  However, Lebrilla and co-workers have shown that the 
fragmentation efficiency in IRMPD is greater than that in CAD for large 
oligosaccharides.36  In addition, ECD has been applied to protonated 
chitooligosaccharides, and yielded primarily glycosidic cleavages corresponding to B and 
C-type ions.  ECD is based on the dissociative recombination of polycationic molecules 
with low-energy electrons (<1 eV), generating charge reduced radical species and product 
ions.39-44  The implementation of ECD in biomolecular structural analysis is rapidly 
expanding, and while it is known to be extremely valuable for post-translational 
modification analysis, including protein glycosylation,45-50 its applicability towards 
oligosaccharide characterization has not been fully explored.   
 We have previously shown that divalent metal-adduction can greatly improve 
positive ion mode ionization efficiency of acidic sulfated peptides.51  In addition, 
utilization of divalent metal adducts to positively ionize such acidic molecules facilitates 
formation of the doubly-charged species that are required for ECD.   Furthermore, we and 
others have reported that ECD fragmentation can be drastically different as a function of 
metal charge carrier, thereby allowing directed bond cleavage.51-54  Our current objective 
is to examine ECD fragmentation of oligosaccharides ionized with various cationizing 
agents, to determine whether the combination of ECD and metal ion adduction is a viable 
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analytical tool for oligosaccharide structural characterization.  Following ECD and 
IRMPD, we compare fragmentation patterns to determine whether ECD provides 
complementary information.  Cationizing agents were select Group I, Group II, and 
transition metal species, including Na+, K+, Ca2+, Ba2+, Mg2+, Mn2+, Co2+, and Zn2+.  
Several cationizing agents were chosen in order to determine which metal adducts, if any, 
provide the most extensive fragmentation (and thereby structural information) from ECD.  
Model oligosaccharides examined are maltoheptaose, para-lacto-N-hexaose, and an N-
linked glycan from human α1-acid glycoprotein.  Both linear and branched 
oligosaccharides are investigated, to determine whether oligosaccharide branching affects 
ECD fragmentation.   
 
4.2 Experimental 
4.2.1 Sample Preparation 
 Maltoheptaose, para-lacto-N hexaose, and a complex type N-glycan from human 
α1-acid glycoprotein were obtained from Sigma Chemical Co. (St. Louis, MO).  All salts, 
including NaCl, KCl, Ca(C2H3O2)2, MgBr2, BaCl2, CoBr2, ZnBr2, and McCl2 were also 
from Sigma.  Samples were prepared by mixing oligosaccharides (5 or 2.5 μM final 
concentration) and salts (20 or 10 μM final concentration) in a water:methanol (1:1 v/v) 
solution.  These concentrations are comparable to those used in similar analyses.26,27  For 





4.2.2 FT-ICR Mass Spectrometry 
 All experiments were performed with an actively shielded 7 T FT-ICR mass 
spectrometer with a quadrupole front-end (APEX-Q, Bruker Daltonics, Billerica, MA), as 
previously described.55  An indirectly heated hollow dispenser cathode was used to 
perform ECD.56  IRMPD was performed with a vertically mounted 25-W, 10.6-μm, CO2 
laser (Synrad, Mukilteo, WA).  Samples were infused either via an external Apollo or 
Apollo II electrospray ion source at a flow rate of 60 μL/h with the assistance of N2 
nebulizing gas.  Oligosaccharides adducted with either sodium, calcium, or potassium 
were examined using the Apollo II ion source, while the rest were analyzed with the 
original Apollo source.  Due to the increased sensitivity with the Apollo II ion source, 
sample concentrations were reduced by a factor of two.  Following ion accumulation in 
the first hexapole for 0.05 s, ions were mass selectively accumulated in the second 
hexapole for 1-7 s.  Ions were then transferred through high-voltage ion optics and 
captured with dynamic trapping in an Infinity ICR cell.57  The experimental sequence up 
to the ICR cell fill was looped 3 - 15 times to achieve maximum precursor ion signal.  
Due to contaminating salts present in all samples (all samples were used without further 
purification), several ion fills and longer accumulation times were often necessary in 
order to achieve abundant precursor ion signal of the metal-adducted species of interest.  
Precursor ions were further isolated in the ICR cell using correlated harmonic excitation 
fields (CHEF).58,59  For ECD, the cathode heating current was kept constant at 1.8 A and 
the cathode voltage was pulsed during the ECD event to a bias voltage of (- 0.1)-(- 1.0) V 
for 30-175 ms to generate low energy electrons.  A lens electrode located immediately in 
front of the cathode was kept at 1-2 V to improve electron injection.  IRMPD was 
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performed with a laser power of 7.5-15 W and with firing times ranging from 0.1-1 s.  
For activated-ion ECD of the N-glycan, ions were heated before they underwent electron 
capture for 25-100 ms with a 7.5-15 W laser pulse.  This activation was to aid in the 
destabilization of gas-phase secondary structure.60   
4.2.3 Data Analysis 
 All mass spectra were acquired with XMASS software (Bruker Daltonics) with 
256 data points from m/z 200-2500 and summed over 30-80 scans.  Data processing was 
performed with MIDAS software.61  Data were zero filled once, Hanning apodized, and  
exported to Microsoft Excel for internal frequency-to-mass calibration with a two-term 
calibration equation.62  Product ion spectra were interpreted with the aid of the web 
application GlycoFragment (www.dkfz.de/spec/projekte/fragments/).63  Product ions 
were not assigned unless they were at least 3x the noise level.  Many unlabeled product 
ions in several spectra are often assignable, but due to high mass error were left 
unlabeled. 
 
4.3 Results and Discussion 
 According to the Domon and Costello nomenclature64 product ions containing the 
reducing end of an oligosaccharide are designated as X (cross-ring cleavage), Y and Z-
type ions (glycosidic cleavage).  Those fragments containing the non-reducing end are 
designated A (cross-ring), B and C-type ions (glycosidic).  Subscript numerals denote 
where cleavage occurred, and superscript numerals denote between which bonds cross-
ring cleavage occurred.  In certain examples, when a product ion may correspond to 
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several possibilities, all possible ions are listed (alternative product ion assignments are 
indicated by parentheses). 
4.3.1 Linear Oligosaccharide: Maltoheptaose 
 Due to the symmetric nature of maltoheptaose, a number of ions cannot be 
distinguished based on their m/z ratio (B and Z, C and Y, and several A and X).  
However, earlier studies have shown that product ions formed from cleavage on the non-
reducing side of glycosidic oxygens (B and Y ions) are more abundant than those due to 
cleavage on the reducing side (C and Z ions).4  For maltoheptaose ionized with divalent 
cations, Harvey observed several Y ions, but could not distinguish between B and Z 
ions.27  Similarly, several of the A and X ions observed following IRMPD cannot be 
distinguished based on their m/z ratios, but CAD labeling studies have shown that cross-
ring cleavage products begin at the reducing end of the oligosaccharide to generate A-
type ions and proceed in a stepwise fashion towards the non-reducing end.17,18  
Commonly observed cross-ring cleavage fragments of metal-adducted oligosaccharides 
include 0,2A and 2,4A-type ions (low energy fragmentation techniques).  Based on this 
information, assumptions can be made regarding which product ion types are observed 
following IRMPD.  However, the precise ECD mechanism is yet to be fully elucidated,40-
43,65-68  and thus it is prudent to avoid making assumptions regarding which ion types are 
observed following ECD.  Throughout our discussion, when a product ion may 
correspond to several possibilities, all possible ions are listed for both IRMPD and ECD. 
 The IRMPD (Figure 4.1a) and ECD (Figure 4.1b) spectra obtained from barium-
adducted maltoheptaose are shown in Figure 4.1.  It should be noted that barium is not 
typically used as a metal cationizing agent for oligosaccharides.  Larger metal ions are 
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generally not favorable for oligosaccharide fragmentation because as metal ion size 
increases, there is a general tendency for poorer fragmentation.19,22  This trend has been 
attributed to the inability of many metal complexes with large metal cations to undergo 
charge-induced fragmentation.  For this reason, we were interested in examining whether 
barium would be an effective metal for catalyzing cross-ring fragmentation following 








































































































































































































2,4A7a) Ba - IRMPD b) Ba - ECD
0,2A7
Figure 4.1. FT-ICR tandem mass spectra of Ba2+-adducted maltoheptaose.  a) IRMPD 
(30 scans, 120 ms irradiation with 10 W laser power) and b) ECD (40 scans, 100 ms with 
a bias voltage of (- 0.2) V).  All ions in the spectra contain Ba.  Specific cleavages are 
indicated in the oligosaccharide structure above each spectrum (product ions with neutral 
losses are not indicated in the upper figure).  Due to the symmetry of the molecule, 
several product ions cannot be unambiguously assigned (indicated by parentheses in the 
labels in each spectra).  In the upper oligosaccharide structure, only one cleavage site is 
indicated if several are possible (to aid readability).  
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 In Figure 4.1a and 4.1b, all product ions retained barium.  Singly-charged product 
ions observed following IRMPD are due to accompanying proton loss, which is likely 
from a hydroxyl group.17  This proton loss would leave a structure containing an ion pair 
between the barium and an anionic oxygen,27 resulting in a metal-adducted product ion 
with one less charge than the precursor ion and a complementary protonated product ion.  
These protonated product ions are not present in the maltoheptaose spectra, due to the 
low m/z excitation/detection being set to 200.  In this example, IRMPD of barium-
adducted maltoheptaose (Figure 4.1a) results in predominantly doubly-charged product 
ions.  The preference for singly or doubly-charged product ions following IRMPD 
depends on the metal species, and reflects the second ionization energy of the 
coordinating metal.27  IRMPD of barium-adducted maltohepatose results in extensive 
glycosidic cleavage, as well as several less abundant cross-ring cleavage fragments.  In 
the IRMPD spectrum in Figure 4.1a, loss of 60 Da corresponds to loss of C2H4O2, which 
is probably a 0,2A cleavage in the reducing terminal saccharide.23,27   
 Following ECD of barium-adducted maltoheptaose (Figure 4.1b), all product ions 
are singly-charged even-electron ions, resulting from gain of an electron and subsequent 
loss of hydrogen.  Comparing Figures 4.1a and 4.1b, IRMPD of barium-adducted 
maltoheptaose does not result in extensive cross-ring cleavage.  However, in the ECD 
spectrum cross-ring cleavage is the dominant fragmentation pathway.  In Figure 4.1b, 
only three glycosidic cleavage fragments are observed compared to six cross-ring 
fragments.  It is interesting to note that glycosidic cleavage fragments from ECD 
correspond to the C(Y) ion type, but not the B(Z) type.  In addition, a charge-reduced 
species, [M + Ba]+●, is not observed.  ECD of protonated chitooligosaccharides,37 and 
 83
polyethylene glycol molecules69,70 also resulted in no apparent charge-reduced species.   
Following ECD of all metal-adducted forms of maltoheptaose, charge-reduced species 
were not observed, but in certain examples a proton-stripped species, [M + metal - H]+, is 
present. 
 The ECD spectrum of [M + 2Na]2+ is shown in Figure 4.2a.  Here, the most 
abundant fragmentation channel is loss of a sodium ion.  Similar to barium-adducted 
maltoheptaose, glycosidic cleavages observed following IRMPD of [M + 2Na]2+ 
correspond to B(Z)-type ions, whereas ECD only results in C(Y)-type glycosidic 
cleavage.  In Figure 4.2a, singly-charged ECD product ions are not due to loss of sodium 
but rather the gain of an electron and loss of hydrogen, as previously discussed.  The 
product ion at m/z 1076 has lost an additional hydrogen.71  Such additional hydrogen loss 
is observed occasionally following ECD (forming odd-electron species), but not 
following IRMPD.  Similarly, electron induced dissociation of protonated 
chitooligosaccharides occasionally resulted in minor odd-electron species 1 Da lighter 
than the corresponding even-electron species.37  ECD of the [M + 2K]2+ species was also 
examined (see Figure 4.3).  The results are similar to the [M + 2Na]2+ species, with 
relatively poor fragmentation yield and a mixture of glycosidic and cross-ring cleavages.  
 Figure 4.2b shows the ECD spectrum of [M + Mg]2+.  Numerous cross-ring 
cleavage fragments corresponding to 0,2A(2,4X) and 2,4A(0,2X)-type ions are observed, 
along with several glycosidic cleavage product ions.  The ECD spectrum of [M + Ca]2+ is 
shown in Figure 4.2c.  The dominant fragmentation pathway following ECD is the 
generation of a 2,4A7(0,2X6) product ion, which was not observed following IRMPD.  
Compared to some of the other species examined, IRMPD of calcium-adducted  
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Figure 4.2. ECD FT-ICR tandem mass 
spectra of the a) 2 Na+ adduct of 
maltoheptaose (60 scans, 50 ms with a 
bias voltage of (- 0.5) V) b) Mg2+ 
adduct of maltoheptaose (80 scans, 
100 ms with a bias voltage of (- 0.2) 
V) and c) Ca2+ adduct of 
maltoheptaose (60 scans, 75 ms with a 
bias voltage of (- 0.2) V).  * denotes 
electronic noise peaks.   indicates 
water loss from an adjacent peak.  
Product ions are underlined if they 













































































































































Figure 4.3.  ECD FT-ICR (20 scans, 60 ms with a bias voltage of -1.0 V) tandem mass 
spectrum of 2K adducted maltoheptoase.  * denotes electronic noise.  Product ions are 
underlined if they were not observed following IRMPD. 
 
maltoheptaose produces more extensive cross-ring cleavages (data not shown).  However, 
glycosidic cleavage was still the favored fragmentation pathway.  It is important to note 
that in a previous CAD examination of calcium-adducted maltoheptaose, several 0,2A and 
2,4A-type ions were observed, some of which are not seen in our IRMPD spectrum 
(including 2,4A6 and 2,4A5).27  Slight differences in fragmentation are due to the nature of 
the IRMPD process, which results in more extensive fragmentation compared to CAD.  
These larger 2,4A-type ions are not observed following IRMPD because they are likely 
further fragmented into smaller product ions.   
 The ECD spectrum of several transition metal adducts of maltoheptaose are 
shown in Figure 4.4.  Similar to previous examples, the most abundant product ions 
observed following ECD correspond to 2,4A7(0,2X6) and 2,4A6(0,2X5).  The ECD spectrum 
of [M + Mn]2+ is shown in Figure 4.4a, and demonstrates a mixture of glycosidic and 
cross-ring cleavage.  The proton-stripped peak is also quite abundant, which is not the 
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case for any of the other ECD examples with maltoheptaose.  The ECD spectrum of [M + 
Co]2+ is shown in Figure 4.4b.  Unlike previous ECD spectra, the occurrence of 
glycosidic cleavage is fairly abundant.  However, all of the glycosidic cleavage product 
ions observed are also present following IRMPD.  The ion labeled as [M - 90]+ 
corresponds to loss of C3H6O3, which could be a 0,3A fragment in the reducing terminal 
saccharide.  Figure 4.4c displays the ECD spectrum of [M + Zn]2+.  Zinc is not typically 
used as a cationizing agent for oligosaccharide analysis because it forms relatively weak 
complexes.23  Consequently, several seconds of ion accumulation and several cell fill 
cycles were required for the zinc-adducted species, in order to produce an ion signal 
sufficient for ECD.  These measures were necessary due to the lower fragmentation 
efficiency in ECD compared to traditional MS/MS techniques.  Following IRMPD, only 
one cross-ring cleavage fragment is observed, ([M - 60]+), and glycosidic cleavage 
fragments are much less abundant compared to the other examples discussed thus far.  
The ECD fragmentation pattern of the zinc adduct demonstrates that cross-ring 
fragmentation is the preferred fragmentation pathway.  Several additional cross-ring 
fragments were observed, however, due to poor S/N ratio were not labeled.  Although 
ECD of zinc-adducted maltoheptoase demonstrates that cross-ring fragmentation is 
extensive, selecting a metal ion which more effectively ionizes the oligosaccharide would 
shorten the ECD experimental sequence while still providing similar fragmentation 
information.   During this examination, calcium was particularly effective in ionizing 
maltoheptaose.  The ability of divalent metals to ionize neutral oligosaccharides has been 




Figure 4.4. ECD FT-ICR tandem mass 
spectra of the a) Mn adduct of 
maltoheptaose (40 scans, 100 ms with 
a bias voltage of (- 0.2) V) b) Co 
adduct of maltoheptaose (40 scans, 
125 ms with a bias voltage of (- 0.2) 
V), and c) Zn adduct of maltoheptaose 
(40 scans, 50 ms with a bias voltage of 
(- 0.1) V).  * denotes electronic noise.  
 indicates water loss from an 
adjacent peak.  Product ions are 
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4.3.2 Linear Oligosaccharide: Para-lacto-N-hexaose 
 To further examine the ECD fragmentation patterns of metal-adducted 
oligosaccharides, a second linear oligosaccharide was examined.  The IRMPD and ECD 
spectra of manganese-adducted para-lacto-N-hexaose (pLNH) are shown in Figures 4.5a 
and 4.5b, respectively.  In the IRMPD spectrum of [M + Mn]2+ in Figure 4.5a, the most 
abundant product ion corresponds to a protonated B2 ion (protonated species are denoted 
by H+).  This ion along with a dehydroxy-N-acetyl glucosamine, labeled as [GlcNAc - 
H2O]*+, are observed in every IRMPD and ECD spectrum of pLNH.  Cleavage to the 
reducing side of GlcNAc is a facile process, and energy imparted into the precursor ion 
during quadrupole and in-cell CHEF isolation was sufficient for formation of these ions.  
Following IRMPD, the two most abundant metal-adducted glycosidic cleavage fragments 
are B2 and Y4, which both correspond to cleavage to the reducing side of GlcNAc.  In 
Figure 4.5a, three 2,4A(0,2X) and one 0,2A(2,4X)-type cross-ring cleavage product are also 
observed.  Following ECD, the most abundant product ions are C5(Y5), [C5(Y5) - 42], and 
2,4A6(0,2X5).  Loss of 42 Da corresponds to loss of a ketene molecule (CH2CO) from N-
acetylglucosamine, which was previously observed following ECD of protonated 
chitooligosaccharides.37  The three most abundant product ions observed following ECD 
are not present in the IRMPD spectrum, thus demonstrating the complementary 
fragmentation patterns which can be obtained following ECD.   
 The ECD spectra of pLNH adducted with either Ca, Mg, Ba, Co, or Zn are shown 
in Figures 4.6 and 4.7.  In all cases, several additional cross-ring cleavage product ions 























































































































































































a) Mn - IRMPD b) Mn - ECD
Figure 4.5. FT-ICR tandem mass spectra of Mn-adducted para-lacto-N-hexaose. a) 
IRMPD (40 scans, 150 ms irradiation with 7.5 W laser power) and b) ECD (80 scans, 50 
ms with a bias voltage of (- 0.2) V).  All product ions contain Mn, unless denoted by  H+, 
indicating protonation.   indicates water loss from an adjacent peak.  Specific cleavages 
are indicated in the oligosaccharide structure above each spectrum (product ions with 
neutral losses are not indicated in the upper figure).  Due to the structure of the molecule, 
several product ions cannot be unambiguously assigned (indicated by parentheses in 
labels in each spectra).  In the upper oligosaccharide structure, only one cleavage site is 
indicated if several are possible (to aid readability). 
 
spectra are underlined in both Figures 4.6 and 4.7.  Several neutral molecule losses are 
also observed in these spectra, including loss of 42 Da as previously discussed.  In 
addition, loss of 57 Da is observed, which likely corresponds to loss of C2H3NO from N-
acetyl glucosamine.  The [M + 2Na]2+ and [M + 2K]2+ species of pLNH were not 
investigated, because the dominant fragmentation pathway following ECD is loss of a 
sodium or potassium ion, as demonstrated from the examples with maltoheptaose.   
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Figure 4.6. ECD FT-ICR tandem 
spectra of metal-adducted species of 
para-lacto-N-hexaose a) Mg adduct 
(80 scans, 150 ms with a bias voltage 
of -0.5 V).  Product ion a = 
[0,2A4(2,4X3,1,3A3)]+, b = 
[2,4A5(0,2X4,1,3X1) - 57]+, c = [2,5A5 - 57 
- H]+, and d = [M - 90 - 42]+.  b) Ca 
adduct (60 scans, 75 ms with a bias 
voltage of -0.2 V).  Product ion e = 
[0,2A4(2,4X3,1,3A3) - 2(42) - 57]+, f = 
[0,2A4(2,4X3,1,3A3) – 2(42)]+, g = 
[2,4A5(0,2X4,1,3X1) – 57 - Hex]+, h = 
[0,2A4(2,4X3,1,3A3) - 42]+, i = [2,3X3 - 
42]+. c) Ba adduct (60 scans, 125 ms 
with a bias voltage of -0.2 V). Product 
ion j = [0,2A4(2,4X3,1,3A3) - 2*42 - 57]+, 
k = [2,4A4(0,2X3) - 57]+, l = 
[0,2A4(2,4X3,1,3A3) - 2*42]+, and m = 
[2,4A5(0,2X4,1,3X1) - 57]+.  * denotes 
electronic noise.  indicates water 
loss from an adjacent peak.  All 
product ions contain a metal, unless 
denoted by H+, indicating protonation. 
Product ions are underlined if they 
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Figure 4.7. ECD FT-ICR tandem 
spectra of metal-adducted species of 
para-lacto-N-hexaose a) Co adduct (80 
scans, 175 ms with a bias voltage of -
0.75 V).  b) Zn adduct (80 scans, 100 
ms with a bias voltage -0.5 V).  
Product ion a= [2,4A5(0,2X4,1,3X1) - 
57]+.  * denotes electronic noise.  
indicates water loss from an adjacent 
peak.  All product ions contain the 
metal unless denoted by H+, indicating 
protonation. Product ions are 











4.3.3 Branched N-linked Oligosaccharide 
 To determine whether ECD is applicable to non-linear oligosaccharides, a 
branched N-linked glycan was also examined.  The structure of this glycan from human 
α1-acid glycoprotein, with the general saccharide composition [Gal-GlcNAc]3-Man3-
GlcNAc2, is shown in Figure 4.8.  The IRMPD and ECD spectra of the doubly protonated 
species are shown in Figures 4.8a and 4.8b.  Unlike maltoheptaose and pLNH, a doubly 
protonated species was easily generated if the sample was electrosprayed under acidic 
m / z














































































conditions.  Following both IRMPD and ECD, several product ions are due to the 
combination of cleavages on both the reducing and non-reducing ends, such as the case 
with C5/Z4.  Product ions corresponding to multiple cleavage sites are indicated by a 
front-slash.  Several product ions in the ECD spectrum may be caused by vibrational 
excitation, since activated-ion ECD was necessary in order to fragment this 
oligosaccharide.  Without ion activation, very little ECD fragmentation was observed.    
 Following IRMPD of the doubly protonated species, the most abundant product 
ions in the spectrum, B2 and Y4, correspond to cleavage adjacent to N-acetylglucosamine.  
One of the most diagnostic product ions observed in Figure 4.8a corresponds to “ion D”, 
labeled as [GlcNAcMan3 - H2O]+.12  This ion is due to the loss of the 3-linked antennae 
and reducing end N-acetylglucosamines, and its presence allows for the determination of 
the saccharide composition of the 6-linked antenna.  Following ECD of the protonated 
species, several additional product ions are observed; however most of these correspond 
to glycosidic cleavages.  The product ion observed at m/z 1857.7 corresponds to loss of 
149 Da from the neutral precursor ion, and could potentially be assigned as [0,3A6 - 
H2O]+.  The product ion observed 162 mass units lower than this ion is due to loss of a 
non-reducing end saccharide (Y5 cleavage).  The product ion labeled as [M]+ in Figure 
4.8b corresponds to the proton-stripped species, not to be confused with the charge-
reduced radical species.    
 Figure 4.9 shows the IRMPD and ECD spectra of the cobalt-adducted N-linked 
glycan.  The ECD fragmentation patterns of several other metal adducts of this 













































































































































































































Figure 4.8. FT-ICR tandem mass spectra of a doubly protonated N-linked glycan. a) 
IRMPD (20 scans, 125 ms irradiation with 7.5 W laser power) and b) ECD (40 scans, 100 
ms with a bias voltage of (- 0.2) V).  indicates water loss from an adjacent peak.  In the 
ECD spectrum, product ion a = [Z4]+, and b = [0,3A6 - H2O]+.  Specific cleavages are 
indicated in the oligosaccharide structure above each spectrum (product ions with neutral 
losses are not shown in the upper figure).  * indicates electronic noise.  For several 
product ions, including Y5, B2, Y4, and Z4, cleavage may occur at several sites.  In the 
upper oligosaccharide figure, only one site is indicated (to aid readability). 
 
 
As with maltoheptaose and pLNH, ECD of the metal-adducted species always resulted in 
additional product ions compared to IRMPD and yielded complementary structural 
information.  In Figure 4.9a, several diagnostic cross-ring cleavage product ions are 
observed.  The cross-ring cleavage fragments that result from multiple bond scissions 
within the core branching mannose are especially useful for structural characterization.  
Several product ions correspond to a combination of 2,4A cleavage within the reducing 
terminal GlcNAc, along with additional glycosidic cleavage (for example 2,4A6/Y4 and 
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2,4A6/Z4).  An earlier study by Leary and co-workers, who compared the fragmentation 
spectra of Cu2+, Mn2+, Co2+, Zn2+, and Ca2+-adducted oligosaccharides, similarly 
demonstrated that a cobalt-coordinated oligosaccharide generated a unique fragmentation 
spectrum.   
 ECD of the cobalt-adducted species (Figure 4.9b) resulted in several additional 
product ions, yielding complementary information.  Additional cross-ring cleavages 
include 0,2A5, 1,5X4, and 1,5X3α.  Both high-energy CAD11,31-33 and 157 nm 
photodissociation38 of oligosaccharides generate 1,5X-type product ions.  Moreover, it 
should be noted that with maltoheptaose and pLNH, several ECD product ions could not 
be absolutely identified as A or X-type ions because of the symmetry of the molecule.  
However, the fragmentation patterns observed following ECD of an N-linked glycan 
indicate that previously observed ECD product ions correspond to 0,2A and 2,4A-type ions.  
With this knowledge, re-examination of the ECD fragmentation patterns of 
maltoheptaose and pLNH demonstrates that cross-ring cleavages preferably occur 
towards the reducing end of the oligosaccharide. 
 Two of the most abundant product ions in Figure 4.9b are the proton-stripped 
species, [M]+, and [2M]3+.  The latter triply-charged species can be explained by 
dimerization.  During the electrospray process, dimerization occurred, resulting in a non-
covalent species containing two glycans and two cobalts.  Inspection of the isotopic 
distribution of the precursor ion confirmed the presence of this dimer.  ECD is able to 
maintain this non-covalent interaction, as demonstrated by the presence of [2M]3+, which 
is due to gain of an electron and loss of a hydrogen, and [2M - 42]3+.  The [2M - 42]3+ 















































































































































































































Figure 4.9. FT-ICR tandem mass spectra of a Co-adducted N-linked glycan. a) IRMPD 
(80 scans, 350 ms irradiation with 10 W laser power) and b) ai-ECD (80 scans, 60 ms 
irradiation with 7.5 W laser power, 75 ms with a bias voltage of (- 0.5) V). All product 
ions contain Co, unless denoted by H+, indicating protonation.    indicates water loss 
from an adjacent peak.  In the IRMPD spectrum, product ion a = [2,4A2]+, b = [2,4A6/Y2]+, 
c = [B2 - 42]+, d =[B3β - H2O - 42]+, e = [GlcNAcMan3 - H2O]+ (“ion D”), f = [2,4A6/M - 
(GlcNAcMan)2 - H2O - 42]+, g = [2,4A6/M - (GlcNAcMan)2]+.  In the ECD spectrum, 
product ion h = [C4]+ and i = [C5 - 42]+.  Specific cleavages are indicated in the 
oligosaccharide structure above each spectrum (product ions with neutral losses are not 
shown in the upper figure).  * indicates electronic noise.  For several product ions, 
including Y5, 2,4A2, B2, Y4, Z4, and 1,5X4, cleavage may occur at several sites.  In the 
upper oligosaccharide figure, only one site is indicated (to aid readability). 
 
However in certain cases, such as with the Mg2+-coordinated oligosaccharide, several 
other unique product ions are also observed (data not shown).  These include 
[M/2,4A6]3+,[M/C5]3+, and [M/Y4]3+.  The ability of ECD to maintain non-covalent 
interactions is not a new finding, and it has been utilized for the characterization of both 
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peptides72 and proteins.73-75  However, these results are interesting because the 
application of ECD for the examination of non-covalent interactions of oligosaccharides 
has not been explored. 
4.3.4 ECD Mechanism for Metal-Coordinated Oligosaccharides 
 Prior theoretical and experimental work aimed at establishing the nature of the 
ECD mechanism has focused on multiply-charged peptide ions.  Most of that work only 
considered protonated species, with very few examinations devoted to ECD of metal-
adducted peptides.52-54,76  However, Heck and co-workers have recently proposed that in 
an oxytocin-transition metal complex, the metal ions serve as the main initial electron 
capture site during ECD.  The captured electron is then transferred to other sites to form a 
hydrogen radical, which can drive subsequent fragmentation.52  Previous work from our 
group examining metal-adducted Substance P indicates that hydrogen radicals are not 
necessarily involved in this process.54  Those results imply that initial electron capture is 
at the metal and is followed by electron and proton transfer, which is rationalized by the 
“amide superbase” mechanism.43  Furthermore, Chan and co-workers have also used 
metal ions as charge carriers for ECD of peptides.53  They explained that due to the 
peptide existing predominantly in the zwitterionic form, electron capture leads to 
reduction of a mobile proton rather than the metal ion.  In our investigation, a 
zwitterionic oligosaccharide is unlikely due to the absence of acidic sites, so the first two 
proposals may be more applicable here.  
 Metal coordination drastically changes the ECD fragmentation spectra of 
oligosaccharides compared to their protonated counterparts.  The differences in ECD 
fragmentation of protonated versus metal-complexed oligosaccharides are likely due to 
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differences in metal coordination.  While protonation is localized to the glycosidic 
oxygen, metals are able to undergo coordination with several oxygen atoms 
simultaneously.15,22  If electron transfer is involved, multiple coordination could also 
explain why metal-adducted oligosaccharides fragment differently.  According to the 
previously discussed mechanisms, the coordination of the metal to the oligosaccharide 
and the second ionization energy are expected to significantly affect ECD fragmentation.  
However, additional fundamental studies are required in order to understand the ECD 
mechanism in regards to oligosaccharide fragmentation. 
 
4.4 Conclusions 
 We demonstrate that metal adduction allows ECD of oligosaccharides that do not 
contain basic sites.  In addition, we show that complementary structural information can 
be obtained from ECD of such metal-adducted species as compared to IRMPD.  
Depending on the metal ion and oligosaccharide structure, in certain examples we have 
shown that cross-ring cleavage can be greatly enhanced (particularly for maltoheptaose).  
A comparison of the ECD spectra of linear oligosaccharides with varying metal charge 
carriers demonstrates subtle differences in fragmentation.  These subtle differences are 
likely due to several factors, including coordination number and second ionization energy 
of each metal.  The fragmentation pattern of a branched oligosaccharide was also 
examined to determine whether branching would significantly affect the ECD 
fragmentation pattern.  The larger branched oligosaccharide was more difficult to 
fragment with ECD, presumably due to secondary structure, therefore a direct 
 98
comparison of ECD fragmentation efficiencies of linear versus branched oligosaccharides 
is difficult to make here.   
 Following ECD of oligosaccharides ionized with two sodium or potassium ions, 
the predominant fragmentation pathway was loss of sodium and potassium (with only a 
few low abundance glycosidic and cross-ring fragments).  Of the divalent metal-adducted 
oligosaccharides examined, our results do not indicate that there is a clearly optimal 
metal which will maximize cross-ring fragmentation for both branched and linear 
oligosaccharides following ECD.  ECD of all metal-adducted oligosaccharides 
consistently provided complementary fragmentation behavior as compared to IRMPD.  
However, for the characterization of oligosaccharides with the combination of ECD and 
metal adduction, it is advantageous to select a metal which ionizes the oligosaccharide 
most effectively.  ECD fragmentation efficiency is lower compared to traditional MS/MS 
techniques, thus selecting a metal ion which maximizes precursor ion signal is an 
important factor to consider.  In summary, when used in conjunction with IRMPD, ECD 
of metal-adducted oligosaccharides results in complementary fragmentation behavior, 
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 Glycosylation is a highly prevalent post-translational modification (PTM), whose 
role has been linked to a wide variety of biological activities,1,2 ranging from protein 
folding3 to immune system response.4  Unlike most biomolecules, oligosaccharides often 
exist as several isomeric forms with diverse linkages, and may form linear or branched 
structures.  Complete structural characterization of oligosaccharides requires the 
determination of constituent monosaccharides, their linkage, sequence, and branching 
patterns.  Given their diversity and structural complexity, structural elucidation of 
oligosaccharides often relies upon a wide range of analytical methodologies, of which 
nuclear magnetic resonance spectroscopy and mass spectrometry are two vital 
techniques.  Tandem mass spectrometry (MS/MS) is widely used for glycan structural 
characterization,5-7 due to the advent of instruments that provide high quality spectra 
from even low abundance molecular species.   
 Tandem mass spectra of oligosaccharides consist mainly of glycosidic and cross-
ring product ions (shown in Figure 1.5 in Chapter 1).  Glycosidic cleavage occurs
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between monosaccharide units and provides information regarding saccharide sequence 
and branching.  Cross-ring cleavages can provide valuable information regarding 
saccharide linkage, particularly when occurring at branching residues.  Several factors are 
known to affect oligosaccharide fragmentation and the degree of cross-ring 
fragmentation, such as the ionizing cation, the lifetime of the ion prior to detection, and 
the energy deposited into the ion.     
 Typically, neutral oligosaccharides are analyzed in positive ion mode, via their 
protonated forms or through metal ion adduction.  In addition, chemical derivatization 
such as permethylation is widely used to increase sensitivity, reduce molecular ion 
lability, and produce structurally diagnostic product ions.8-10  Low energy activation 
methods, such as collisional activated dissociation (CAD) and infrared multiphoton 
dissociation (IRMPD), applied to protonated oligosaccharides results in predominantly 
glycosidic cleavages.  However, oligosaccharides ionized with alkali, alkaline earth, and 
transition metals often fragment to yield more cross-ring cleavages compared to their 
protonated counterparts.11-14  Although fragmentation of neutral oligosaccharides in 
negative ion mode is not as frequently examined, it has been demonstrated that native, 
neutral oligosaccharide anions produce abundant C-type glycosidic cleavages and A-type 
cross-ring cleavages in CAD, as opposed to B- and Y-type glycosidic cleavages which 
are commonly observed for oligosaccharide cations (Domon and Costello 
nomenclature15).16-19  Low energy CAD combined with negative ion mode electrospray 
ionization (ESI) has been used for examining neutral glycans from human urine and 
milk.19-22  Less work has been done on negative ions from N-linked glycans, but it has 
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been shown that neutral, singly deprotonated N-glycans are highly susceptible to in-
source fragmentation during electrospray ionization.23 
 Many oligosaccharides derived from glycoproteins and glycolipids contain sialic 
acids, monosaccharides which contain a carboxylic acid group at the C-1 position (shown 
in Figure 1.1 in Chapter 1).  Oligosaccharides containing sialic acids typically yield more 
abundant signal in negative ion mode mass spectrometry.  When sialylated 
oligosaccharides are analyzed in positive ion mode, sialic acids may be lost, resulting in 
an absence of information regarding sialic acid linkage.5,6  Native sialylated 
oligosaccharides are particularly fragile in matrix-assisted laser desorption/ionization 
(MALDI) in which they often undergo in-source fragmentation, thereby suggesting 
electrospray ionization is more suitable for their analysis.  The influence of sialylation on 
negative ion mode CAD for milk and N-glycans has been recently examined.24  These 
results demonstrated that deprotonated sialylated oligosaccharides required more energy 
to fragment compared to either their deprotonated asialo or nitrate adducted counterparts.  
Zaia and co-workers explain that sialylated glycans are more stable in the gas phase 
because negative charge resides on the carboxyl group.  However, for asialo 
oligosaccharides, a proton is extracted from a ring hydroxyl group during electrospray 
ionization, which imparts more energy than it would for a sialylated oligosaccharide. 
 Although most modern mass analyzers utilize low energy dissociation techniques 
such as low energy CAD, several alternative fragmentation techniques have been 
developed and applied to oligosaccharides including high-energy CAD,25-27 IRMPD,28,29 
electron capture dissociation (ECD),30,31 electron detachment dissociation (EDD),32,33 and 
157 nm photodissociation.34  In particular, the use of ion-electron reactions for 
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biomolecular structural characterization is rapidly expanding.  ECD has been used 
extensively for the characterization of peptide and protein cations,35 due to its ability to 
promote extensive peptide backbone fragmentation without the loss of labile 
modifications such as glycosylation.36-41  In ECD, polycationic molecules are irradiated 
with low-energy electrons (<1 eV), generating charge reduced radical species and product 
ions.42,43  ECD has been applied to protonated chitooligosaccharides, which yielded 
primarily glycosidic cleavages corresponding to B and C-type ions,30 and recently to 
permethylated oligosaccharides.44  In Chapter 4, we demonstrated that ECD of 
oligosaccharides ionized with divalent metal ions can result in additional fragmentation 
not observed following vibrational excitation.31   
 Electron detachment dissociation (EDD) was introduced in 2001 as a 
fragmentation technique for polyanions.45  In EDD, polyanions are irradiated with >10 
eV electrons, resulting in electron detachment and subsequent product ions.  EDD has 
been applied to peptides,45-47 oligonucleotides,48,49 gangliosides,50 and recently 
glycosaminoglycans (GAGs).32,33  GAGs are linear polysaccharides consisting of  
repeating disaccharide units and are frequently polysulfated.  EDD of GAGs resulted in 
information-rich mass spectra with both cross-ring and glycosidic cleavages.  In contrast, 
CAD and IRMPD of GAGs resulted in predominantly glycosidic cleavages.    
 EDD has, to our knowledge, not previously been applied to a wide variety of 
oligosaccharides, including neutral and sialylated glycans, as well as branched 
oligosaccharides.  In the current manuscript, we examine the fragmentation patterns of 
neutral and sialylated oligosaccharides following EDD and compare these fragmentation 
patterns to those obtained from IRMPD and CAD.  In addition, both linear and branched 
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oligosaccharides are examined to determine what effect branching has upon EDD 
fragmentation.   
 
5.2 Experimental 
5.2.1 Sample Preparation 
 Maltoheptaose (Sigma, St. Louis, MO), LS-tetrasaccharides (LSTa and LSTb), 
disialyllacto-N-tetraose (DSLNT), an asialo biantennary glycan (NA2) (V-labs, 
Covington, LA), and a monosialylated biantennary glycan (A1F) (Calbiochem, San 
Diego, CA) were prepared in a solution of 50 % methanol (Fisher, Fair Lawn, NJ) and 
0.1 % ammonium hydroxide (Sigma) to a final concentration of 3 μM. 
5.2.2 FT-ICR Mass Spectrometry 
 All experiments were performed with an actively shielded 7 T Fourier transform 
ion cyclotron resonance (FT-ICR) mass spectrometer with a quadrupole front-end 
(APEX-Q, Bruker Daltonics, Billerica, MA), as previously described.51  Samples were 
infused via an Apollo II ion source at a flow rate of 60 μL/h with the assistance of N2 
nebulizing gas.  Following ion accumulation in the first hexapole for 0.05 s, ions were 
mass selectively accumulated in the second hexapole for 2 - 6 s.  Ions were then 
transferred through high-voltage ion optics and captured with dynamic trapping in an 
Infinity ICR cell.52  The experimental sequence up to the ICR cell fill was looped 4 - 8 
times to achieve maximum precursor ion signal for EDD.  Precursor ions were further 
isolated in the ICR cell using correlated harmonic excitation fields (CHEF).53  An 
indirectly heated hollow dispenser cathode was used to perform EDD.54  IRMPD was 
performed with a vertically mounted 25-W, 10.6-μm, CO2 laser (Synrad, Mukilteo, WA).  
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External CAD was performed in a hexapole following mass selective ion accumulation 
with argon as a collision gas.  For EDD, the cathode heating current was kept constant at 
2.0 A and the cathode voltage was pulsed during the EDD event to a bias voltage of (- 20 
) - (- 30 ) V for 1 - 2 s.  A lens electrode located immediately in front of the cathode was 
kept 0.8 - 1 V higher than the cathode bias voltage. 
5.2.3 Data Analysis 
 All mass spectra were acquired with XMASS software (Bruker Daltonics) with 
256 data points and summed over 30 scans.  Data processing was performed with 
MIDAS software.55  Data were zero filled once, Hanning apodized, and exported to 
Microsoft Excel for internal frequency-to-mass calibration with a two-term calibration 
equation.  The precursor ion and charge reduced radical species were used for calibration 
of EDD spectra.  For CAD, IRMPD, and EDD spectra where the charge reduced species 
was not observed (or with only low abundance), an abundant glycosidic cleavage product 
ion and the precursor were used for calibration.    Product ion spectra were interpreted 
with the aid of the web application GlycoFragment 
(www.dkfz.de/spec/projekte/fragments/).56  
 
5.3 Results and Discussion 
 All product ions are labeled according to the Domon and Costello nomenclature.15  
Ions due to multiple cleavage sites are designated with a slash between sites of cleavage 
(e.g., 2,4A6/Y5).  When several product ion assignments are possible, alternative 
assignments are indicated in parentheses (e.g., Y4α(Y3β)).  For branched oligosaccharides, 
the letter α represents the largest branch. 
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5.3.1 MS/MS of Neutral Oligosaccharides 
 Two neutral oligosaccharides were examined to evaluate the EDD fragmentation 
patterns of oligosaccharides lacking acidic moieties.  These oligosaccharides include 
maltoheptaose, a linear oligosaccharide containing seven α1→4 linked glucose 
molecules (Scheme 5.1), and an asialo, biantennary glycan (NA2) with a composition of 
Galβ4GlcNAcβ2Manα6(Galβ4GlcNAcβ2Manα3)Manβ4GlcNAcβ4-GlcNAc (Scheme 
5.2).  Due to the symmetric nature of maltoheptaose, a number of ions cannot be 
distinguished based on their m/z ratios (C and Y, and several A and X).  However, native 
neutral oligosaccharide anions that are 1-4 or 1-6 linked have been shown to produce 
predominantly C-type and A-type ions during CAD.16-20  The majority of ions observed 
following CAD (Figure 5.1a) and IRMPD (Figure 5.1b) of maltoheptaose are singly 
charged, with exceptions being denoted by an asterisk.  The CAD and IRMPD spectra 
show very similar fragmentation patterns, although they are not identical.  Several lower 
molecular weight glycosidic and cross-ring cleavage product ions were only observed 
following IRMPD.  Although IRMPD and low-energy CAD are both low energy 
vibrational excitation techniques, Lebrilla and co-workers have shown that the 
fragmentation efficiency in IRMPD is greater than that in CAD for larger 
oligosaccharides.57  An alternative explanation for the absence of low molecular weight 
species following CAD is the time-of-flight effect when transferring ions from the 
external hexapole to the ICR cell.  Low m/z species will arrive at the cell sooner than 
higher m/z species, thereby displaying optimum capture at different experimental 
conditions.  Cross-ring cleavages observed following both fragmentation techniques 
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corresponded either to 0,2A-type or 2,4A-type ions, consistent with α1-4 linked 









































































































0,2A5 (2,4X4) - H2O
C5(Y5)





2,4A7(0,2X6) [M - 2H]-●
 
Figure 5.1.  FT-ICR tandem mass spectra of doubly deprotonated maltoheptaose.  a) 
CAD (30 scans, collision cell voltage 3 V) b) IRMPD (30 scans, 200 ms irradiation, 2.5 
W) c) EDD (30 scans, 2 s, bias voltage of – 25 V).  Doubly deprotonated product ions are 
indicated with an asterisk next to a product ion assignment.  Asterisks above a peak 
indicate electronic noise.   Squares indicate water loss from an adjacent product ion.  
Underlined product ions exhibit minor radical species (with a mass corresponding to 
hydrogen loss).  Due to the symmetry of the molecule, several product ions cannot be 
unambiguously assigned (indicated by parentheses in the labels in each spectrum).   
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examined, and are shown in Figure 5.2.  Product ions observed from the [M - H]- species 
were very similar to those from the [M - 2H]2- precursor ions.  Although maltoheptaose is 
a neutral oligosaccharide, under the negative ion mode electrospray conditions described 
earlier, the relative abundance of the doubly deprotonated species was typically at least 
50%.  Thus EDD of this neutral oligosaccharide was not hindered by poor ion signal.   
 
Scheme 5.1. Fragmentation pattern 
observed following CAD, IRMPD, and 
EDD of doubly deprotonated 










 The EDD spectrum of doubly deprotonated maltoheptaose (Figure 5.1c) contains 
only singly charged product ions, including the charged reduced species, [M – 2H]-•.  
Singly charged product ions can arise via two fragmentation mechanisms, either through 
direct decomposition of the activated precursor ion, or through electron detachment from 
the precursor and subsequent fragmentation.32  A mixture of even- and odd-electron 
species are observed following EDD of maltoheptaose.  Ions which exhibit minor 
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product ions, hydrogen loss was a relatively minor fragmentation pathway.  One 
exception is the ion at m/z 646.2, denoted B4(Z4) - H, in which the radical species is more 
abundant than the even-electron species.  Product ions corresponding to loss of hydrogen 
from B-type ions have also been observed following EDD of GAGs.32  Odd-electron 
product ions can be formed following hydrogen loss from an even-electron species, or 






















































Figure 5.2.  FT-ICR tandem mass spectra of singly deprotonated maltoheptaose.  a) CAD 
(30 scans, collision cell voltage 14 V) b) IRMPD (30 scans, 150 ms irradiation 2.5 W).  
Squares indicate water loss from an adjacent product ion.  Due to the symmetry of the 
molecule, several product ions cannot be unambiguously assigned (indicated by 
parentheses in the labels in each spectrum).   
 
 EDD of maltoheptaose results in a combination of glycosidic and cross-ring 
fragmentation, and exhibits several unique product ions not observed following either 
CAD or IRMPD.  In addition to several 0,2A(2,4X) and 2,4A(0,2X)-type cross-ring 
cleavages, 1,5X and 3,5A-type ions are observed, including 1,5X2, 1,5X4, 3,5A4, and 3,5A5.  
 112
Both 1,5X and 3,5A-type cross-ring cleavages are commonly observed following positive 
ion mode high-energy CAD (heCAD) of oligosaccharides,27,58 and were also noted 
following EDD of GAGs.32  X-type cross-ring cleavages are typically not observed 
following low energy CAD or IRMPD. 
 Three unique product ions denoted Y4 - 15.99 Da, Y5 - 15.99 Da, and Y6 - 15.99 
Da were observed following EDD of maltoheptaose.  These ions were not reported by 
Amster and co-workers following EDD of GAGs.  Kováčik et al.59 and Harvey et. al.58 
have reported Y - 16 Da ions following positive ion mode heCAD.  In their experiments, 
only Y - 16 Da ions were observed, as opposed to C - 16 Da (a possible alternative 
assignment due to the symmetry of maltoheptaose).  However, following EDD of other 
neutral and sialylated oligosaccharides (discussed below), only losses of 16 mass units 
are observed from Y-type ions.  We propose that these ions correspond to Z + 2H ions.  
Kováčik et al. proposed that these ions were due to internal residue losses.  However, for 
maltoheptaose, internal residue loss would not account for the molecular weight of these 
product ions.  The same authors also discussed that these product ions could correspond 
to Z + 2H ions, but later disregarded this explanation.  We believe there are several lines 
of evidence to support that these ions observed following EDD are Z + 2H species.  
Hydrogen addition and abstraction following ECD of peptides have been well 
documented,60,61 and have also been reported for EDD of peptides.45  Following EDD of 
GAGs, hydrogen abstraction from B- and C-type ions has also been noted, and observed 
as B - H, C - H, and C - 2H type ions.32,33  Of particular interest is the product ion type C 
- 2H, which also has been reported by several investigators following positive ion mode 
heCAD58,62-65 and, which is observed following EDD of sialylated oligosaccharides in our 
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examination.  The complementary fragment for a C - 2H product ion would be a Z + 2H 
species.  For both maltoheptaose and an asialo biantennary glycan (NA2) (Figure 5.4), Z 
+ 2H (or Y - 16 Da) product ions are observed while their complementary C - 2H species 














































Figure 5.3.  FT-ICR tandem mass spectra of doubly deprotonated NA2.  a) CAD (30 
scans, collision cell voltage 8 V) b) IRMPD (30 scans, 125 ms irradiation 5 W).  Doubly 
deprotonated product ions are indicated with an asterisk next to a product ion assignment.  
Squares indicate water loss from an adjacent product ion.   
 
 The CAD and IRMPD spectra of a doubly deprotonated asialo, biantennary 
glycan (NA2) are shown in Figure 5.3.  The corresponding singly deprotonated species 
was of relatively poor abundance following ESI, and was not examined.  Using negative 
ion mode ESI conditions as described, the singly charged species had a relative 
abundance of less than 5%.   Both CAD and IRMPD of the doubly deprotonated species 
resulted in a mixture of glycosidic and cross-ring cleavages, where glycosidic cleavages 
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included both C- and B-type ions (which could also correspond to water losses from C-
type ions).  Cross-ring fragments were almost exclusively 0,2A and 2,4A-type ions.  The 
singly deprotonated glycan has also been examined in negative ion mode CAD following 
ESI by Harvey66 and by Zaia and co-workers,24 showing a similar fragmentation pattern 
to the doubly deprotonated species examined here.    
 Unlike maltoheptaose, a mixture of doubly and singly charged product ions was 
observed following EDD of NA2 (Figure 5.4 and Scheme 5.2).  Doubly charged product 
ions, including C4*, C5*, 0,2A5*, 0,2A6*, and 2,4A6* are likely due to direct decomposition of 
the activated precursor ion (an asterisk indicates doubly charged ions).  The majority of 
product ions generated following EDD are even-electron species.  Several product ions 
are due to multiple cleavages, many of which involve a combination of glycosidic and 
cross-ring fragmentation.  In addition to 2,4A and 0,2A-type cross-ring cleavages, 1,5X and 
3,5X-type product ions were observed.  One of the most abundant product ions detected 
following EDD corresponds to 3,5X3(3,5X5), at m/z 1565.55.  Also observed is the product 
ion at m/z 688.23 labeled GlcNAcMan3 - H2O, otherwise known as “ion D”.  This ion is 
due to loss of the 3-linked antenna and two reducing GlcNAc residues.  Ion D allows for 
determination of the monosaccharide composition of the 6-linked antenna, and by 
subtraction also the 3-linked antenna.  This ion was also observed following IRMPD and 
CAD.  Two Y -16 Da type ions, or as we propose Z + 2H ions, are also observed 
following EDD (denoted as Y4 - 15.99 Da and C4/Y5 - 15.99 Da).  Similar to 
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Figure 5.4. EDD FT-ICR (30 scans, 1 s, bias voltage of – 25 V) tandem mass spectrum 
of a doubly deprotonated asialo, biantennary glycan (NA2).  Doubly deprotonated 
product ions are indicated with an asterisk next to a product ion assignment.  Asterisks 
above a peak indicate electronic noise.  Squares indicate water loss from an adjacent 
product ion.  Underlined product ions exhibit minor radical species (with a mass 
corresponding to loss of hydrogen).  Ions due to multiple cleavage sites are designated 
with a slash between sites of cleavage.  Product ions which cannot be unambiguously 
assigned are indicated by parentheses in the labels.  
 
 
Scheme 5.2. Fragmentation pattern 
observed following EDD of a doubly 
deprotonated asialo, biantennary glycan 
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5.3.2 MS/MS of Sialylated Oligosaccharides 
 The CAD, IRMPD, and EDD fragmentation patterns of four sialylated 
oligosaccharides were next examined.  The first oligosaccharide examined, LSTa, is a 
linear oligosaccharide with the composition Neu5Acα3Galβ3GlcNAcβ3Galβ4Glc 
(Scheme 5.3a).  A related branched oligosaccharide, LSTb, in which the sialic acid is 
instead α2 6 linked to GlcNAc (Scheme 5.3b) was also examined.  The third 
oligosaccharide, a disialyllacto-N-tetraose oligosaccharide (DSLNT), is similar to LSTa 
but with a second sialic acid α2 6 linked to GlcNAc (Scheme 5.4).  The last 
oligosaccharide examined was an N-linked monosialylated, biantennary glycan (A1F), 
with the composition Neu5Aca3/6Galβ4GlcNAcβ2Manα6(Galβ4GlcNAcβ2Manα3)- 
Manβ4GlcNAcβ4(Fucα6)-GlcNAc (Scheme 5.5).    
 CAD and IRMPD of both doubly and singly deprotonated LSTa were examined 
and are shown in Figures 5.5 and 5.6 respectively.  Under standard negative ion mode 
electrospray ionization conditions, the average relative abundance of doubly deprotonated 
LSTa was 30%.  Although the generation of this doubly deprotonated species is more 
difficult compared to maltoheptoase or the branched NA2 glycan, EDD of this species 
was facilitated by longer accumulation times and cell fills. CAD and IRMPD of both 
singly and doubly deprotonated LSTa resulted in 0,2A and 2,4A cross-ring cleavages in the 
reducing end glucose.  Cross-ring cleavage in the reducing terminal residue and for 
internal 4-linked residues are commonly observed in negative ion mode low energy 
vibrational excitation fragmentation.15,19,20  In addition, glycosidic cleavage 
(predominantly resulting in C-type ions) was observed between every residue.  As has 
been shown for sialylated oligosaccharides by Zaia and co-workers, 24 singly 
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deprotonated LSTa (Figure 5.6) required more energy for fragmentation during CAD 
compared to the energies used for asialo oligosaccharides previously discussed (30 V for 


































Figure 5.5.  FT-ICR tandem mass spectra of doubly deprotonated LSTa.  a) CAD (60 
scans, collision cell voltage 2 V) b) IRMPD (30 scans, 100 ms irradiation 2.5 W).  
Doubly deprotonated product ions are indicated with an asterisk next to a product ion 
assignment.  Squares indicate water loss from an adjacent product ion.   
 
 Only singly charged product ions were observed following EDD of LSTa (Figure 
5.7a).  Glycosidic cleavage was noted between every pair of saccharide residues and two 
cross-ring cleavage products, 2,4X3(1,3A2) and 3,5A5 were also observed following EDD.  
These cross-ring cleavages were not seen following CAD or IRMPD of either the singly 
or doubly deprotonated species (Figures 5.5 and 5.6).  Loss of CH3O from the charge 
reduced species has been previously detected following EDD of GAGs.  It is also 
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interesting to note that both Y - 16 Da species (Y3 - 15.99 Da and Y4 - 15.99 Da) and C - 

















































Figure 5.6. FT-ICR tandem mass spectra of singly deprotonated LSTa.  a) CAD (30 
scans, collision cell voltage 30 V) b) IRMPD (30 scans, 175 ms irradiation 5 W).  
Squares indicate water loss from an adjacent product ion.  Ions due to multiple cleavage 
sites are designated with a slash between sites of cleavage.     
 
 As previously discussed, C - 2H species have been reported in several instances 
following heCAD in positive ion mode and recently following EDD of GAGs.  During 
positive ion mode heCAD, the precise mechanism which generates these ions is 
somewhat unclear.58  In EDD, Wolff et. al. have proposed that electron detachment at a 
carboxylate group is followed by hydrogen transfer to form either an oxy radical at C-2 
or a radical at C-3, which can lead to the formation of C - 2H product ions by α-
cleavage.33  Following EDD of GAGs, the complementary Z + 2H ions (or Y - 16 Da 
species) were not observed.  In our experiments, such species were observed following  
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Figure 5.7.  EDD FT-ICR tandem mass spectra of doubly deprotonated oligosaccharides 
a) LSTa (30 scans, 1 s, bias voltage of – 30 V) and b) LSTb (30 scans, 1 s, bias voltage of 
– 25 V).  Squares indicate water loss from an adjacent product ion.  Underlined product 
ions exhibit minor radical species (with a mass corresponding to loss of hydrogen).  Ions 
due to multiple cleavage sites are designated with a slash between sites of cleavage.  
Product ions which cannot be unambiguously assigned are indicated by parentheses in the 
labels.  The branch containing sialic acid is referred to as the α-branch in product ion 
labels.   
 
 Scheme 5.3. Fragmentation patterns 
observed following EDD of doubly 
deprotonated oligosaccharides LSTA 
















































































EDD of maltoheptaose and NA2, while the C - 2H species were absent.  This observation 
may be due to differences in the sites of deprotonation in neutral versus acidic 
oligosaccharides.  For the neutral oligosaccharides examined, both sites of deprotonation 
should be hydroxyl groups.  The allylic hydroxyl hydrogen67 on C-1 and the C-3 
hydroxyl hydrogen68 have been shown to be acidic sites.  LSTa, which contains one sialic 
acid, most likely has one deprotonation site at the carboxylate group while the other site 
should be a hydroxyl group. 
The CAD and IRMPD spectra of doubly (Figure 5.8) and singly deprotonated 
(Figure 5.9) LSTb showed relatively similar fragmentation patterns.  The relative 
abundance of doubly deprotonated LSTb was similar to LSTa, and EDD was facilitated 
by longer accumulation times and cell fills.  CAD and IRMPD of the singly and doubly 
deprotonated species exhibited 0,2A and 2,4A-type cleavage in the reducing terminal 
glucose.  The majority of observed product ions retained sialic acid and two of the most 
informative product ions observed were C2/Z3β  (D-type cleavage) and 0,4A2.  Residues 
which are 1-3 linked often produce C-type cleavage on the reducing side and Z-type 
cleavage on the non-reducing side in negative ion mode.19  Both of these ions provide 
information regarding the linkage position of sialic acid. 
 EDD of LSTb (Figure 5.7b) resulted in more extensive fragmentation compared 
to CAD and IRMPD of the singly (Figure 5.9) and doubly deprotonated species (Figure 
5.8).  In addition to extensive glycosidic cleavage, several cross-ring cleavage product 
ions were observed following EDD.  Along with 0,2A and 2,4A-type cleavage within the 
reducing end glucose (which were also observed from IRMPD and CAD), 1,3X, 3,5A, and 













































Figure 5.8.  FT-ICR tandem mass spectra of doubly deprotonated LSTb.  a) CAD (30 
scans, collision cell voltage 3 V) b) IRMPD (30 scans, 100 ms irradiation 7.5 W).  
Doubly deprotonated product ions are indicated with an asterisk next to a product ion 
assignment.  Squares indicate water loss from an adjacent product ion.  Ions due to 
multiple cleavage sites are designated with a slash between sites of cleavage.  Product 
ions which cannot be unambiguously assigned are indicated by parentheses in the labels.        
 
branching GlcNAc residue, including 1,3X2, 3,5A2, and 0,4A2.  The 0,4A2 and 3,5A2 product 
ions indicate the attachment of sialic acid to C-6 while the 1,3X2 ion indicates a likely 
linkage position for the 3-linked galactose.  Two hydrogen losses from several C-type 
ions (or hydrogen loss from a radical C-type ion) were also seen, including C2/Z3β - 2H, 
C2 - 2H, and C3(Y3) - 2H.  Two unique product ions, denoted NeuAcGal - H2O and 
NeuAcGal2 - H2O are also interesting to note in the EDD spectrum.  These ions can only 
be formed by saccharide rearrangement.  Other carbohydrates have also been shown to 
undergo rearrangement reactions with losses of internal saccharide residues during 






































Figure 5.9.  FT-ICR tandem mass spectra of singly deprotonated LSTb.  a) CAD (30 
scans, collision cell voltage 26 V) b) IRMPD (30 scans, 125 ms irradiation 10 W).  
Squares indicate water loss from an adjacent product ion.  Ions due to multiple cleavage 
sites are designated with a slash between sites of cleavage.  Product ions which cannot be 
unambiguously assigned are indicated by parentheses in the labels.        
  
 CAD and IRMPD of a doubly (Figure 5.10) and singly deprotonated (Figure 5.11) 
disialylated oligosaccharide (DSLNT) were examined.  As expected, the relative 
abundance of the doubly deprotonated form was always much larger than the singly 
deprotonated form.  CAD and IRMPD of the singly deprotonated species resulted in less 
fragmentation than the doubly deprotonated species.  In CAD and IRMPD of the doubly 
deprotonated species (Figure 5.10), both glycosidic and cross-ring cleavages were 
observed, similar to other oligosaccharides examined thus far.  Both 0,2A and 2,4A-type 
cleavages were present in the reducing terminal saccharide.  Similar to IRMPD and CAD, 
several product ions observed following EDD (Figure 5.12) are due to multiple 







































































Figure 5.10.  FT-ICR tandem mass spectra of doubly deprotonated DSLNT.  a) CAD (30 
scans, collision cell voltage 22 V) b) IRMPD (30 scans, 75 ms irradiation 10 W).  Doubly 
deprotonated product ions are indicated with an asterisk next to a product ion assignment.  
Squares indicate water loss from an adjacent product ion.  Ions due to multiple cleavage 
sites are designated with a slash between sites of cleavage.  Product ions which cannot be 
unambiguously assigned are indicated by parentheses in the labels.        
 
with losses of CO2 and CH3O being the most predominant.  In addition to a 0,2A-type 
cleavage in the reducing terminal saccharide, several additional cross-ring cleavages are 
observed following EDD which were not present in CAD or IRMPD spectra.  These 
correspond to 3,5A, 1,5A, 0,2X, 4,5X, and 1,5X type product ions.  One of the most abundant 
product ions observed following EDD is at m/z 977.34 (Y3α(Y3β)), due to loss of sialic 
acid.  Another product ion is observed that is 2 Da lighter, and would appear to 
correspond to a loss of two hydrogens from this Y-type ion (or loss of one hydrogen from 
the radical Y-type species).  Y - 2H product ions have also been observed following 










































Figure 5.11.  FT-ICR tandem mass spectra of singly deprotonated DSLNT.  a) CAD (30 
scans, collision cell voltage 34 V) b) IRMPD (30 scans, 75 ms irradiation 10 W).  
Squares indicate water loss from an adjacent product ion.  Ions due to multiple cleavage 
sites are designated with a slash between sites of cleavage.  Product ions which cannot be 
unambiguously assigned are indicated by parentheses in the labels.        
 
 The product ion at m/z 833.27 has been assigned as a Y - 2H type product ion (Y3α - 2H), 
but given that EDD of DSLNT resulted in significant internal cleavages, this ion could 
also be assigned C4/Y4 - 2H.  Similar to other EDD spectra, C - 2H, Y - 16 Da, and B - H 
product ions are also seen following EDD of DSLNT.  Many of these product ion types 
have been observed in heCAD, but only C - 2H  and B - H ions have been noted 
following EDD of GAGs.  However, the electron energies used in our examination were 
higher (20 - 30 eV) compared to those used in EDD of GAGs (19 eV), which may result 
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[M - CH3O 
- 2H]-●
[M - CO2 - 2H]-●
[M - CO2 - CH3O - 2H]-●
B1α (1β)
Y4α(3β)
Figure 5.12.  EDD FT-ICR tandem mass spectrum of doubly deprotonated DSLNT (30 
scans, 2 s, bias voltage of – 20 V).  Squares indicate water loss from an adjacent product 
ion.  Doubly deprotonated product ions are indicated with an asterisk next to a product 
ion assignment.    Underlined product ions exhibit minor radical species (with a mass 
corresponding to loss of hydrogen).  Ions due to multiple cleavage sites are designated 
with a slash between sites of cleavage.  Product ions which cannot be unambiguously 
assigned are indicated by parentheses in the labels.  The α-branch refers to the heavier 





Scheme 5.4. Fragmentation pattern 
























































 The singly deprotonated sialylated N-linked glycan (A1F) was of relatively low 
abundance following negative mode electrospray ionization (<5%), and was therefore not 
examined.  Using negative ion mode ESI conditions as described, the singly charged 
species had a relative abundance of less than 1%.  CAD and IRMPD of the doubly 
deprotonated species (shown in Figure 5.13) resulted in several glycosidic cleavages, 
which corresponded mainly to C- and B-type ions (which may also be due to water loss 
from C-type ions).  0,2A and 2,4A-type cleavages were observed in both reducing terminal 
GlcNAc residues.  These ions are useful for determining the presence of a core fucose 
residue.  Fragmentation following EDD (Figure 5.14 and Scheme 5.5) was more 
extensive than either CAD or IRMPD, and resulted in several glycosidic and cross-ring 
product ions.  The most abundant product ions correspond to C-type cleavages.  In many 
instances the C - 2H species were more abundant than typical C-type product ions (for 
example C6 - 2H ad C5 - 2H).  This behavior is similar to what was observed in EDD of 
DSLNT.  Similar to other EDD spectra of neutral and sialylated oligosaccharides, EDD 
of A1F resulted in several internal cleavages.  Several additional cross-ring cleavages 
were observed following EDD compared to CAD and IRMPD, including those 
corresponding to 1,5X, 3,5X, 4,5X, 1,5A, 0,2A, and 2,4A product ions.  Two cross-ring 
fragments within the branching mannose residue were observed, including 1,5A5 and 
4,5X2.  The latter ion provides information regarding the linkage position of the α-branch.  
Similar to other EDD spectra, Y - 16 Da product ions are also observed.  Also detected 
was an ion due to loss of a fucose residue, Y1γ, which was not observed following CAD 
or IRMPD.  In negative ion mode, it has been observed that fucose tends not to be lost 




























































Figure 5.13.  FT-ICR tandem mass spectra of doubly deprotonated A1F.  a) CAD (30 
scans, collision cell voltage 9 V) b) IRMPD (30 scans, 85 ms irradiation 10 W).  Doubly 
deprotonated product ions are indicated with an asterisk next to a product ion assignment.  
Squares indicate water loss from an adjacent product ion.  Ions due to multiple cleavage 
sites are designated with a slash between sites of cleavage.  Product ions which cannot be 
unambiguously assigned are indicated by parentheses in the labels.      
 
 
demonstrates that EDD fragmentation efficiency does not seem to be affected by 
oligosaccharide branching.  In Chapter 4, we showed that ECD of larger, branched 
oligosaccharides requires ion activation (presumably due to secondary structure) to 
fragment efficiently.31  However, electron energies used for EDD (20 – 30 eV in the 
current experiments) are much higher than those typically used for ECD (< 1eV).  These 
























GlcNAcMan3 - H2O, 










































[ M - 2H]-●
[ M - 2H - CH3O]-●
Y6α
 
Figure 5.14.  EDD FT-ICR tandem mass spectrum of doubly deprotonated A1F (30 
scans, 2 s, bias voltage of – 30 V).  Squares indicate water loss from an adjacent product 
ion.  Underlined product ions exhibit minor radical species (with a mass corresponding to 
loss of hydrogen).  Ions due to multiple cleavage sites are designated with a slash 
between sites of cleavage.  Product ions which cannot be unambiguously assigned are 




Scheme 5.5. Fragmentation pattern 
observed following EDD of a doubly 
deprotonated A1F glycan.  This glycan 
sample contains both 2 3 and 2 6 linked 
sialic acid, but only the 2 6 linkage is 
shown.  The α-branch contains the sialic 
acid residue while the γ-branch contains 














































































 Our results demonstrate that EDD of neutral and sialylated oligosaccharides 
provides structural information that is complementary to that obtained following IRMPD 
and CAD.  One potential issue with this approach is that, for neutral and singly sialylated 
oligosaccharides, doubly charged anions (which are required for EDD) are sometimes 
more difficult to obtain compared to singly charged anions.  However, for both the 
neutral glycan (NA2) and the singly sialylated glycan (A1F) examined here, the doubly 
deprotonated species was more easily produced in negative ion mode ESI compared to 
the singly deprotonated species.  These results indicate that EDD is a potentially valuable 
tool for the characterization of biologically relevant N-linked glycans, even if they are not 
highly acidic.  Cross-ring cleavages observed following IRMPD and CAD of doubly and 
singly deprotonated oligosaccharides were typically either 0,2A or 2,4A type cleavages.  
These product ion types can also be observed following IRMPD and low energy CAD in 
positive ion mode MS/MS, however cross-ring fragments are generally more prevalent 
for metal adducted oligosaccharides compared to protonated species.   Following EDD, 
several additional types of cross-ring cleavages were observed, such as 3,5A, 1,5A, 1,5X, 
and 3,5X type ions.  These product ion types are usually not produced from either positive 
or negative ion mode IRMPD or low energy CAD.  In most cases, cross-ring 
fragmentation in EDD was more extensive than in CAD or IRMPD.  A comparison of the 
fragmentation patterns of branched and linear oligosaccharides demonstrates that 
branching does not seem to affect EDD fragmentation.  Throughout these experiments, 
several unique product ions were observed.  These include C - 2H, Y - 16Da, and Y - 2H 
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product ions.  These ion types have all been observed following heCAD, but only C - 2H 
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 Glycosylation is one of the most prevalent post-translational modifications 
(PTMs) in eukaryotes, and glycoproteins have been found to play a wide variety of roles 
in biological systems.1,2  Protein glycan expression is highly affected by cellular 
conditions, and it has often been shown that glycan structures change with the onset of 
cancer and inflammation.  Such alterations may include increased glycan branching and 
elevated levels of sialic acid.3-6  In cancer, glycosylation alterations may affect growth, 
differentiation, transformation, adhesion, metastasis, and immune surveillance of the 
tumor.7  Currently, many glycoproteins act as clinical biomarkers and therapeutic agents 
in several forms of cancer.  For example, in ovarian cancer the CA 125 assay (a mucin-
type glycoprotein) is used as a blood test for ovarian cancer.8  Unfortunately, in many 
cases, no reliable diagnostic biomarkers exist for early disease detection.   
 Pancreatic cancer is one of the most frequent causes of cancer death in the United 
States and Europe.9  This disease has a poor prognosis, with few treatment options 
available for patients.  No reliable biomarkers have been identified that allow for early 
 135
detection.  Currently, the serum glycoprotein marker CA 19-9 is the most commonly used 
biomarker for pancreatic cancer.  However, this biomarker lacks sensitivity and 
specificity, and is not recommended for diagnostic purposes.10  In addition, CA 19-9 is 
not useful for distinguishing between pancreatic cancer or a less severe case of chronic 
pancreatitis.      
 It has been known for several years that oligosaccharides on cancer cells differ 
from those on normal cells.11-15  As disease markers, oligosaccharides are an attractive 
option because there are fewer potential oligosaccharide biomarkers compared to the total 
number of potential protein and peptide biomarkers.  There are several reports which 
have examined the glycan profiles of serum from pancreatic cancer patients.  In 2006, 
Okuyama and co-workers identified fucosylated haptoglobin as a novel marker for 
pancreatic cancer.16  In addition, Lubman and co-workers have developed a screening 
approach for comprehensive analysis of N-glycans and glycosylation sites in serum 
proteins.  They reported forty-four N-linked glycans which were unique to pancreatic 
cancer serum.17 
 On the surface of cancer cells, mucin glycoproteins (a family of glycoproteins, 
often highly O-glycosylated) are typically over-expressed and also aberrantly 
glycosylated.  These glycoproteins are often shed into intracellular space.  Recently, 
Lebrilla and co-workers have examined O-linked oligosaccharides in conditioned media 
from ovarian cancer cells and compared them to oligosaccharides in serum from ovarian 
cancer patients.8  Conditioned media (the supernatant) of various ovarian cancer cell lines 
were extracted and examined without the cells.  Due to the presence of shed glycoproteins 
in the growth media, many of the same oligosaccharides were observed in
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both media and serum samples.  These O-linked oligosaccharides have the potential to be 
used as markers for ovarian cancer.  Although no protein information is obtained through 
this type of analysis, their approach is simpler than monitoring the presence of intact 
glycoproteins.   
 Here, we present a strategy for the characterization of O-linked glycans shed from 
pancreatic cancer cells into growth media.  Given the success of the recent studies done 
by Lebrilla and co-workers on ovarian cancer and breast cancer,18 it may be possible to 
find diagnostic glycans for pancreatic cancer in conditioned media.  Although sera N-
glycan profiles of pancreatic cancer5,17,19 have been recently characterized, these studies 
focused on overall glycan composition (not specific structural information).  In addition, 
there has been very little work done on the analysis of O-linked glycans associated with 
this disease.  Here, we apply an approach similar to that used by Lebrilla and co-workers 
towards pancreatic cancer.  One major difference, however, is that in their experiments a 
matrix-assisted laser desorption/ionization (MALDI) source was used for the generation 
of gas-phase glycan ions.  In the work presented here, an electrospray ionization (ESI) 
source is utilized.  ESI has a lower tolerance to salt contamination compared to MALDI, 
and glycan ionization efficiency is not as high.  However, native sialylated 
oligosaccharides and sulfated oligosaccharides are particularly fragile in MALDI and 
may undergo in-source fragmentation, whereas ESI tends to be a gentler ionization 
source.  Another advantage of ESI is its ability to generate multiply charged ions, 
allowing for fragmentation techniques such as electron capture dissociation (ECD) and 
electron detachment dissociation (EDD) to be utilized.  To examine the O-linked 
oligosaccharides present in conditioned media, several clean-up strategies were explored 
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with a model glycoprotein, bovine fetuin.  Discussions of these strategies and the 
oligosaccharides observed from the conditioned media of two cell lines, BxPC-3 (from 




6.2.1 Bovine Fetuin Oligosaccharides Sample Preparation 
 Between 1-10 nmoles of bovine fetuin (Sigma, St Louis, MI) was treated for 
approximately 15 hours at 42°C with 500 μL of alkaline borohydride solution (a 1:1 
mixture of 1M NaBH4  and 0.1 M NaOH).8  After the reaction, acetic acid was slowly 
added to each sample on ice until a pH of 6-7 was achieved.  These samples were then 
treated via three different strategies; a) samples were desalted with graphitized carbon 
cartridges (Alltech, Deerfield, IL); b) Pepclean C-18 Spin Columns (Pierce, Rockford, 
IL) were used and samples were further desalted with graphitized carbon cartridges; or c) 
phenol and chloroform extraction was performed and samples were further desalted with 
graphitized carbon cartridges.  
 Graphitized carbon solid-phase extraction (SPE) cartridges were activated with 5 
mL of 0.1% formic acid in 80% acetonitrile/water (v/v) and washed with 5 mL of water.  
The solution of released oligosaccharides was loaded onto the cartridge and washed with 
10 mL of water.  Oligosaccharides were eluted with 1.5 mL of 0.5% formic acid in 40% 
acetonitrile/water (v/v) and concentrated in vacuo.  Borate was removed with repeated 
addition and evaporation (50 μL each) of 1% acetic acid in methanol.20  Prior to mass 
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spectrometric analysis, 200 μL of negative ion mode electrospray solution was added to 
each sample (50% methanol with 0.1% ammonium hydroxide). 
 Pepclean C-18 Spin Columns (Pierce, Rockford, IL) were equilibrated with and 
washed according to the manufacturers recommendations.  Sample was loaded and the 
flow-through was collected.  The flow-through was dried in vacuo, reconstituted in 400 
μl of water, and further desalted with a graphitized carbon cartridge as previously 
described. 
 For phenol/chloroform extraction, 500 μl of phenol/chloroform/isoamyl alcohol 
(25:24:1) was added to samples of released sugars.  The samples were vortexed and 
centrifuged, and the aqueous layer was retained. This procedure was repeated until 
precipitate was no longer observed (2-3 times).  An equal volume of chloroform was 
added to the aqueous layer, followed by vortexing and centrifugation.  The aqueous layer 
was removed and further desalted with a graphitized carbon cartridge as described 
previously.  
6.2.2 Conditioned Media Oligosaccharides Sample Preparation 
 Conditioned media from BxPC-3 and HDPE cell lines was provided by the 
laboratory of Dr. Diane Simeone (Department of Surgery, University of Michigan).21   
The BxPC-3 cell line is from a pancreatic adenocarcinoma, and was cultured in RPMI-
1640 media supplemented with 10% fetal bovine serum.  The HDPE cell line is from 
normal pancreatic ductal epithelial cells and is cultured in Dulbecco’s Modified Eagle’s 
Medium (DMEM) media without fetal bovine serum.  RPMI-1640 media supplemented 
with fetal bovine serum and DMEM media were used as control samples.  Conditioned 
media and control samples were sterile filtered (0.2 μM syringe filters) and frozen at        
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-80°C.  Samples were thawed and 12 mL of each sample was concentrated to 
approximately 500 μL with Vivaspin 20 (5,000 MW cutoff) concentrators (VivaScience, 
Edgewood, NY).  Concentrated solutions of NaBH4 and NaOH were added to each 
sample to obtain a final concentration of 0.5 M NaBH4 and 0.05 M NaOH.  Beta-
elimination proceeded for approximately 15 hours at 42°C in a water bath.  
 Following oligosaccharide release, samples were placed on ice and adjusted to pH 
6-7 with acetic acid and then desalted using a combination of C-18 SPE and graphitized 
carbon SPE.  Sep-Pack C18 cartridges (Waters, Milford, MA) were activated with 5 mL 
50% acetonitrile/water (v/v) and equilibrated with 5 mL of 0.1% formic acid in 5% 
acetonitrile/water (v/v).  Samples were loaded onto the cartridge and the flow-through 
was retained.  The cartridge was washed with an additional 4 mL of water and this flow-
through was also retained and pooled.  The flow-through was further desalted with a 
graphitized carbon cartridge.  The procedure is as previously described, except 
oligosaccharides were stepwise eluted with 0.5 mL 10% acetonitrile in water, 0.5 mL 
20% acetonitrile in water, and 0.5 mL 40% acetonitrile/0.05% formic acid in water.  
Samples were dried in vacuo, and borate was removed as previously described.  Samples 
were reconstituted in 100 μl of water.  For direct infusion mass spectrometric analysis, 10 
μl aliquots were diluted 4-12 fold in negative ion mode electrospray solution.  For liquid 
chromatography-mass spectrometry, a 50 μl aliquot was dried in vacuo and reconstituted 
in 5 μl of 95% acetonitrile/water (v/v) and injected onto the column.  
6.2.3 Liquid Chromatography-Mass Spectrometry 
 Oligosaccharides were separated on a Tosoh TSK-GEL Amide-80 column (5 μm; 
100 Å; 1 mm x 25 cm; Montgomeryville, PA) with an Agilent 1100 HPLC.  Solvent A 
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was acetonitrile with 2.5 mM NH4C2H3O2 and solvent B was water with 2.5 mM  
NH4C2H3O2.  The following gradient was used: t = 0 min, 0% solvent B; t = 10 min, 30% 
solvent B; t = 90 min, 35% solvent B, t = 95 min, 95% solvent B; t = 115 min, 95% 
solvent B.  The flow rate was 30 μL/min (with the use of a pre-column flow splitter).  
The HPLC was directly coupled to the mass spectrometer via an Apollo II ion source. 
6.2.4 FT-ICR Mass Spectrometry 
 All experiments were performed with an actively shielded 7 T FT-ICR mass 
spectrometer with a quadrupole front-end (APEX-Q, Bruker Daltonics), as previously 
described.22  Bovine fetuin oligosaccharide samples were electrosprayed with an Apollo 
II ion source at 60 μL/hour, while oligosaccharides from media samples were 
nanosprayed at 15 μl/hr with 30 μm i.d. fused-silica PicoTips (New Objective, Woburn, 
MA).  External CAD was performed in a hexapole following mass selective ion 
accumulation.    
 Mass spectra were acquired with XMASS software (Bruker Daltonics) with 256k 
data points and summed over 10 scans (direct infusion experiments).  LC-MS data were 
acquired with Bruker Hystar software.  LC-MS and MS data were analyzed with Bruker 
Data Analysis software.  Potential oligosaccharide structures in conditioned media 
samples were determined using Glycomod (http://www.expasy.ch/tools/glycomod).23   
 
6.3 Results and Discussion 
6.3.1 Protocol Optimization with Bovine Fetuin  
 Bovine fetuin was used as a model protein to optimize β-elimination and desalting 
of O-linked oligosaccharides.  O-linked glycans account for 20% of fetuin-
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oligosaccharides, while N-linked glycans comprise the remaining 80%.24  Bovine fetuin 
has three O-linked glycans, including a trisaccharide NeuAc(α-2-3)Gal(β1-3)GalNAc, a 
tetrasaccharide NeuAc(α2-3)Gal(β1-3)[NeuAc(α2-6)]GalNAc, and a hexasaccharide 
NeuAc(α2-3)Gal(β1-4)GlcNAc(β1-6)[NeuAc(α 2-3)Gal(β1-3)].25  The N-linked glycans 
of bovine fetuin consist of a wide variety of di- and tri-branched sialylated structures.  
Although it is often stated that harsher alkali conditions (1M NaOH) are necessary during 
β-elimination to observe the release of N-linked glycans, in these experiments a wide 
variety of N-linked glycans and N-linked glycopeptides were observed from bovine 
fetuin with only 0.05 M NaOH present during β-elimination.  Similar instances of N-
glycan release from β-elimination  have been previously reported.20,26,27   
 Several strategies were explored for the purification and desalting of 
oligosaccharides released from bovine fetuin.  As an initial strategy, samples were 
desalted with graphitized carbon SPE cartridges.  Graphitized carbon is commonly used 
for the chromatographic separation of oligosaccharides, but is also useful for the isolation 
and clean-up of mixtures of oligosaccharides.  It has been shown that graphitized carbon 
SPE can separate oligosaccharides from contaminants such as salts, detergents, proteins, 
as well as reagents commonly used during β-elimination (such as sodium borohydride).28  
In addition, neutral oligosaccharides can be fractionated from acidic oligosaccharides 
(such as sialylated species) by adjusting elution conditions.  The mass spectrum of a 
bovine fetuin sample desalted with graphitized carbon SPE following β-elimination is 
shown in Figure 6.1a.  One O-linked glycan was observed, a tetrasaccharide at m/z 675.  
However, the majority of ions shown in Figure 6.1a are singly charged species, and are 
likely due to remaining salts and β-elimination reagents (NaOH and NaBH4) as well as 
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bovine fetuin peptides.  The recent work done by Lebrilla and co-workers utilizing a 
similar approach was done with a MALDI ionization source.  As previously discussed, 
MALDI is more tolerant to salt contamination than ESI, thus this was not a major 
obstacle in their work.   
 To remove peptides and protein remaining following β-elimination, two strategies 
were explored.  First, C18 spin-columns were utilized for peptide/protein removal prior to 
desalting with graphitized carbon SPE cartridges.  A similar strategy has been utilized for 
sample cleanup of human serum samples.29  C18 resin shows excellent retention of 
hydrophobic species such as proteins and peptides, but has less affinity for hydrophilic 
species such as oligosaccharides.  Figure 6.1b shows the spectrum of bovine fetuin 
oligosaccharides observed following C18 spin-column treatment and graphitized carbon 
SPE.  All three O-linked oligosaccharides are observed as either singly or doubly 
deprotonated species at m/z 482 (doubly deprotonated tetrasaccharide), 665 (doubly 
deprotonated hexasaccharide), 675 (singly deprotonated trisaccharide), and at 966 (singly 
deprotonated tetrasaccharide).  In addition, several abundant N-linked glycans and N-
linked glycopeptides are observed.  Similar results have been previously reported.20  It is 
also interesting to note that in Figure 6.1a, 10 nmoles of bovine fetuin were subjected to 
β-elimination and only resulted in the observation of one O-linked glycan, whereas in 
Figures 1b and 1c only 1 nmole of protein was utilized.  These results demonstrate the 
necessity of protein and peptide removal. 
 As an alternative strategy for protein and peptide removal, a phenol/chloroform 
extraction was utilized prior to graphitized carbon SPE.  This technique is commonly 
used for purifying DNA contaminated by proteins, however there are very few reports of 
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Figure 6.1.  FT-ICR mass spectra (10 scans) of bovine fetuin oligosaccharides released 
via β-elimination. a) Bovine fetuin samples desalted with graphitized carbon SPE. b) 
Bovine fetuin samples following peptide/protein removal with C18 SPE and desalting 
with graphitized carbon SPE.  c) Bovine fetuin samples following peptide/protein 




this strategy for the clean-up of oligosaccharides released from glycoproteins.30  Figure 
6.1c shows the glycan profile of bovine fetuin following phenol/chloroform extraction 
and desalting with graphitized carbon SPE.  All three O-linked glycans are observed, as 
well as several N-linked glycans and N-linked glycopeptides.  The most abundant ion in 
Figure 6.1c is at m/z 857.1, and could not be identified.  MS/MS of this ion (via collision 
activated dissociation (CAD)) did not indicate this species was an oligosaccharide.  This 
ion was often one of the more abundant peaks observed following phenol/chloroform 
extraction and graphitized carbon SPE of bovine fetuin samples.  This species was not 
observed in Figure 6.1b (although an abundant ion of similar mass at m/z 857.4 was 
present).  These results indicate that the combination of C18 SPE and graphitized carbon 
SPE provided the best clean-up strategy for oligosaccharides released from bovine fetuin.  
A similar strategy was utilized for sample cleanup of conditioned media oligosaccharides. 
6.3.2 Direct Infusion of Conditioned Media Oligosaccharides 
 Conditioned media from two pancreatic cell lines, BxPC-3 and HDPE, were 
examined.  HDPE is from normal pancreatic ductal epithelial cells whereas the source of 
the BxPC-3 cell line is pancreatic adenocarcinoma.  One of the reported cellular products 
of the latter cell line is mucins.  Mucins are a family of glycoproteins that help maintain 
the integrity of, lubricate, and protect epithelial surfaces.  Alterations in mucin 
glycosylation have been observed in several forms of cancer.12,13,31  In pancreatic cancer, 
several reports have indicated that many mucins demonstrate over-expression and 
aberrant glycosylation. 32-37         
 The protocol optimized with bovine fetuin was applied to oligosaccharides in 
conditioned media from the BxPC-3 and HDPE cell lines.  Following β-elimination, 
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samples were treated with C18 SPE cartridges and further desalted with graphitized 
carbon SPE.  Samples were stepwise eluted from the graphitized carbon SPE cartridge 
with 10% acetonitrile, 20% acetonitrile, and 40% acetonitrile.  Lebrilla and co-workers 
utilized a similar protocol, and observed that small anionic oligosaccharides were 
observed in fractions eluted with a lower acetonitrile concentration, while larger 
oligosaccharides were observed in the 40% acetonitrile fraction.8   
 Figure 6.2 shows the mass spectra of two graphitized carbon SPE fractions (10% 
and 20% acetonitrile) from the BxPC-3 cell line.  The fraction eluted with 40% 
acetonitrile (data not shown) appeared similar to the fraction eluted with 20% 
acetonitrile.  Spectra were deconvoluted, and ion masses were submitted to the online 
software tool GlycoMod, in order to predict potential oligosaccharide structures.23  
Potential oligosaccharide species are indicated with black circles in Figure 6.2.  Potential 
oligosaccharides with structures that have been reported in the literature (and have been 
added to the GlycoSuiteDB database) are indicated with asterisks in Figure 6.2.  All 
potential oligosaccharides in Figure 6.2a (top) correspond to O-linked oligosaccharides, 
except for the ion at m/z 1519.567, which may correspond to an N-linked structure.  In 
Figure 6.2b (bottom), many of the potential oligosaccharides observed would correspond 
to N-linked glycans.  These results are consistent with the behavior of bovine fetuin, 
which demonstrated that the β-elimination procedure was able to release both O- and N-
linked oligosaccharides.  
 To verify that these ions are oligosaccharides, tandem mass spectrometry was 
necessary.  In the 10% acetonitrile fraction, ions at m/z 675.248, 966.342, 1351.501, 
1533.597, and 1644.588 were fragmented with CAD and, in the 20% fraction, ions at m/z 
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Figure 6.2. Negative ion mode FT-ICR mass spectra (10 scans) of BxPC-3 conditioned 
media oligosaccharides released via β-elimination. a) Fraction eluted from graphitized 
carbon SPE with 10% acetonitrile/water b) Fraction eluted from graphitized carbon SPE 
with 20% acetonitrile/water.  Neutral masses were submitted to GlycoMod, to identify 
potential oligosaccharides.  Black dots indicate potential oligosaccharides, while asterisks 
indicate potential oligosaccharides with structures that have been reported in the 
GlycoSuiteDB database. 
 
1111.395, 1331.472, 1419.573, 1439.019, 1488.543, 1584.543, and 1639.146 were 
fragmented.  CAD spectra of all ions exhibited characteristic oligosaccharide 
fragmentation patterns (glycosidic cleavages were almost exclusively observed).  Several 
of the species observed in Figure 6.2 were assigned as potential oligosaccharides, but 
with structures that had not been reported in the GlycoSuiteDB database.  CAD 
fragmentation patterns indicated that some of these species may actually be due to 
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dimerization in the gas-phase, as was previously reported in Chapter 4 for metal-adduced 
oligosaccharides (although in this instance, there is no evidence to indicate metal 
adduction).  As an example, the CAD spectra of the most abundant ions in Figure 6.2a (at 
m/z 675.248, 966.342, and 1351.501) are shown in Figure 6.3.  The former two ions may 
be assigned as a sialylated trisaccharide, (Hex)1(HexNAc)1(NeuAc)1 and a disialylated 
tetrasaccharide, (Hex)1(HexNAc)1(NeuAc)2, respectively.  Following CAD, loss of sialic 
acid is the predominant fragmentation pathway for both of these ions (Figure 6.3a and 
6.3b).  The ion at m/z 1351.501 has two potential oligosaccharide structures, either (Hex)4 
(HexNAc)2 (Deoxyhexose)1 (Pent)1, or (Hex)2 (Deoxyhexose)6 (Pent)1.  However, CAD 
of this species disproves both of these assignments, and indicates this oligosaccharide is a 
sialylated species.  Considering the possibility of dimerization in the gas-phase, a 
possible assignment for this species is a dimer consisting of two (Hex)1 (HexNAc)1 
(NeuAc)1 oligosaccharides.  The ion at m/z 1351.501 was fragmented with a much lower 
energy compared to the other oligosaccharide species shown in Figure 6.3 (collision  
voltage of 10 V versus 18-20 V).  In addition, one of the major product ions observed in 
Figure 6.3c is a trisaccharide at m/z 675.259.  This sialylated trisaccharide is the most 
abundant species observed in the 10% acetonitrile fraction (at m/z 675.248 in Figure 
6.2a).   Its relatively high concentration could explain the presence of a gas-phase dimer.   
 As a control sample, RPMI-1640 media supplemented with 10% fetal bovine 
serum was subjected to the same treatment as the BxPC-3 conditioned media samples and 
examined.  All potential oligosaccharides observed in the BxPC-3 conditioned media 
sample were also present in the control sample.  These results were surprising, because 
Lebrilla   and   co-workers   also   used   conditioned   media   from   cell  lines  that  were  
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Figure 6.3.  CAD FT-ICR tandem mass spectra (10 scans) of several oligosaccharides 
observed in the 10% elution fraction from BxPC-3 conditioned media. a) CAD spectrum 
(collision voltage 18 V) of an oligosaccharide with the potential structure 
(Hex)1(HexNAc)1(NeuAc)1 b) CAD spectrum (collision voltage 20 V) of an 
oligosaccharide with the potential structure (Hex)1(HexNAc)1(NeuAc)2 c) CAD spectrum 
(collision voltage 10 V) of a potential oligosaccharide dimer consisting of two 
(Hex)1(HexNAc)1(NeuAc)1 trisaccharides.  A black diamond indicates the parent ion in 
each CAD spectrum. 
 
supplemented with 10% fetal bovine serum.  They reported very few oligosaccharides 
originating from fetal bovine serum, whereas our results indicate that a plethora of O-
linked and N-linked oligosaccharides are present.  To determine whether there are any 
low-abundance oligosaccharides unique to conditioned media from the BxPC-3 cell line, 
liquid chromatographic separation was also utilized (see section 6.3.3).  Due to ionization 
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suppression by fetal bovine serum oligosaccharides, it may be difficult to observe 
pancreatic cancer associated oligosaccharides in a direct infusion experiment. 
 HDPE conditioned media was also examined.  Several potential oligosaccharides 
were observed, and several of these had structures which are reported in the 
GlycoSuiteDB database (data not shown).  However, CAD did not indicate any of these 
species are oligosaccharides.  As a control sample, DMEM media was also subjected to 
the same treatment as conditioned media.  Similar to the BxPC-3 conditioned media, the 
majority of potential oligosaccharides observed in the HDPE conditioned media samples 
were also present in the control DMEM media.  DMEM media is not supplemented with 
fetal bovine serum, or any other glycoprotein sources.  Unlike the BxPC-3 cell line, the 
HDPE cell line is from normal pancreatic ductal epithelial cells, which should not exhibit 
overexpression of mucins.  It may therefore be more difficult to observe oligosaccharides 
in HDPE conditioned media compared to pancreatic cancer tumor cell lines.   
6.3.3 Liquid-Chromatography Mass Spectrometry of Oligosaccharides from   
BxPC-3 Conditioned Media  
 Online-LC-ESI-MS characterization of underivatized oligosaccharides is often 
performed using graphitized carbon chromatography.20,38-41    However, Wuhrer and co-
workers have demonstrated that normal-phase liquid chromatography of underivatized 
oligosaccharides is also a useful separation tool for complex oligosaccharide mixtures.42  
Their results demonstrated that normal-phase chromatography is a powerful alternative to 
graphitized carbon chromatography for LC-MS of oligosaccharides. 
 Oligosaccharides released from conditioned media from the BxPC-3 cell line 
were separated with normal-phase liquid chromatography, which was directly coupled to 
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an FT-ICR mass spectrometer.  Figure 6.4 shows the total ion chromatogram of 
conditioned media oligosaccharides from the BxPC-3 cell line.  The majority of 
oligosaccharides elute between 70-100 minutes.  Retention of oligosaccharides is caused 
by polar interactions, and typically increases as glycan chain length increases.  Thus, 
smaller O-linked oligosaccharides elute earlier while larger N-linked glycans elute later.  
A list of potential oligosaccharides observed throughout the LC-MS run is shown in 
Table 6.1 at the end of this Chapter.  Only potential oligosaccharides that have been 
reported in the GlycoSuiteDB database are indicated in this Table, which lists a mixture 
of both O-linked and N-linked glycans, as well as some glycopeptides that may have a 
single asparagine attached to the glycan portion (which was also seen with bovine fetuin 
samples).   
 As a control sample, oligosaccharides released from RMPI-1640 media 
supplemented with fetal bovine serum were also separated with normal phase LC/FT-ICR 
MS.  All potential oligosaccharides shown in Table 6.1 from conditioned media samples 
were also observed following chromatographic separation of the control sample.  These 
results indicate that with both a direct infusion experiment, and with an online liquid 
chromatographic separation, it is extremely difficult to identify oligosaccharides 
specifically associated with the BxPC-3 cell line due to the presence of fetal bovine 
serum in the media. 
  6.4 Conclusions  
 An optimal strategy for examining O-linked oligosaccharides from conditioned 
media from pancreatic cell lines has been developed.  This strategy is based upon the 
treatment of released oligosaccharides with reversed-phase SPE and desalting with 
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Figure 6.4. Normal-phase LC-ESI FT-ICR MS total ion chromatogram of 
oligosaccharides released from BxPC-3 conditioned media.  Table 6.1 includes a list of 
potential oligosaccharides observed throughout the chromatogram. 
 
graphitized carbon SPE.  This approach allows for the examination of oligosaccharides 
from complex samples with an ESI mass spectrometer.  Oligosaccharides from 
conditioned media of two cell lines, HDPE and BxPC-3 were examined.  Currently, no 
oligosaccharides have been found in conditioned media from the HDPE cell line.  This 
negative result may be due to a lack of mucin overexpression in this cell line.  In 
conditioned media from the BxPC-3 cell line, normal-phase LC-ESI-FT-ICR MS 
revealed several O-linked and N-linked oligosaccharides.  However, all of these species 
were also found in a control sample consisting of RPMI-1640 supplemented with fetal 
bovine serum.  These results were surprising, because Lebrilla and co-workers reported 
very few oligosaccharides originating from fetal bovine serum.  However, our results 
clearly demonstrate that fetal bovine serum oligosaccharides are a major interference in 
these samples.  One possible solution is to avoid supplementing growth media with fetal 
bovine serum.  A wide variety of serum-free media are commercially available.  










Although it has already been demonstrated that human pancreatic cancer cell lines can be 
adapted for growth in serum-free media,43,44 it is unclear what effect a change in media 
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Control? Potential Structural Assignment
70-75 min
676.255 100.0 Y (Hex)1 (HexNAc)1 (NeuAc)1* or  (HexNAc)1 (Deoxyhexose)1 (NeuGc)1*
75-80 min
676.262 1.6 Y (Hex)1 (HexNAc)1 (NeuAc)1* or  (HexNAc)1 (Deoxyhexose)1 (NeuGc)1*
692.256 0.7 Y (Hex)1 (HexNAc)1 (NeuGc)1*
838.312 0.2 Y (Hex)2 (HexNAc)1 (NeuAc)1* or  (Hex)1 (HexNAc)1 (Deoxyhexose)1 (NeuGc)1*
967.350 31.9 Y
(Hex)1 (HexNAc)1 (NeuAc)2* or  (Hex)1 (HexNAc)3 (HexA)1* or (HexNAc)1 
(Deoxyhexose)1 (NeuAc)1 (NeuGc)1*
983.348 0.9 Y (Hex)1 (HexNAc)1 (NeuAc)1 (NeuGc)1* or  (HexNAc)1 (Deoxyhexose)1 (NeuGc)2*
999.352 0.6 Y (Hex)1 (HexNAc)1 (NeuGc)2* or  (Hex)1 (HexNAc)1 (Deoxyhexose)3 (HexA)1*
1332.478 1.4 Y (Hex)2 (HexNAc)2 (NeuAc)2* 
80 -85 min
1041.386 2.0 Y (Hex)2 (HexNAc)2 (NeuAc)1* or  (Hex)1 (HexNAc)2 (Deoxyhexose)1 (NeuGc)1*
1332.488 79.6 Y (Hex)2 (HexNAc)2 (NeuAc)2*
1364.485 3.7 Y (Hex)4 (HexNAc)2 (Deoxyhexose)2* 
1623.588 2.2 Y (Hex)1 (HexNAc)2 (Deoxyhexose)1 + (Man)3(GlcNAc)2*  
1908.613 0.5 Y (Hex)1 (HexNAc)3 (Deoxyhexose)1 (Phos)1 + (Man)3(GlcNAc)2*
85-90  min
880.346 1.8 Y (Hex)1 (HexNAc)2 (Deoxyhexose)2*
1057.383 1.0 Y (Hex)2 (HexNAc)2 (NeuGc)1*
1083.435 0.3 Y (Hex)1 (HexNAc)3 (Deoxyhexose)2*
1203.439 1.0 Y (Hex)3 (HexNAc)2 (NeuAc)1* or  (Hex)2 (HexNAc)2 (Deoxyhexose)1 (NeuGc)1*
90-95 min
750.293 4.7 Y (Hex)2 (HexNAc)2*
1083.431 2.0 Y (Hex)1 (HexNAc)3 (Deoxyhexose)2*
2266.807 2.0 Y (Hex)1 (HexNAc)3 (Deoxyhexose)2 (NeuAc)1 + (Man)3(GlcNAc)2* 
2401.827 1.6 Y (Hex)1 (HexNAc)4 (Deoxyhexose)1 (NeuAc)1 (Sulph)1 + (Man)3(GlcNAc)2*
Table 6.1 Potential oligosaccharides observed in a normal-phase LC-ESI-MS chromatogram of conditioned media from BxPC-3.  Only structures which 
have been reported in the GlycoSuiteDB database are indicated. The approximate elution time, neutral mass, and relative abundance are indicated.  As 
a control sample, RPMI-1640 media supplemented with 10% fetal bovine serum was subjected to the same treatment as conditioned media.  All 




(Hex)2 (HexNAc)2 (NeuAc)3 + (Man)3(GlcNAc)2*, (Hex)2 (HexNAc)2 
(Deoxyhexose)2 (NeuAc)2 + (Man)3(GlcNAc)2*
2881.041 1.7 Y (Hex)3 (HexNAc)3 (NeuAc)3 + (Man)3(GlcNAc)2* 
2923.042 7.9 Y N+  (Hex)5 (HexNAc)4 (NeuAc)1 + (Man)3(GlcNAc)2* 
3172.142 71.1 Y
(Hex)3 (HexNAc)3 (NeuAc)4 + (Man)3(GlcNAc)2* or N+  (Hex)3 (HexNAc)3 
(Deoxyhexose)1 (NeuGc)3 + (Man)3(GlcNAc)2* 
3214.132 2.4 Y N + (Hex)5 (HexNAc)4 (NeuAc)2 + (Man)3(GlcNAc)2* 
3463.224 5.8 Y (Hex)3 (HexNAc)3 (NeuAc)5 + (Man)3(GlcNAc)2* 
95-100 min
668.245 1.3 Y (Hex)4*
2224.804 29.2 Y
(Hex)2 (HexNAc)2 (NeuAc)2 + (Man)3(GlcNAc)2* or  (Hex)2 (HexNAc)2 
(Deoxyhexose)2 (NeuAc)1 + (Man)3(GlcNAc)2* 
2240.799 1.0 Y
(Hex)2 (HexNAc)2 (NeuAc)1 (NeuGc)1 + (Man)3(GlcNAc)2* or  (Hex)3 (HexNAc)2 
(Deoxyhexose)1 (NeuAc)1 + (Man)3(GlcNAc)2* 
2524.927 0.8 Y N+  (Hex)2 (HexNAc)3 (NeuAc)2 + (Man)3(GlcNAc)2* 
2881.034 100.0 Y (Hex)3 (HexNAc)3 (NeuAc)3 + (Man)3(GlcNAc)2* 
2897.039 3.0 Y (Hex)4 (HexNAc)3 (Deoxyhexose)1 (NeuAc)2 + (Man)3(GlcNAc)2* 
2976.985 0.3 Y (Hex)4 (HexNAc)3 (Deoxyhexose)1 (NeuAc)2 (Sulph)1 + (Man)3(GlcNAc)2* 
3036.096 0.7 Y N+ (Hex)3 (HexNAc)4 (Deoxyhexose)1 (NeuAc)2 + (Man)3(GlcNAc)* 
3172.141 11.5 Y
(Hex)3 (HexNAc)3 (NeuAc)4 + (Man)3(GlcNAc)2* or N+ (Hex)3 (HexNAc)3 
(Deoxyhexose)1 (NeuGc)3 + (Man)3(GlcNAc)2* 
3181.140 1.2 Y N+ (Hex)3 (HexNAc)4 (NeuAc)3 + (Man)3(GlcNAc)2* 
3327.195 1.1 Y N +  (Hex)3 (HexNAc)4 (Deoxyhexose)1 (NeuAc)3 + (Man)3(GlcNAc)2* 
3457.168 1.8 Y (Hex)5 (HexNAc)6 (Deoxyhexose)1 (NeuAc)1 (Sulph)1 + (Man)3(GlcNAc)2* 
3537.250 1.0 Y (Hex)4 (HexNAc)4 (NeuAc)4 + (Man)3(GlcNAc)2* 
100-105 min
912.347 4.2 Y (Hex)3 (HexNAc)2*
2223.817 38.8 Y (Hex)2 (HexNAc)2 (NeuAc)2 + (Man)3(GlcNAc)2*
2240.809 8.5 Y
(Hex)2 (HexNAc)2 (NeuAc)1 (NeuGc)1 + (Man)3(GlcNAc)2* or  (Hex)3 (HexNAc)2 
(Deoxyhexose)1 (NeuAc)1 + (Man)3(GlcNAc)2* 
2322.861 14.6 Y
N+  (Hex)2 (HexNAc)2 (NeuAc)2 + (Man)3(GlcNAc)2* or N+  (Hex)2 (HexNAc)2 
(Deoxyhexose)2 (NeuAc)1 + (Man)3(GlcNAc)2* 
2514.924 2.0 Y (Hex)2 (HexNAc)2 (NeuAc)3 + (Man)3(GlcNAc)2* 
2588.929 5.2 Y (Hex)3 (HexNAc)3 (NeuAc)2 + (Man)3(GlcNAc)2* 
2687.953 1.6 Y N+  (Hex)3 (HexNAc)3 (NeuAc)2 + (Man)3(GlcNAc)2* 
2734.978 3.0 Y (Hex)3 (HexNAc)3 (Deoxyhexose)1 (NeuAc)2 + (Man)3(GlcNAc)2* 
2838.023 24.6 Y
(Hex)3 (HexNAc)3 (Deoxyhexose)1 (NeuAc)2 (NeuGc)1 + (Man)3(GlcNAc)1*or  
(Hex)4 (HexNAc)3 (NeuAc)3 + (Man)3(GlcNAc)1*  
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2880.056 100.0 Y (Hex)3 (HexNAc)3 (NeuAc)3 + (Man)3(GlcNAc)2* 
2896.045 20.2 Y (Hex)4 (HexNAc)4 (Deoxyhexose)1 (NeuAc)2 + (Man)3(GlcNAc)1* 
2979.077 41.9 Y N+  (Hex)3 (HexNAc)3 (NeuAc)3 + (Man)3(GlcNAc)2* 
3036.107 5.1 Y N+ (Hex)3 (HexNAc)4 (Deoxyhexose)1 (NeuAc)2 + (Man)3(GlcNAc)2* 
3171.167 67.0 Y (Hex)3 (HexNAc)3 (NeuAc)4 + (Man)3(GlcNAc)2* 
3181.143 3.8 Y N+  (Hex)3 (HexNAc)4 (NeuAc)3 + (Man)3(GlcNAc)2* 
3270.197 21.4 Y N+ (Hex)3 (HexNAc)3 (NeuAc)4 + (Man)3(GlcNAc)2* 
3391.292 2.9 Y (Hex)4 (HexNAc)4 (Deoxyhexose)1 (NeuAc)3 + (Man)3(GlcNAc)2* 
3536.224 2.0 Y (Hex)4 (HexNAc)4 (NeuAc)4 + (Man)3(GlcNAc)2* 
105-115 min




Conclusions and Prospects for Future Work 
 
7.1 Challenges of Glycosylation Characterization and Goals of this Dissertation 
 Due to the vast complexity of glycans, their structural characterization and 
profiling remain as difficult tasks.  Several disease states (such as cancer and 
inflammation) exhibit aberrant glycosylation, a fact which has fueled research pertaining 
to glycan profiling and structural analysis.  Complete glycosylation characterization 
demands knowledge of saccharide linkage, branching, sequence, glycosylation location, 
heterogeneity, and occupancy.  Several analytical techniques are available for 
glycosylation characterization and were described in Chapter 1.  Amongst this wide 
variety of techniques, mass spectrometry is one of the most versatile, due to its sensitivity 
and low sample consumption.  In particular, tandem mass spectrometry is a powerful tool 
for the structural characterization of both proteins and oligosaccharides. 
 Many approaches for glycosylation characterization have been utilized, although 
typically glycosylation is examined at the glycopeptide level or following enzymatic or 
chemical removal of the glycan.  The advantage of analyzing glycosylation at the 
glycopeptide level is that glycosylation location and heterogeneity can be determined.  
However, for specific structural information, tandem mass spectrometry of glycopeptides 
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is necessary.  With conventional collisional activated dissociation (CAD) of 
glycopeptides, preferential cleavage of glycosidic bonds is often observed.  This tendency 
makes the localization of glycosylation sites within the peptide difficult to determine.  
However, within the past decade several groups have utilized an alternative 
fragmentation technique, electron capture dissociation (ECD), for the characterization of 
glycopeptides.  ECD, unlike CAD, tends to preferentially cleave the peptide backbone, 
allowing for localization of glycosylation sites.   
 In addition to glycopeptide analysis, another common approach for glycosylation 
characterization is the enzymatic or chemical removal of glycans from the glycoprotein, 
and subsequent analysis of the glycan mixture.  The principal disadvantage of this 
technique is that information regarding glycosylation location and heterogeneity is lost.  
Following glycan release, there are several mass spectrometric approaches available.  In 
positive ion mode, the protonated or metal adducted form of the oligosaccharide can be 
examined.  Oligosaccharide anions can also be examined with mass spectrometry, 
although this approach is typically utilized to a lesser degree.  Upon CAD of 
oligosaccharides (in both positive and negative ion mode) glycosidic cleavages are often 
the most abundant product ions observed.  Although these ions provide information 
regarding the monosaccharide composition of oligosaccharides, cross-ring cleavages 
provide linkage information.  Strategies such as metal-adduction with CAD have been 
utilized to increase cross-ring fragmentation. 
 The main goal behind the research presented in this dissertation was to explore 
the utility of ion-electron and ion-photon based fragmentation for glycosylation 
characterization.  Several topics are explored, including lectin de novo sequencing, 
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glycopeptide and oligosaccharide structural characterization.  To prove the validity of 
ion-electron reactions for glycosylation characterization, extensive comparisons were 
made between vibrational excitation fragmentation patterns (CAD and infrared 
multiphoton dissociation (IRMPD)) and ion-electron based fragmentation reactions (ECD 
and electron detachment dissociation (EDD)). 
 
7.2 Summary of Results 
 Lectins are an extremely useful tool for glycoprotein isolation and purification.  
Several lectins are currently commercially available, however new ones are constantly 
being isolated.  In Chapter 2, we illustrated how the combination of vibrational excitation 
(here IRMPD) and electron based fragmentation (ECD) allows for de novo sequencing of 
a lectin.  The overlap between infrared multiphoton and electron capture dissociation 
data, indicated by so called “golden pairs”, is a powerful tool for de novo sequencing of 
proteins originating from organisms with unsequenced genomes.   
 The characterization of high-mannose type glycopeptides using both vibrational 
excitation (here IRMPD) and electron-based fragmentation (ECD) was also examined.  
Previously, IRMPD was understood to selectivity cleave glycosidic bonds in the gas 
phase.  Our results demonstrate that IRMPD of high-mannose type glycopeptides exhibits 
a unique fragmentation behavior, and often results in a mixture of glycan and peptide 
backbone cleavage.  In contrast, ECD of high-mannose type glycopeptides results in 
extensive peptide backbone cleavage.  The fragmentation spectrum of the largest 
glycopeptide examined with ECD to date was illustrated in Chapter 3.   
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 Glycopeptide anion fragmentation behavior was also examined (Appendix A).  
Our results indicate that negative ion mode vibrational excitation results in a highly 
complicated mass spectrum, due to a mixture of glycan and peptide backbone cleavage.  
In addition, electron-based fragmentation in negative ion mode with EDD demonstrated 
that glycan cleavages are predominant.  These results illustrate that glycopeptide 
characterization in positive ion mode results in more useful fragmentation information. 
 Both Chapter 4 and Chapter 5 focus on oligosaccharide structural characterization 
with a combination of vibrational excitation and electron based fragmentation.  Although 
it is well established that CAD of metal-adducted oligosaccharides often exhibits more 
cross-ring fragments compared to protonated species, very little work had focused on 
ECD of oligosaccharides.  We show that complementary structural information can be 
obtained from ECD of metal-adducted species as compared to IRMPD.  Depending on 
the metal ion and oligosaccharide structure, in certain examples cross-ring cleavage can 
be greatly enhanced. 
 Many oligosaccharides are neutral or contain acidic saccharides, such as sialic 
acid.  In these instances, negative ion mode mass spectrometry would be more suitable 
than positive ion mode characterization.  Electron detachment dissociation (EDD) has 
recently been shown by Amster and co-workers to constitute a valuable analytical 
approach for the structural characterization of glycosaminoglycans (linear sulfated 
oligosaccharides).1  We have explored the application of EDD to neutral and sialylated 
oligosaccharides.  Our results demonstrate that EDD of both neutral and sialylated 
oligosaccharides provides structural information that is complementary to that obtained 
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from vibrational excitation.  In most cases, cross-ring fragmentation obtained via EDD is 
more extensive than that obtained from vibrational excitation.   
 Finally, Chapter 6 focuses on strategies for the examination of O-linked glycans 
found in conditioned media from pancreatic cancer cell lines.  Lebrilla and co-workers 
have demonstrated for ovarian and breast cancer that cancer associated O-linked glycans 
are present in both conditioned media and serum.2,3  To examine the O-linked 
oligosaccharides present in conditioned media, several clean-up strategies were explored 
with a model glycoprotein, bovine fetuin.  We have developed an optimal strategy for 
examining O-linked oligosaccharides from conditioned media from pancreatic cell lines.  
However, our results demonstrate that fetal bovine serum oligosaccharides are a major 
interference in these samples.   
 
7.3 Prospects for Future Work 
 Our results clearly demonstrate the utility of both metal-adduction in combination 
with ECD for oligosaccharide structural characterization, as well as EDD for the analysis 
of neutral and sialylated oligosaccharides.  This work was performed on model 
oligosaccharides.  Having proven the utility of these techniques, the next logical step 
would be the implementation of these strategies for the structural analysis of 
oligosaccharides from biological samples.   
  Chapter 6 demonstrates that fetal bovine serum oligosaccharides present in 
growth media hinders the analysis of pancreatic cancer associated O-glycans in 
conditioned media.  One possible solution is to use serum-free media.  However, another 
approach to characterize cell-surface glycosylation would be to analyze glycans present 
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in the cell membrane fractions of pancreatic cancer cells.  Kakehi and co-workers 
recently described an approach for glycan profiling of cell surface glycosylation from a 
variety of cancerous cell lines.4  In the future, optimization and application of a similar 
protocol can be applied to pancreatic cancer cells.  Although there are already several 
reports on the glycan profiles associated with pancreatic cancer from serum and 
pancreatic cancer cells (as described in Chapter 6), the majority of these reports focused 
on N-glycosylation.  As previously discussed, the over-expression of mucins in 
pancreatic cancer indicates the relevance of O-glycans.  However, very few studies have 
examined O-glycans in this disease.  In addition, the majority of work performed on 
pancreatic cancer glycan profiles focused more on overall glycan composition, and not 
specific structural information.  Given that pancreatic cancer exhibits a unique 
glycosylation profile, a potential future goal would be to design a vaccine based on these 
cancer-associated glycans in order to illicit an immune system response.  However, in 
order to do so, complete structural characterization of these glycans is necessary.   
 The combination of vibrational excitation and ion-electron based fragmentation 
should provide extensive structural characterization for pancreatic cancer associated 
oligosaccharides.  However, one main concern with utilizing ion-electron based 
fragmentation techniques for biomolecular structural characterization is that both ECD 
and EDD are not easily combined with on-line liquid chromatographic separation due to 
relatively long ECD and EDD fragmentation events.  For the analysis of N- and O-
glycans from pancreatic cancer cells, liquid chromatography is necessary due to the 
complexity of these samples.  Chapter 6 demonstrates that normal-phase chromatography 
of underivatized oligosaccharides would be an appropriate choice for separation.  
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However, in order to utilize ECD and EDD for structural characterization, off-line liquid 
chromatography would be required.  For metal-adducted ECD, metal salts also need to be 
added prior to mass spectrometric analysis.  In the future, optimization of the off-line 
separation of N- and O-glycans from pancreatic cancer cells is needed.   
 Another variable which needs consideration is whether positive ion mode ESI-MS 
or negative ion mode ESI-MS will be utilized for glycan characterization.  ECD is only 
feasible for glycan cations, while EDD is only applicable to glycan anions.  As previously 
discussed, biologically relevant glycans are often neutral or contain acidic saccharides.  
This acidity would suggest that negative ion mode characterization would be more 
appropriate for glycans containing sialic acid or sulfated monosaccharides.  Although 
EDD of neutral and sialylated oligosaccharides provides very extensive cross-ring 
fragmentation, due to the lower fragmentation efficiency associated with EDD, this 
technique may be difficult to implement with biological samples if sample quantities are 
minute.  The work presented in this dissertation on ECD of oligosaccharides focused on 
neutral species, but recent findings in our group have also illustrated how ECD of metal-
adducted acidic N-glycans provides complementary structural information to vibrational 
excitation.  In these instances, metal-adducted ECD in combination with vibrational 
excitation fragmentation would be an attractive alternative to negative ion mode 
characterization.   
 Overwhelming evidence indicates the functional role of glycosylation in various 
forms of cancer.  In order to fully comprehend how changes in glycosylation are related 
to cancer progression, detailed structural characterization of N- and O-glycans is 
essential.  The work presented in this dissertation demonstrates how ion-electron 
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reactions, ECD and EDD, can provide additional structural information for glycans.  
With the detailed structural characterization of pancreatic cancer N- and O-glycans, 
several potential future goals can be envisioned.  Glycoconjugates are already used as 
targets in many therapeutic applications such as cancer chemotherapy, diabetes therapy, 
antibiotics, antivirals, and anti-inflammatories.5-10  A detailed characterization of 
pancreatic cancer associated glycans may permit the identification of cancer vaccine 
candidates.  Given the link between aberrant glycosylation and malignancy, it may also 
be feasible to design therapeutics which prevent or perturb the formation of specific 
cancer associated glycans.  This strategy is somewhat complex, because in addition to 
knowing specific glycan structures, these glycans must also demonstrate a specific role in 
cancer progression.  Currently, the precise link between specific glycan structures and 
disease states, such as cancer, are often poorly understood.  Finally, as previously 
discussed in Chapter 6, no reliable biomarkers exist for early detection of pancreatic 
cancer.  A complete glycan profile of N- and O-glycans from pancreatic cancer cells may 
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Infrared Multiphoton Dissociation and Electron Detachment 
Dissociation of Glycopeptide Anions 
 
A.1 Introduction 
 Chapter 3 explores the fragmentation behavior of glycopeptide cations with 
infrared multiphoton dissociation (IRMPD) and electron capture dissociation (ECD).  
ECD of high-mannose type glycopeptide cations results in extensive backbone peptide 
cleavage and no cleavage within the glycan portion.  This trend has also been observed 
with other varieties of N-linked glycopeptides and O-linked glycopeptides.1-5  Chapter 3 
also demonstrates that IRMPD of high-mannose type glycopeptides may result in a 
mixture of both peptide and glycosidic cleavages.  However, IRMPD of complex type1,2,6 
and hybrid type7 glycopeptides typically results in exclusively glycosidic cleavages.    
The investigations presented thus far on glycopeptide fragmentation have pertained to 
glycopeptide cations; however, the fragmentation of glycopeptide anions with IRMPD 
has yet to be examined.  In addition, while ECD is only applicable towards multiply 
charged positive ions, electron detachment dissociation (EDD) is only possible with 
polyanionic species.  EDD has been shown to cleave the peptide backbone while 
retaining post-translational modifications such as tyrosine phosphorylation and 
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sulfation.8-10  Since many peptides contain acidic residues, EDD would be a useful 
fragmentation technique.  In addition, many glycopeptides contain acidic saccharides, 
such as sialic acid and sulfated residues.  For these reasons, the fragmentation behavior of 
glycopeptide anions with IRMPD and EDD is explored here.  A xylose type and high-
mannose type glycopeptide from model glycoproteins, a lectin from Erythrina cristagalli 
and ribonuclease B, are examined. 
 
A.2 Experimental 
 Approximately 1.25 nmols of ribonuclease B and lectin from Erythrina cristagalli 
(Sigma, St. Louis, MO) were used for enzymatic digestion.  Ribonuclease B was digested  
(after reduction and alkylation) with GluC (Roche Applied Science, Indianapolis, IN) for 
either 6 hours (1:20 GluC:protein w/w) or for 13 hours (1:100) at 25°C.  The lectin was 
digested with trypsin (Princeton Separations, Adelphia, NJ) at 37°C for 15 hours (1:30).  
Digests were desalted with C18 ZipTips (Millipore, Billerica, MA) and diluted to 10-5 M 
in 1:1 water:isopropanol (Fisher, Fair Lawn, NJ) with 20 mM tripropylamine (Acros 
Organics, Morris Plains, NJ).   
 Samples were electrosprayed (60 μL/h) into a 7.0 Tesla Fourier transform ion 
cyclotron resonance mass spectrometer (APEX-Q, Bruker Daltonics, Billerica, MA).  
Glycopeptide precursor ions were isolated using the quadrupole and externally 
accumulated, followed by injection and dynamic trapping in a cylindrical ICR cell.  EDD 
(17-18 eV electrons) was performed with an indirectly heated hollow dispenser cathode 
(Heat Wave, Watsonville, CA) with irradiation times ranging from 0.75 - 1.0 seconds.  
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IRMPD was performed with a 25 W CO2 laser (Synrad, Mukilteo, WA) at 30% power 
with 90 ms irradiation. 
 
A.3 Results and Discussion 
A.3.1 IRMPD and EDD of a Xylose Type Glycopeptide 
 Following a trypsin digestion, a xylose type glycopeptide from the lectin 
Erythrina cristagalli was examined with both IRMPD and EDD.  This lectin was chosen 
as a model glycoprotein because the N-linked oligosaccharides11 and amino acid 
sequence12 of this protein have been previously characterized.  In addition, the IRMPD 
and ECD fragmentation behavior of this glycopeptide were examined in Chapter 3.  The 
IRMPD mass spectrum of a doubly deprotonated xylose type glycopeptide is shown in 
Figure A.1 along with its structure.  The most abundant product ion observed following 
IRMPD is the loss of the entire glycan (labeled as [M - glycan]-).  The majority of other 
product ions correspond to peptide backbone cleavage, including several b- and y-type 
ions.  In some cases, the glycan portion remains attached to these ions (indicated with the 
label [b/y + g]).  However, in many cases the glycan portion has been lost (indicated with 
the label [b/y - g]).  Neutral molecule losses, such as loss of H2O and NH3, as well as 
internal fragmentation product ions (indicated by [i] and [iN]) are also observed.  
Following IRMPD, several product ions due to cleavage within the glycan portion of the 
glycopeptide are also noted.  The intact glycan is observed at m/z 1186.  One of the most 
abundant product ions, at m/z 677, corresponds to a 2,4A3 cross-ring cleavage in an N-
acetylglucosamine residue (cleavage is indicated in Figure A.1).  A product ion at m/z 
545 corresponds to loss of xylose from this product ion.  In addition, C-type cleavage is 
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observed at m/z 635.  Unlike IRMPD of the cationic form (as shown in Chapter 3), 
IRMPD of this species results in a highly complicated mass spectrum. 
Figure A.1. IRMPD FT-ICR tandem mass spectrum (100 scans, 90 ms with 7.5 W) of a 
doubly deprotonated xylose type lectin glycopeptide at m/z 1499.  The top figure shows 
m/z 300-1,200 while the bottom shows 1,200 – 2,700.  The most abundant product ion 
corresponds to loss of the entire glycan (indicated as [M - g]-).  g is the abbreviation for 
glycan.  [i] indicates an internal fragment product ion without the asparagine to which the 
glycan is originally attached, whereas [iN] indicates an ion that contains this asparagine. 
(■=GlcNAc, ●=Man, ◄=Fuc, ◊=Xyl). 
 
 EDD of the same xylose type glycopeptide examined in Figure A.1 is shown in 
Figure A.2.  Following EDD, several product ions are observed in the upper m/z region.  
These product ions correspond to the charge reduced non-fragmented species (at m/z 
2997), as well as several ions due to the loss of mannose, fucose, xylose, and small 
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molecules from the charge reduced species.  Unlike ECD of glycopeptides, EDD of this 
glycopeptide anion resulted in exclusively glycan cleavage.  These EDD results 
contradict those which have been observed for sulfated and phosphorylated peptides, 
where the post-translational modification was retained following fragmentation.  
Although the EDD mechanism remains highly debated, cleavages are postulated to occur 
at or near sites of negative charge or charge solvation for peptides.9  The xylose type 
glycopeptide examined in Figure A.2 does not contain acidic residues such as aspartic or 
glutamic acid.  Exclusive glycan cleavage following EDD may be due to deprotonation 
being localized within the glycan portion of the molecule. 
 
Figure A.2. EDD FT-ICR tandem mass spectrum (64 scans, 750 ms with a bias voltage 
of -18 V) of a doubly deprotonated xylose type lectin glycopeptide at m/z 1499.  The 
most abundant product ion corresponds to the charge reduced non-fragmented radical 
species, indicated by [M – 2H]-•.  Other product ions include loss of mannose, fucose, 
xylose, and small molecules from the charge reduced species.  No peptide backbone 





A.3.2 EDD of a High-Mannose Type Glycopeptide 
 The EDD fragmentation behavior of another glycopeptide, a high-mannose type 
glycopeptide from ribonuclease B, was also examined.  ECD of high-mannose type 
glycopeptides (examined in Chapter 3) results in extensive peptide backbone cleavages.  
EDD was performed on a GluC digest glycopeptide from ribonuclease B, with a 
molecular weight of 5919 Da.  The EDD spectrum of this glycopeptide, as well as the 
glycopeptide structure is shown in Figure A.3.  Following EDD, several product ions are 
observed in the upper m/z region.  The most abundant product ion, at m/z 2,959, 
corresponds to the charge reduced non-fragmented radical species.  Several product ions 
due to glycan cleavages, as well as small molecule losses, are also observed.  Glycan 
cleavages include the loss of mannose and an X-type sugar cross-ring cleavage.  Several 
small molecule losses are also denoted in Figure A.3, including the loss of 31 Da (which 
could correspond to the loss of CH3O), loss of 45 Da (which could correspond to the loss 
of C2H5O), and loss of C2H4ONS (presumably from carboxyamidomethylation of 
cysteine).  These results are similar to those for EDD of a xylose type glycopeptide.  
However, unlike the previously examined xylose-type glycopeptide, this high-mannose 
type glycopeptide contains several acidic residues (2 aspartic acids and 1 glutamic acid).  
This peptide acidity implies deprotonation sites should be along the peptide backbone and 
not within the glycan. 
 
A.4 Conclusions 
 Here, it is shown that IRMPD of a xylose type glycopeptide anion results in a 
highly complicated fragmentation pattern, with a mixture of both glycan and peptide  
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Figure A.3. EDD FT-ICR tandem mass spectrum (100 scans, 1 s with 18 eV electrons) of 
a triply deprotonated high-mannose type ribonuclease B glycopeptide at m/z 1973.  The 
most abundant product ion corresponds to the charge reduced non-fragmented radical 
species, indicated by [M – 3H]2-•.  Other product ions include loss of mannose, as well as 
several neutral molecule losses.  These products include the loss of 31 Da (which could 
correspond to the loss of CH3O), loss of 45 Da (which could correspond to the loss of 
C2H5O), and loss of C2H4ONS (presumably from carboxyamidomethylation of cysteine).   
 
backbone cleavage.  In addition, several internal fragments and neutral molecule losses 
are observed.  In general, negative ion mode tandem mass spectrometry of peptides and 
proteins is rarely used for obtaining structural information,13 one reason being that CAD 
(and vibrational excitation techniques in general) of deprotonated peptides often result in 
relatively complex fragmentation patterns.  Figure A.1 demonstrates that this same trend 
is also observed following glycopeptide fragmentation.   
 Figures A.2 and A.3 show that EDD of glycopeptides results in glycan cleavage 
and small molecule losses.  Unlike EDD of phosphorylated and sulfated peptides, the 
post-translational modification is cleaved during the fragmentation process.  For the 
xylose type glycopeptide, it was hypothesized that since there are no acidic residues 
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located within the glycopeptide, deprotonation within the glycan portion of the molecule 
may explain why glycan cleavage is observed following EDD.  However, for the high-
mannose type glycopeptide, several acidic residues are located within the peptide.  It is 
unclear how the location of deprotonation sites affects EDD fragmentation behavior, 
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Collision Activated Dissociation and Electron Detachment Dissociation 
of a Chloride Adducted Oligosaccharide 
 
B.1 Introduction 
 Chapter 5 explores the fragmentation behavior of oligosaccharides in negative ion 
mode mass spectrometry, with collision activated dissociation (CAD), infrared 
multiphoton dissociation (IRMPD), and electron detachment dissociation (EDD).  Our 
results demonstrate that EDD of both neutral and sialylated oligosaccharides provides 
structural information that is complementary to that obtained from both CAD and 
IRMPD.  In all cases, EDD resulted in additional cross-ring cleavages.  In most cases, 
cross-ring fragmentation obtained via EDD is more extensive than that obtained from 
IRMPD or CAD.     
 Chapter 5 examines the fragmentation behavior of singly and doubly-
deprotonated oligosaccharide species.  As an alternative to deprotonated species, Cole 
and co-workers have introduced a promising negative ion method for the analysis of 
neutral and acidic oligosaccharides utilizing anion attachment.1-3  It has been extensively 
demonstrated that certain metal ions can aid the ionization of oligosaccharides via metal 
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adduction, and often provide more informative fragmentation mass spectra (as discussed 
in Chapter 4).  However, there are very few reports on the effects upon oligosaccharide 
fragmentation with anion attachment in negative ion mode mass spectrometry.  In 2005, 
Cole and co-workers examined the CAD fragmentation of singly deprotonated 
disaccharides along with their fluoride, acetate, and chloride adducted counterparts.3  
Although CAD fragmentation patterns for all species were similar, chloride adducts 
provided greater precursor ion signal than the singly deprotonated species.  This signal 
enhancement indicates their potential for improving the ionization of neutral 
oligosaccharides.  In addition, the fragmentation behavior of chloride adducted 
stereoisomers was examined.  The ratio of chloride ions to non-chloride CAD product 
ions indicated their potential for differentiating the anomeric configuration of the 
glycosidic oxygen. 
 Here, the fragmentation behavior of a chloride adducted linear oligosaccharide, 
maltoheptoase, is examined.  The CAD and EDD fragmentation patterns of the [M + Cl -
H]2- and [M + 2Cl]2- species are explored.  CAD and EDD fragmentation patterns of 
chloride-adducted species are compared to the corresponding [M - 2H]2- species, as 
shown in Chapter 5.  Unlike the previous study performed by Cole and co-workers, a 
larger oligosaccharide (7 monosaccharide residues) is examined here.  Furthermore, this 
work constitutes the first examination of an anion adducted oligosaccharide with EDD. 
 
B.2 Experimental 
B.2.1 Sample Preparation 
 Maltoheptaose (Sigma, St. Louis, MO) was prepared in a solution of 50% 
 178
methanol (Fisher, Fair Lawn, NJ) and 20 μM ammonium chloride (Sigma) to a final 
concentration of 5 μM.  
B.2.2 FT-ICR Mass Spectrometry 
 All experiments were performed with an actively shielded 7 T Fourier transform 
ion cyclotron resonance (FT-ICR) mass spectrometer with a quadrupole front-end 
(APEX-Q, Bruker Daltonics, Billerica, MA), as previously described.4  Samples were 
infused via an Apollo II ion source at a flow rate of 60 μL/h with the assistance of N2 
nebulizing gas.  Ions were mass selectively accumulated with a quadrupole, transferred 
through high-voltage ion optics and captured with dynamic trapping in an Infinity ICR 
cell.5  External CAD was performed in a hexapole following mass selective ion 
accumulation with argon as a collision gas.  An indirectly heated hollow dispenser 
cathode was used to perform EDD.6  For EDD, the cathode heating current was kept 
constant at 2.0 A and the cathode voltage was pulsed during the EDD event to a bias 
voltage of (- 20) - (- 30 ) V for 3 - 5 s.  A lens electrode located immediately in front of 
the cathode was kept 0.8 V higher than the cathode bias voltage.    
 
B.3 Results and Discussion 
B.3.1 CAD and EDD of [M + Cl - H]2- 
 The CAD fragmentation of singly deprotonated, chloride adducted maltoheptaose, 
[M + Cl - H]2-, is shown in Figure B.1.  Following CAD, several glycosidic and cross-
ring cleavages are observed.  Due to the symmetric nature of maltoheptaose, a number of 
ions cannot be distinguished based on their m/z ratios (C and Y, and several A and X 
ions).  However, native neutral oligosaccharide anions that are 1-4 or 1-6 linked have 
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been shown to produce predominantly C-type and A-type ions during CAD.7-11  
Following CAD of [M + Cl - H]2-, several glycosidic and cross-ring cleavages (0,2A- and 
2,4A-type) are observed.  Product ions consist of both singly charged and doubly charged 
species.  Singly charged species are either deprotonated (indicated by H in the labels) or 
contain a chloride ion (indicated by Cl in the labels).   
 Upon CAD, there are several potential decomposition pathways.  Cole and co-
workers have previously examined the fragmentation behavior of a chloride adducted 
disaccharide.  They proposed that upon CAD there are two predominant fragmentation 
pathways 1) loss of chloride or 2) loss of HCl and subsequent fragmentation.  In the 
example presented here, because the oligosaccharide is both deprotonated and chloride 
adducted, the fragmentation behavior is slightly more complex.  The presence of doubly 
charged product ions, due to a chloride adduct and deprotonation site (indicated by * in 
Figure B.1), indicate that direct decomposition of the oligosaccharide is one observed 
fragmentation pathway.  Singly charged chloride adducted product ions also confirm 
retention of a chloride ion, perhaps due to direct decomposition of the precursor.  Singly 
charged, deprotonated, product ions may arise via two pathways.  These product ions 
may be simply due to direct decomposition of the precursor ion.  Alternatively, these 
product ions may be due to loss of HCl and subsequent fragmentation.  The presence of 
an ion at m/z 575, which is assigned as [M - 2H]2-, confirms that some loss of HCl does 
occur upon CAD.  The ion at m/z 1151, assigned as [M - H]-, indicates that loss of 
chloride is also observed.  Overall, the CAD fragmentation pattern of [M + Cl - H]2- is 
similar to that of [M -2H]2- (shown in Chapter 5).  Several glycosidic and cross-ring 
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cleavages are observed, all of which are also observed from CAD of doubly deprotonated 
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Figure B.1. CAD FT-ICR (30 scans, collision cell voltage 6V) tandem mass spectrum of 
deprotonated, chloride adducted maltoheptaose.  Doubly charged product ions, due to 
deprotonation and chloride adduction, are indicated with an asterisk.  Singly charged 
product ions due to deprotonation are indicated with “H” in the labels, while those 
containing chloride are indicated by “Cl”.  Squares indicate water loss from an adjacent 
product ion.  ν3 indicates a harmonic.   
 
 EDD of the [M + Cl - H]2- species of maltoheptaose is shown in Figure B.2.  
Following EDD, only singly charged product ions are observed.  These ions are a mixture 
of both deprotonated and chloride adducted product ions, similar to the CAD spectrum in 
Figure B.1.  A [M - 2H]-• (at m/z 1150) ion is observed following EDD, indicating the 
loss of HCl and an electron (or due to loss of a chloride and a hydrogen).  The ion [M + 
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Cl – H – CH3O]- • at m/z 1155 is also observed.  Loss of CH3O from the charge reduced 
species was also noted following EDD of sialylated oligosaccharides in Chapter 5.   
 In Figure B.2, product ions consist of a mixture of both glycosidic and cross-ring 
fragments.  Glycosidic cleavages are more extensive following EDD than following CAD 
(shown previously in Figure B.1).  Both C-type (or Y) type cleavages and B-type (or Z) 
type cleavages are observed.  Several additional cross-ring cleavages are seen following 
EDD, which are not observed following CAD of this same species.  In particular, two X-
type cross-ring cleavages are observed (1,5X5 and 1,5X4).  EDD of doubly deprotonated 
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Figure B.2. EDD FT-ICR (30 scans, 3 sec with a bias voltage - 20 eV) tandem mass 
spectrum of deprotonated, chloride adducted maltoheptaose.  Singly charged product ions 
due to deprotonation are indicated with “H” in the labels, while those containing chloride 
are indicated by “Cl”.  Squares indicate water loss from an adjacent product ion.  ν3 
indicates a harmonic.   
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X-type cross-ring cleavages (see Chapter 5).  However, following EDD of the doubly 
deprotonated species, 0,2A and 2,4A-type cleavages are typically more abundant than other 
types of cross-ring fragmentation.  Here, X-type product ions observed following EDD of 
[M + Cl - H]2- are more abundant than the A-type product ions.  These results indicate 
that the formation of X-type product ions is a preferred fragmentation pathway.  Also 
observed in Figure B.2 are product ions due to hydrogen losses and loss of 15.99 Da from 
C-type ions.  These same types of product ions were reported following EDD of doubly 
deprotonated maltoheptaose and discussed in Chapter 5.  
B.3.2 CAD and EDD of [M + 2Cl]2- 
 The CAD fragmentation behavior of the [M + Cl]2- species of maltoheptaose was 
examined and is shown in Figure B.3.  Following CAD, both singly and doubly charged 
product ions are observed.  Doubly charged product ions due to both chloride adduction 
and deprotonation are formed via loss of HCl from the precursor (indicated by * in Figure 
B.3).  Doubly charged product ions from the loss of two protons are the result of the loss 
of two HCl molecules.  No product ions are observed which contain two chloride ions.  
Several singly charged product ions are also observed, including [M + Cl]- at m/z 1187 
and [M - H]- at m/z 1151.  The former ion is due to loss of a chloride from the precursor, 
while the latter is due to loss of chloride and HCl.  Other singly charged product ions 
observed following CAD predominantly consist of singly deprotonated species (indicated 
by H in the label).  However, two chloride adducted C-type ions are also detected 
(indicated by Cl in the label).  Overall, the fragmentation behavior of the [M + 2Cl]2- 
maltoheptaose species is very similar to the doubly deprotonated species (as shown in 
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Chapter 5), and results in a mixture of glycosidic (C-type) and cross-ring cleavages (0,2A 
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Figure B.3. CAD FT-ICR (30 scans, collision cell voltage 8V) tandem mass spectrum of 
maltoheptaose adducted with two chloride ions.  Doubly charged product ions due to 
deprotonation and chloride adduction, are indicated with an asterisk.  Singly charged 
product ions due to deprotonation are indicated with “H” in the labels, while those 
containing chloride are indicated by “Cl”.  Squares indicate water loss from an adjacent 
product ion.  ν3 indicates a harmonic.   
  
 The EDD fragmentation behavior of the [M + Cl]2- species of maltoheptaose was 
examined and is shown in Figure B.4.  Almost all product ions observed following EDD 
are singly charged, and are either singly deprotonated or contain a chloride ion.  
However, two doubly charged product ions are observed, [M - 2H]2- and [M]* (the latter 
has both a deprotonation site and a chloride ion adduct).  Doubly charged product ions 
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Figure B.4. EDD FT-ICR (30 scans, 5 s with a bias voltage of - 30 eV) tandem mass 
spectrum of maltoheptaose adducted with two chloride ions.  Doubly charged product 
ions due to deprotonation and chloride adduction are indicated with an asterisk.  Singly 
charged product ions due to deprotonation are indicated with “H” in the labels, while 
those containing chloride are indicated by “Cl”.  Squares indicate water loss from an 
adjacent product ion.  ν3 indicates a harmonic. 
 
 
process.  These same ions are also observed following CAD, implying they are due to 
vibrational excitation.  Both glycosidic and cross-ring cleavages are observed following 
EDD of this oligosaccharide.  Glycosidic cleavage is more extensive compared to CAD 
of this same species (shown in Figure B.3).   A mixture of A- type and X-type product 
ions are also observed.  Similar to EDD of [M + Cl - H]2-, the X-type product ions (1,5X4 
and 1,5X5) are more abundant than A-type product ions.  This higher abundance further 
indicates that the formation of X-type ions is a preferred fragmentation pathway for 
chloride adducted species.  Similar to EDD of doubly deprotonated maltoheptaose and 
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the [M + Cl - H]2- species, hydrogen losses and losses of 15.99 Da are observed for 
several C-type ions. 
B.4 Conclusions 
 The fragmentation behavior of the [M + Cl - H]2- and [M + 2Cl]2- forms of 
maltoheptaose were examined.  The CAD fragmentation patterns of these ions are similar 
to the corresponding doubly deprotonated species.  EDD of chloride adducted 
maltoheptaose results in a mixture of glycosidic and cross-ring fragmentation.  For both 
species examined, cross-ring fragmentation is less extensive compared to EDD of the 
doubly deprotonated species.  However, our results indicate that X-type ions are 
preferentially formed over A-type ions following EDD of chloride adducted 
maltoheptaose.  This behavior contrasts with data shown in Chapter 5, where 0,2A and 
2,4A-type ions were the most abundant cross-ring cleavages observed.  To determine if 
this cleavage preference is generally true for chloride adducted oligosaccharides, further 
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